1
|
Llorca-Bofí V, Madero S, Amoretti S, Cuesta MJ, Moreno C, González-Pinto A, Bergé D, Rodriguez-Jimenez R, Roldán A, García-León MÁ, Ibáñez A, Usall J, Contreras F, Mezquida G, García-Rizo C, Berrocoso E, Bernardo M, Bioque M. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia. Schizophr Res 2024; 267:24-31. [PMID: 38513331 DOI: 10.1016/j.schres.2024.03.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Revised: 02/19/2024] [Accepted: 03/14/2024] [Indexed: 03/23/2024]
Abstract
BACKGROUND The clinical course following a first episode of schizophrenia (FES) is often characterized by recurrent relapses, resulting in unfavorable clinical and functional outcomes. Inflammatory dysregulation has been implicated in relapse risk; however, the predictive value of inflammatory blood cells in clinically remitted patients after a FES has not been previously explored. METHODS In this study, we closely monitored 111 patients in remission after a FES until relapse or a three-year follow-up endpoint. The participants were recruited from the multicenter 2EPS Project. Data on inflammatory blood cells and ratios were collected at baseline and at the time of relapse or after three years of follow-up. RESULTS Monocyte counts (OR = 1.91; 95 % CI = 1.07-3.18; p = 0.009) and basophil counts (OR = 1.09; 95 % CI = 1.01-1.12; p = 0.005) at baseline were associated with an increased risk of relapse, while the platelet-lymphocyte ratio (OR = 0.98; 95 % CI = 0.97-0.99; p = 0.019) was identified as a protective factor. However, after adjusting for cannabis and tobacco use during the follow-up, only monocyte counts (OR = 1.73; 95 % CI = 1.03-2.29; p = 0.027) and basophil counts (OR = 1.08; 95 % CI = 1.01-1.14; p = 0.008) remained statistically significant. ROC curve analysis indicated that the optimal cut-off values for discriminating relapsers were 0.52 × 10^9/L (AUC: 0.66) for monocytes and 0.025 × 10^9/L (AUC: 0.75) for basophils. When considering baseline inflammatory levels, no significant differences were observed in the inflammatory biomarkers at the endpoint between relapsers and non-relapsers. CONCLUSION This study provides evidence that higher monocyte and basophil counts measured at remission after a FES are associated with an increased risk of relapse during a three-year follow-up period.
Collapse
Affiliation(s)
- Vicent Llorca-Bofí
- Department of Medicine, University of Barcelona, Barcelona, Spain; Department of Psychiatry, Santa Maria University Hospital Lleida, Lleida, Spain; Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain
| | - Santiago Madero
- Department of Medicine, University of Barcelona, Barcelona, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.
| | - Silvia Amoretti
- Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic of Barcelona, Spain; Bipolar and Depressive Disorder Unit, Neuroscience Institute, Hospital Clínic de Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) Instituto de Salud Carlos III, Spain; Group of Psychiatry, Mental Health and Addictions, Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Spain; University of Barcelona, Spain.
| | - Manuel J Cuesta
- Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
| | - Carmen Moreno
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.
| | - Ana González-Pinto
- Bioaraba, Alava University Hospital, UPV/EHU, Vitoria, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain.
| | - Dani Bergé
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain; Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.
| | - Roberto Rodriguez-Jimenez
- Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; CIBERSAM (Biomedical Research Networking Centre in Mental Health), Spain; Universidad Complutense de Madrid (UCM), Madrid, Spain
| | - Alexandra Roldán
- Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, IIB-SANT PAU, Barcelona, Spain; CIBERSAM, ISCIII, Spain.
| | - María Ángeles García-León
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
| | - Angela Ibáñez
- Department of Psychiatry, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid, Spain; Centro de Investigación Biomédica en red en salud Mental (CIBERSAM), ISCIII, Madrid, Spain
| | - Judith Usall
- Research Institute Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain.
| | - Fernando Contreras
- Psychiatric Service, Bellvitge Universitari Hospital, IDIBELL, CIBERSAM, Spain.
| | - Gisela Mezquida
- University of Barcelona, Spain; Barcelona Clinic Schizophrenia Unit, Hospital Clínic of Barcelona, Neuroscience Institute, Spain; Institut d'Investigacions Biomèdiques, August Pi i Sunyer, Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Instituto de Salud Carlos III, Spain.
| | - Clemente García-Rizo
- Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain.
| | - Esther Berrocoso
- Neuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, University of Cádiz, Cádiz, Spain; Instituto de Investigación e Innovación Biomédica de Cádiz, INiBICA, Hospital Universitario Puerta del Mar, Cádiz, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
| | - Miquel Bernardo
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic, Departament de Medicina, Institut de Neurociències (UBNeuro), Universitat de Barcelona (UB), Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), CIBERSAM, ISCIII, Barcelona, Spain.
| | - Miquel Bioque
- Department of Medicine, University of Barcelona, Barcelona, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en red en salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Spain.
| |
Collapse
|
2
|
Razavi-Shearer D, Gamkrelidze I, Pan C, Jia J, Berg T, Gray R, Lim YS, Chen CJ, Ocama P, Desalegn H, Abbas Z, Abdallah A, Aghemo A, Ahmadbekova S, Ahn SH, Aho I, Akarca U, Al Masri N, Alalwan A, Alavian S, Al-Busafi S, Aleman S, Alfaleh F, Alghamdi A, Al-Hamoudi W, Aljumah A, Al-Naamani K, Al-Rifai A, Alserkal Y, Altraif I, Amarsanaa J, Anderson M, Andersson M, Armstrong P, Asselah T, Athanasakis K, Baatarkhuu O, Ben-Ari Z, Bensalem A, Bessone F, Biondi M, Bizri AR, Blach S, Braga W, Brandão-Mello C, Brosgart C, Brown K, Brown, Jr R, Bruggmann P, Brunetto M, Buti M, Cabezas J, Casanovas T, Chae C, Chan HLY, Cheinquer H, Chen PJ, Cheng KJ, Cheon ME, Chien CH, Choudhuri G, Christensen PB, Chuang WL, Chulanov V, Cisneros L, Coffin C, Contreras F, Coppola N, Cornberg M, Cowie B, Cramp M, Craxi A, Crespo J, Cui F, Cunningham C, Dalgard O, De Knegt R, De Ledinghen V, Dore G, Drazilova S, Duberg AS, Egeonu S, Elbadri M, El-Kassas M, El-Sayed M, Estes C, Etzion O, Farag E, Ferradini L, Ferreira P, Flisiak R, Forns X, Frankova S, Fung J, Gane E, Garcia V, García-Samaniego J, Gemilyan M, Genov J, Gheorghe L, Gholam P, Gish R, Goleij P, Gottfredsson M, Grebely J, Gschwantler M, Guingane NA, Hajarizadeh B, Hamid S, Hamoudi W, Harris A, Hasan I, Hatzakis A, Hellard M, Hercun J, Hernandez J, Hockicková I, Hsu YC, Hu CC, Husa P, Janicko M, Janjua N, Jarcuska P, Jaroszewicz J, Jelev D, Jeruma A, Johannessen A, Kåberg M, Kaita K, Kaliaskarova K, Kao JH, Kelly-Hanku A, Khamis F, Khan A, Kheir O, Khoudri I, Kondili L, Konysbekova A, Kristian P, Kwon J, Lagging M, Laleman W, Lampertico P, Lavanchy D, Lázaro P, Lazarus JV, Lee A, Lee MH, Liakina V, Lukšić B, Malekzadeh R, Malu A, Marinho R, Mendes-Correa MC, Merat S, Meshesha BR, Midgard H, Mohamed R, Mokhbat J, Mooneyhan E, Moreno C, Mortgat L, Müllhaupt B, Musabaev E, Muyldermans G, Naveira M, Negro F, Nersesov A, Nguyen VTT, Ning Q, Njouom R, Ntagirabiri R, Nurmatov Z, Oguche S, Omuemu C, Ong J, Opare-Sem O, Örmeci N, Orrego M, Osiowy C, Papatheodoridis G, Peck-Radosavljevic M, Pessoa M, Pham T, Phillips R, Pimenov N, Pincay-Rodríguez L, Plaseska-Karanfilska D, Pop C, Poustchi H, Prabdial-Sing N, Qureshi H, Ramji A, Rautiainen H, Razavi-Shearer K, Remak W, Ribeiro S, Ridruejo E, Ríos-Hincapié C, Robalino M, Roberts L, Roberts S, Rodríguez M, Roulot D, Rwegasha J, Ryder S, Sadirova S, Saeed U, Safadi R, Sagalova O, Said S, Salupere R, Sanai F, Sanchez-Avila JF, Saraswat V, Sargsyants N, Sarrazin C, Sarybayeva G, Schréter I, Seguin-Devaux C, Seto WK, Shah S, Sharara A, Sheikh M, Shouval D, Sievert W, Simojoki K, Simonova M, Sinn DH, Sonderup M, Sonneveld M, Spearman CW, Sperl J, Stauber R, Stedman C, Sypsa V, Tacke F, Tan SS, Tanaka J, Tergast T, Terrault N, Thompson A, Thompson P, Tolmane I, Tomasiewicz K, Tsang TY, Uzochukwu B, Van Welzen B, Vanwolleghem T, Vince A, Voeller A, Waheed Y, Waked I, Wallace J, Wang C, Weis N, Wong G, Wong V, Wu JC, Yaghi C, Yesmembetov K, Yip T, Yosry A, Yu ML, Yuen MF, Yurdaydin C, Zeuzem S, Zuckerman E, Razavi H. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol 2023; 8:879-907. [PMID: 37517414 DOI: 10.1016/s2468-1253(23)00197-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Revised: 06/25/2023] [Accepted: 06/27/2023] [Indexed: 08/01/2023]
Abstract
BACKGROUND The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV) infection as a public health threat by 2030; existing therapies and prophylaxis measures make such elimination feasible, even in the absence of a virological cure. We aimed to estimate the national, regional, and global prevalence of HBV in the general population and among children aged 5 years and younger, as well as the rates of diagnosis, treatment, prophylaxis, and the future burden globally. METHODS In this modelling study, we used a Delphi process with data from literature reviews and interviews with country experts to quantify the prevalence, diagnosis, treatment, and prevention measures for HBV infection. The PRoGReSs Model, a dynamic Markov model, was used to estimate the country, regional, and global prevalence of HBV infection in 2022, and the effects of treatment and prevention on disease burden. The future incidence of morbidity and mortality in the absence of additional interventions was also estimated at the global level. FINDINGS We developed models for 170 countries which resulted in an estimated global prevalence of HBV infection in 2022 of 3·2% (95% uncertainty interval 2·7-4·0), corresponding to 257·5 million (216·6-316·4) individuals positive for HBsAg. Of these individuals, 36·0 million were diagnosed, and only 6·8 million of the estimated 83·3 million eligible for treatment were on treatment. The prevalence among children aged 5 years or younger was estimated to be 0·7% (0·6-1·0), corresponding to 5·6 million (4·5-7·8) children with HBV infection. Based on the most recent data, 85% of infants received three-dose HBV vaccination before 1 year of age, 46% had received a timely birth dose of vaccine, and 14% received hepatitis B immunoglobulin along with the full vaccination regimen. 3% of mothers with a high HBV viral load received antiviral treatment to reduce mother-to-child transmission. INTERPRETATION As 2030 approaches, the elimination targets remain out of reach for many countries under the current frameworks. Although prevention measures have had the most success, there is a need to increase these efforts and to increase diagnosis and treatment to work towards the elimination goals. FUNDING John C Martin Foundation, Gilead Sciences, and EndHep2030.
Collapse
|
3
|
Ospina AV, Brugés R, Triana I, Sánchez-Vanegas G, Barrero A, Mantilla W, Ramos P, Bernal L, Aruachán S, González M, Lobatón J, Quiroga A, Rivas G, González G, Lombana M, Munevar I, Jiménez P, Avendaño AC, Arias MC, López C, González H, Pacheco J, Manneh R, Pinilla P, Russi A, Ortiz J, Insuasty J, Alcalá C, Contreras F, Bogoya J. Impact of vaccination against COVID-19 on patients with cancer in ACHOC-C19 study: Real world evidence from one Latin American country. J Cancer 2023; 14:2410-2416. [PMID: 37670962 PMCID: PMC10475356 DOI: 10.7150/jca.79969] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Accepted: 05/27/2023] [Indexed: 09/07/2023] Open
Abstract
Introduction: During the pandemic, it has been recommended that vaccination against COVID-19 be a priority for patients with cancer; however, these patients were not included in the initial studies evaluating the available vaccines. Objective: To define the impact of vaccination against COVID-19 in preventing the risk of complications associated with the infection in a cohort of patients with cancer in Colombia. Methods: An analytical observational cohort study, based on national registry of patients with cancer and COVID 19 infection ACHOC-C19, was done. The data was collected from June 2021, until October 2021. Inclusion criteria were: Patients older than 18 years with cancer diagnosis and confirmed COVID-19 infection. Data from the unvaccinated and vaccinated cohorts were compared. Outcomes evaluated included all-cause mortality within 30 days of COVID-19 diagnosis, hospitalization, and need for mechanical ventilation. The estimation of the effect was made through the relative risk (RR), the absolute risk reduction (ARR) and the number needed to treat (NNT). Multivariate analysis was performed using generalized linear models. Results: 896 patients were included, of whom 470 were older than 60 years (52.4%) and 59% were women (n=530). 172 patients were recruited in the vaccinated cohort and 724 in the non-vaccinated cohort (ratio: 1 to 4.2). The cumulative incidence of clinical outcomes among the unvaccinated vs vaccinated patients were: for hospitalization 42% (95% CI: 38.7%-46.1%) vs 29%; (95% CI: 22.4%-36.5%); for invasive mechanical ventilation requirement 8.4% (n=61) vs 4.6% (n=8) and for mortality from all causes 17% (n=123) vs 4.65% (n=8). Conclusion: In our population, unvaccinated patients with cancer have an increased risk of complications for COVID -19 infection, as hospitalization, mechanical ventilation, and mortality. It is highly recommended to actively promote the vaccination among this population.
Collapse
Affiliation(s)
- Aylen Vanessa Ospina
- ICCAL Fundación Santa Fe de Bogotá. Asociación Colombiana de Hematología y Oncología - ACHO
| | - Ricardo Brugés
- Instituto Nacional de Cancerología - Pontificia Universidad Javeriana
| | - Iván Triana
- ICCAL Fundación Santa Fe de Bogotá. Asociación Colombiana de Hematología y Oncología - ACHO
| | | | - Angela Barrero
- Asociación Colombiana de Hematología y Oncología - ACHO. Instituto Nacional Cancerología
| | - William Mantilla
- Fundación Cardio infantil, Universidad del Rosario, Grupo ICAROS
| | | | - Laura Bernal
- Clínica Universitaria Colombia Sanitas - Clínica Marly
| | | | | | | | | | | | | | | | - Isabel Munevar
- Hospital Militar Central, Fundación Cardioinfantil. Hemato Oncólogos Asociados
| | - Paola Jiménez
- Hospital Militar Central, Hemato Oncólogos Asociados
| | | | | | | | | | | | - Ray Manneh
- Sociedad de Oncología y Hematología del Cesar
| | | | | | | | - Jesús Insuasty
- Hospital Universitario de Santander - Universidad Industrial de Santander
| | | | | | | |
Collapse
|
4
|
Ospina Serrano AV, Contreras F, Triana I, Sánchez-Vanegas G, Ortíz JD, Ramos P, Vargas C, Arango N, Idrobo H, Munévar I, Yepes A, Mantilla W, Jiménez P, Rivas G, Lema M, Alcalá C, Gómez D, Chinchia M, Barrero A. Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country: Results of the Epidemiological Registry of Malignant Melanoma in Colombia Study. JCO Glob Oncol 2023; 9:e2200377. [PMID: 37216624 PMCID: PMC10497268 DOI: 10.1200/go.22.00377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Revised: 02/13/2023] [Accepted: 03/13/2023] [Indexed: 05/24/2023] Open
Abstract
To describe the population with early malignant melanoma, we performed a cohort study on the basis of the Epidemiological Registry of Malignant Melanoma in Colombia-Asociacion Colombiana de Hematologia y Oncologia. From January 2011 until December 2021, 759 patients were included; the average age was 66 years, 57% were women, acral lentiginous histology was found in 27.8% of patients, and the median follow-up was 36.5 months. The prognostic factors for overall survival in our population are Eastern Cooperative Oncology Group 3-4 (hazard ratio [HR], 13.8), stage III (HR, 5.07), received radiotherapy (HR, 3.38), ulceration on histology (HR, 2.68), chronic sun exposure (HR, 2.3), low income (HR, 2.04), previous local surgery (HR, 0.27), and have received adjuvant treatment (HR, 0.41).
Collapse
Affiliation(s)
- Aylen Vanessa Ospina Serrano
- Asociación Colombiana de Hematología y Oncología—ACHO, ICCAL Hospital, Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - Fernando Contreras
- Instituto Nacional de Cancerología INC, Universidad El Bosque, Bogotá, Colombia
| | - Iván Triana
- Asociación Colombiana de Hematología y Oncología—ACHO, ICCAL Hospital, Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | | | | | - Pedro Ramos
- Clínica Universitaria Colombia Sanitas, Oncocare, Bogotá, Colombia
| | | | | | - Henry Idrobo
- Centro Médico Julián Coronel, Universidad del Valle, Cali, Colombia
| | - Isabel Munévar
- Hospital Militar Central, Fundación Cardio infantil, Hemato Oncólogos Asociados, Bogotá, Colombia
| | - Andrés Yepes
- Hospital Universitario San Vicente Fundación, Medellín, Colombia
| | - William Mantilla
- Fundación Cardio infantil, Universidad del Rosario, Grupo ICAROS, Bogotá, Colombia
| | - Paola Jiménez
- Hemato Oncólogos Asociados, Los Cobos Medical Center, Bogotá, Colombia
| | | | | | | | - Diego Gómez
- Fundación cardiovascular de Colombia, Hospital Internacional de Colombia, Bucaramanga, Colombia
| | | | - Angela Barrero
- Asociación Colombiana de Hematología y Oncología—ACHO, Bogota, Colombia
| |
Collapse
|
5
|
Martínez-Escudero CM, Garrido I, Ros C, Flores P, Hellín P, Contreras F, Fenoll J. Remediation of pesticides in commercial farm soils by solarization and ozonation techniques. J Environ Manage 2023; 329:117062. [PMID: 36549052 DOI: 10.1016/j.jenvman.2022.117062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Revised: 12/05/2022] [Accepted: 12/15/2022] [Indexed: 06/17/2023]
Abstract
Soil contamination by pesticides is a growing environmental problem. Even though nowadays numerous soil remediation technologies are available, most of them have not been tested at field scale. This study attempts to demonstrate the efficiency of solarization-ozonation techniques for the removal of twelve pesticides at full scale. Initial solarization and ozonation trials were conducted in plots located in a greenhouse using freshly and aged contaminated soils under controlled pilot conditions. The combination of solarization and ozonation treatment was efficient for all the studied pesticides both in freshly and in aged contaminated soils, being the lower degradation values found for the second type. This low removal suggests that the increase of pesticides' adsorption on soil resulting from ageing decreases their availability. Once the essays were carried out at pilot scale, the solarization-ozonation applicability was evaluated in a commercial farm soil. This trial was carried out in a greenhouse whose soil had previously been contaminated with some of the pesticides studied. A significant degradation (53.8%) was observed after 40 days of treatment. Pesticides' main metabolites were identified during the different remediation experiments. In addition, the cost of the combined solarization and ozonation technology was evaluated. Finally, our results suggest that this combination of techniques could be considered a promising technology to degrade pesticides in soil.
Collapse
Affiliation(s)
- C M Martínez-Escudero
- Research Group on Sustainability and Quality of Fruit and Vegetable Production. Instituto Murciano de Investigación y Desarrollo Agrario y Medioambiental. C/ Mayor s/n. La Alberca, 30150, Murcia. Spain.
| | - I Garrido
- Research Group on Sustainability and Quality of Fruit and Vegetable Production. Instituto Murciano de Investigación y Desarrollo Agrario y Medioambiental. C/ Mayor s/n. La Alberca, 30150, Murcia. Spain
| | - C Ros
- Department of Crop Protection. Instituto Murciano de Investigación y Desarrollo Agrario y Medioambiental. C/ Mayor s/n. La Alberca, 30150, Murcia. Spain
| | - P Flores
- Research Group on Sustainability and Quality of Fruit and Vegetable Production. Instituto Murciano de Investigación y Desarrollo Agrario y Medioambiental. C/ Mayor s/n. La Alberca, 30150, Murcia. Spain
| | - P Hellín
- Research Group on Sustainability and Quality of Fruit and Vegetable Production. Instituto Murciano de Investigación y Desarrollo Agrario y Medioambiental. C/ Mayor s/n. La Alberca, 30150, Murcia. Spain
| | - F Contreras
- Research Group on Sustainability and Quality of Fruit and Vegetable Production. Instituto Murciano de Investigación y Desarrollo Agrario y Medioambiental. C/ Mayor s/n. La Alberca, 30150, Murcia. Spain
| | - J Fenoll
- Research Group on Sustainability and Quality of Fruit and Vegetable Production. Instituto Murciano de Investigación y Desarrollo Agrario y Medioambiental. C/ Mayor s/n. La Alberca, 30150, Murcia. Spain.
| |
Collapse
|
6
|
Abreu P, Aglietta M, Albury JM, Allekotte I, Almeida Cheminant K, Almela A, Aloisio R, Alvarez-Muñiz J, Alves Batista R, Ammerman Yebra J, Anastasi GA, Anchordoqui L, Andrada B, Andringa S, Aramo C, Araújo Ferreira PR, Arnone E, Arteaga Velázquez JC, Asorey H, Assis P, Avila G, Avocone E, Badescu AM, Bakalova A, Balaceanu A, Barbato F, Bellido JA, Berat C, Bertaina ME, Bhatta G, Biermann PL, Binet V, Bismark K, Bister T, Biteau J, Blazek J, Bleve C, Blümer J, Boháčová M, Boncioli D, Bonifazi C, Bonneau Arbeletche L, Borodai N, Botti AM, Brack J, Bretz T, Brichetto Orchera PG, Briechle FL, Buchholz P, Bueno A, Buitink S, Buscemi M, Büsken M, Caballero-Mora KS, Caccianiga L, Canfora F, Caracas I, Caruso R, Castellina A, Catalani F, Cataldi G, Cazon L, Cerda M, Chinellato JA, Chudoba J, Chytka L, Clay RW, Cobos Cerutti AC, Colalillo R, Coleman A, Coluccia MR, Conceição R, Condorelli A, Consolati G, Contreras F, Convenga F, Correia Dos Santos D, Covault CE, Dasso S, Daumiller K, Dawson BR, Day JA, de Almeida RM, de Jesús J, de Jong SJ, de Mello Neto JRT, De Mitri I, de Oliveira J, de Oliveira Franco D, de Palma F, de Souza V, De Vito E, Del Popolo A, Del Río M, Deligny O, Deval L, di Matteo A, Dobre M, Dobrigkeit C, D'Olivo JC, Domingues Mendes LM, Dos Anjos RC, Dova MT, Ebr J, Engel R, Epicoco I, Erdmann M, Escobar CO, Etchegoyen A, Falcke H, Farmer J, Farrar G, Fauth AC, Fazzini N, Feldbusch F, Fenu F, Fick B, Figueira JM, Filipčič A, Fitoussi T, Fodran T, Fujii T, Fuster A, Galea C, Galelli C, García B, Garcia Vegas AL, Gemmeke H, Gesualdi F, Gherghel-Lascu A, Ghia PL, Giaccari U, Giammarchi M, Glombitza J, Gobbi F, Gollan F, Golup G, Gómez Berisso M, Gómez Vitale PF, Gongora JP, González JM, González N, Goos I, Góra D, Gorgi A, Gottowik M, Grubb TD, Guarino F, Guedes GP, Guido E, Hahn S, Hamal P, Hampel MR, Hansen P, Harari D, Harvey VM, Haungs A, Hebbeker T, Heck D, Hill GC, Hojvat C, Hörandel JR, Horvath P, Hrabovský M, Huege T, Insolia A, Isar PG, Janecek P, Johnsen JA, Jurysek J, Kääpä A, Kampert KH, Keilhauer B, Khakurdikar A, Kizakke Covilakam VV, Klages HO, Kleifges M, Kleinfeller J, Knapp F, Kunka N, Lago BL, Langner N, Leigui de Oliveira MA, Lenok V, Letessier-Selvon A, Lhenry-Yvon I, Lo Presti D, Lopes L, López R, Lu L, Luce Q, Lundquist JP, Machado Payeras A, Mancarella G, Mandat D, Manning BC, Manshanden J, Mantsch P, Marafico S, Mariani FM, Mariazzi AG, Mariş IC, Marsella G, Martello D, Martinelli S, Martínez Bravo O, Mastrodicasa M, Mathes HJ, Matthews J, Matthiae G, Mayotte E, Mayotte S, Mazur PO, Medina-Tanco G, Melo D, Menshikov A, Michal S, Micheletti MI, Miramonti L, Mollerach S, Montanet F, Morejon L, Morello C, Mostafá M, Müller AL, Muller MA, Mulrey K, Mussa R, Muzio M, Namasaka WM, Nasr-Esfahani A, Nellen L, Nicora G, Niculescu-Oglinzanu M, Niechciol M, Nitz D, Norwood I, Nosek D, Novotny V, Nožka L, Nucita A, Núñez LA, Oliveira C, Palatka M, Pallotta J, Papenbreer P, Parente G, Parra A, Pawlowsky J, Pech M, Pękala J, Pelayo R, Peña-Rodriguez J, Pereira Martins EE, Perez Armand J, Pérez Bertolli C, Perrone L, Petrera S, Petrucci C, Pierog T, Pimenta M, Pirronello V, Platino M, Pont B, Pothast M, Privitera P, Prouza M, Puyleart A, Querchfeld S, Rautenberg J, Ravignani D, Reininghaus M, Ridky J, Riehn F, Risse M, Rizi V, Rodrigues de Carvalho W, Rodriguez Rojo J, Roncoroni MJ, Rossoni S, Roth M, Roulet E, Rovero AC, Ruehl P, Saftoiu A, Saharan M, Salamida F, Salazar H, Salina G, Sanabria Gomez JD, Sánchez F, Santos EM, Santos E, Sarazin F, Sarmento R, Sarmiento-Cano C, Sato R, Savina P, Schäfer CM, Scherini V, Schieler H, Schimassek M, Schimp M, Schlüter F, Schmidt D, Scholten O, Schoorlemmer H, Schovánek P, Schröder FG, Schulte J, Schulz T, Sciutto SJ, Scornavacche M, Segreto A, Sehgal S, Shellard RC, Sigl G, Silli G, Sima O, Smau R, Šmída R, Sommers P, Soriano JF, Squartini R, Stadelmaier M, Stanca D, Stanič S, Stasielak J, Stassi P, Streich A, Suárez-Durán M, Sudholz T, Suomijärvi T, Supanitsky AD, Szadkowski Z, Tapia A, Taricco C, Timmermans C, Tkachenko O, Tobiska P, Todero Peixoto CJ, Tomé B, Torrès Z, Travaini A, Travnicek P, Trimarelli C, Tueros M, Ulrich R, Unger M, Vaclavek L, Vacula M, Valdés Galicia JF, Valore L, Varela E, Vásquez-Ramírez A, Veberič D, Ventura C, Vergara Quispe ID, Verzi V, Vicha J, Vink J, Vorobiov S, Wahlberg H, Watanabe C, Watson AA, Weindl A, Wiencke L, Wilczyński H, Wittkowski D, Wundheiler B, Yushkov A, Zapparrata O, Zas E, Zavrtanik D, Zavrtanik M, Zehrer L. Limits to Gauge Coupling in the Dark Sector Set by the Nonobservation of Instanton-Induced Decay of Super-Heavy Dark Matter in the Pierre Auger Observatory Data. Phys Rev Lett 2023; 130:061001. [PMID: 36827568 DOI: 10.1103/physrevlett.130.061001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Revised: 11/30/2022] [Accepted: 12/14/2022] [Indexed: 06/18/2023]
Abstract
Instantons, which are nonperturbative solutions to Yang-Mills equations, provide a signal for the occurrence of quantum tunneling between distinct classes of vacua. They can give rise to decays of particles otherwise forbidden. Using data collected at the Pierre Auger Observatory, we search for signatures of such instanton-induced processes that would be suggestive of super-heavy particles decaying in the Galactic halo. These particles could have been produced during the post-inflationary epoch and match the relic abundance of dark matter inferred today. The nonobservation of the signatures searched for allows us to derive a bound on the reduced coupling constant of gauge interactions in the dark sector: α_{X}≲0.09, for 10^{9}≲M_{X}/GeV<10^{19}. Conversely, we obtain that, for instance, a reduced coupling constant α_{X}=0.09 excludes masses M_{X}≳3×10^{13} GeV. In the context of dark matter production from gravitational interactions alone, we illustrate how these bounds are complementary to those obtained on the Hubble rate at the end of inflation from the nonobservation of tensor modes in the cosmological microwave background.
Collapse
Affiliation(s)
- P Abreu
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Aglietta
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - J M Albury
- University of Adelaide, Adelaide, S.A., Australia
| | - I Allekotte
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | | | - A Almela
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - R Aloisio
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - J Alvarez-Muñiz
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | | | - J Ammerman Yebra
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G A Anastasi
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - L Anchordoqui
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
| | - B Andrada
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - S Andringa
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - C Aramo
- INFN, Sezione di Napoli, Napoli, Italy
| | | | - E Arnone
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | | | - H Asorey
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - P Assis
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - G Avila
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - E Avocone
- Gran Sasso Science Institute, L'Aquila, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - A M Badescu
- University Politehnica of Bucharest, Bucharest, Romania
| | - A Bakalova
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Balaceanu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - F Barbato
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - J A Bellido
- University of Adelaide, Adelaide, S.A., Australia
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
| | - C Berat
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - M E Bertaina
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - G Bhatta
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - P L Biermann
- Max-Planck-Institut für Radioastronomie, Bonn, Germany
| | - V Binet
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
| | - K Bismark
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - T Bister
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - J Biteau
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - J Blazek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C Bleve
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - J Blümer
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Boháčová
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - D Boncioli
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - C Bonifazi
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, RJ, Brazil
| | | | - N Borodai
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - A M Botti
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - J Brack
- Colorado State University, Fort Collins, Colorado, USA
| | - T Bretz
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - P G Brichetto Orchera
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - F L Briechle
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - P Buchholz
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - A Bueno
- Universidad de Granada and C.A.F.P.E., Granada, Spain
| | - S Buitink
- Vrije Universiteit Brussels, Brussels, Belgium
| | - M Buscemi
- INFN, Sezione di Catania, Catania, Italy
| | - M Büsken
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | | | - L Caccianiga
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - F Canfora
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, Netherlands
| | - I Caracas
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - R Caruso
- INFN, Sezione di Catania, Catania, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
| | - A Castellina
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - F Catalani
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, SP, Brazil
| | - G Cataldi
- INFN, Sezione di Lecce, Lecce, Italy
| | - L Cazon
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M Cerda
- Observatorio Pierre Auger, Malargüe, Argentina
| | - J A Chinellato
- Universidade Estadual de Campinas, IFGW, Campinas, SP, Brazil
| | - J Chudoba
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - L Chytka
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - R W Clay
- University of Adelaide, Adelaide, S.A., Australia
| | - A C Cobos Cerutti
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
| | - R Colalillo
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
| | - A Coleman
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
| | | | - R Conceição
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - A Condorelli
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - G Consolati
- INFN, Sezione di Milano, Milano, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
| | - F Contreras
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - F Convenga
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | | | - C E Covault
- Case Western Reserve University, Cleveland, Ohio, USA
| | - S Dasso
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
| | - K Daumiller
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - B R Dawson
- University of Adelaide, Adelaide, S.A., Australia
| | - J A Day
- University of Adelaide, Adelaide, S.A., Australia
| | - R M de Almeida
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, RJ, Brazil
| | - J de Jesús
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - S J de Jong
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, Netherlands
| | - J R T de Mello Neto
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, RJ, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, RJ, Brazil
| | - I De Mitri
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - J de Oliveira
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
| | | | - F de Palma
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - V de Souza
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, SP, Brazil
| | - E De Vito
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - A Del Popolo
- INFN, Sezione di Catania, Catania, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
| | - M Del Río
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - O Deligny
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - L Deval
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | | | - M Dobre
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - C Dobrigkeit
- Universidade Estadual de Campinas, IFGW, Campinas, SP, Brazil
| | - J C D'Olivo
- Universidad Nacional Autónoma de México, México, D.F., México
| | - L M Domingues Mendes
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - R C Dos Anjos
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
| | - M T Dova
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - J Ebr
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - R Engel
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - I Epicoco
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - M Erdmann
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - C O Escobar
- Fermi National Accelerator Laboratory, Fermilab, Batavia, Illinois, USA
| | - A Etchegoyen
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - H Falcke
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, Netherlands
| | - J Farmer
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - G Farrar
- New York University, New York, New York, USA
| | - A C Fauth
- Universidade Estadual de Campinas, IFGW, Campinas, SP, Brazil
| | - N Fazzini
- Fermi National Accelerator Laboratory, Fermilab, Batavia, Illinois, USA
| | - F Feldbusch
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - F Fenu
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - B Fick
- Michigan Technological University, Houghton, Michigan, USA
| | - J M Figueira
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Filipčič
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - T Fitoussi
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - T Fodran
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
| | - T Fujii
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- Present address: Hakubi Center for Advanced Research and Graduate School of Science, Kyoto University, Kyoto, Japan
| | - A Fuster
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - C Galea
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
| | - C Galelli
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - B García
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
| | - A L Garcia Vegas
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - H Gemmeke
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - F Gesualdi
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - A Gherghel-Lascu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - P L Ghia
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - U Giaccari
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
| | | | - J Glombitza
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - F Gobbi
- Observatorio Pierre Auger, Malargüe, Argentina
| | - F Gollan
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - G Golup
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - M Gómez Berisso
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - P F Gómez Vitale
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - J P Gongora
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - J M González
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - N González
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - I Goos
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - D Góra
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - A Gorgi
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - M Gottowik
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - T D Grubb
- University of Adelaide, Adelaide, S.A., Australia
| | - F Guarino
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
| | - G P Guedes
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
| | - E Guido
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - S Hahn
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - P Hamal
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - M R Hampel
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - P Hansen
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - D Harari
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - V M Harvey
- University of Adelaide, Adelaide, S.A., Australia
| | - A Haungs
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - T Hebbeker
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - D Heck
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - G C Hill
- University of Adelaide, Adelaide, S.A., Australia
| | - C Hojvat
- Fermi National Accelerator Laboratory, Fermilab, Batavia, Illinois, USA
| | - J R Hörandel
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, Netherlands
| | - P Horvath
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - M Hrabovský
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - T Huege
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- Vrije Universiteit Brussels, Brussels, Belgium
| | - A Insolia
- INFN, Sezione di Catania, Catania, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
| | - P G Isar
- Institute of Space Science, Bucharest-Magurele, Romania
| | - P Janecek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J A Johnsen
- Colorado School of Mines, Golden, Colorado, USA
| | - J Jurysek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Kääpä
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - K H Kampert
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - B Keilhauer
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - A Khakurdikar
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
| | - V V Kizakke Covilakam
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - H O Klages
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Kleifges
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | | | - F Knapp
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - N Kunka
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - B L Lago
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Nova Friburgo, Brazil
| | - N Langner
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | | | - V Lenok
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - A Letessier-Selvon
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
| | - I Lhenry-Yvon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - D Lo Presti
- INFN, Sezione di Catania, Catania, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
| | - L Lopes
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - R López
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - L Lu
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - Q Luce
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - J P Lundquist
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | | | - G Mancarella
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - D Mandat
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - B C Manning
- University of Adelaide, Adelaide, S.A., Australia
| | - J Manshanden
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
| | - P Mantsch
- Fermi National Accelerator Laboratory, Fermilab, Batavia, Illinois, USA
| | - S Marafico
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - F M Mariani
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - A G Mariazzi
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - I C Mariş
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - G Marsella
- INFN, Sezione di Catania, Catania, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
| | - D Martello
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - S Martinelli
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | | | - M Mastrodicasa
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - H J Mathes
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - J Matthews
- Louisiana State University, Baton Rouge, Louisiana, USA
| | - G Matthiae
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
| | - E Mayotte
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Colorado School of Mines, Golden, Colorado, USA
| | - S Mayotte
- Colorado School of Mines, Golden, Colorado, USA
| | - P O Mazur
- Fermi National Accelerator Laboratory, Fermilab, Batavia, Illinois, USA
| | - G Medina-Tanco
- Universidad Nacional Autónoma de México, México, D.F., México
| | - D Melo
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Menshikov
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - S Michal
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - M I Micheletti
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
| | - L Miramonti
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - S Mollerach
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - F Montanet
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - L Morejon
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - C Morello
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - M Mostafá
- Pennsylvania State University, University Park, Pennsylvania, USA
| | - A L Müller
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - M A Muller
- Universidade Estadual de Campinas, IFGW, Campinas, SP, Brazil
| | - K Mulrey
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, Netherlands
| | - R Mussa
- INFN, Sezione di Torino, Torino, Italy
| | - M Muzio
- New York University, New York, New York, USA
| | - W M Namasaka
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - A Nasr-Esfahani
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - L Nellen
- Universidad Nacional Autónoma de México, México, D.F., México
| | - G Nicora
- Centro de Investigaciones en Láseres y Aplicaciones, CITEDEF and CONICET, Villa Martelli, Argentina
| | - M Niculescu-Oglinzanu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - M Niechciol
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - D Nitz
- Michigan Technological University, Houghton, Michigan, USA
| | - I Norwood
- Michigan Technological University, Houghton, Michigan, USA
| | - D Nosek
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - V Novotny
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - L Nožka
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - A Nucita
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - L A Núñez
- Universidad Industrial de Santander, Bucaramanga, Colombia
| | - C Oliveira
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, SP, Brazil
| | - M Palatka
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Pallotta
- Centro de Investigaciones en Láseres y Aplicaciones, CITEDEF and CONICET, Villa Martelli, Argentina
| | - P Papenbreer
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - G Parente
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Parra
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - J Pawlowsky
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - M Pech
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Pękala
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - R Pelayo
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, D.F., México
| | | | - E E Pereira Martins
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - J Perez Armand
- Universidade de São Paulo, Instituto de Física, São Paulo, SP, Brazil
| | - C Pérez Bertolli
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - L Perrone
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - S Petrera
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - C Petrucci
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - T Pierog
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Pimenta
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - V Pirronello
- INFN, Sezione di Catania, Catania, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
| | - M Platino
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - B Pont
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
| | - M Pothast
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, Netherlands
| | - P Privitera
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - M Prouza
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Puyleart
- Michigan Technological University, Houghton, Michigan, USA
| | - S Querchfeld
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - J Rautenberg
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - D Ravignani
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - M Reininghaus
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - J Ridky
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Riehn
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Risse
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - V Rizi
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | | | - J Rodriguez Rojo
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - M J Roncoroni
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - S Rossoni
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
| | - M Roth
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - E Roulet
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - A C Rovero
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
| | - P Ruehl
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - A Saftoiu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - M Saharan
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
| | - F Salamida
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - H Salazar
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - G Salina
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
| | | | - F Sánchez
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - E M Santos
- Universidade de São Paulo, Instituto de Física, São Paulo, SP, Brazil
| | - E Santos
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Sarazin
- Colorado School of Mines, Golden, Colorado, USA
| | - R Sarmento
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - C Sarmiento-Cano
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - R Sato
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - P Savina
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - C M Schäfer
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - V Scherini
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - H Schieler
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Schimassek
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - M Schimp
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - F Schlüter
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - D Schmidt
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - O Scholten
- Vrije Universiteit Brussels, Brussels, Belgium
| | - H Schoorlemmer
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, Netherlands
| | - P Schovánek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F G Schröder
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
| | - J Schulte
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - T Schulz
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - S J Sciutto
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - M Scornavacche
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - A Segreto
- INFN, Sezione di Catania, Catania, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
| | - S Sehgal
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - R C Shellard
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, RJ, Brazil
| | - G Sigl
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
| | - G Silli
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - O Sima
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Also at University of Bucharest, Physics Department, Bucharest, Romania
| | - R Smau
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - R Šmída
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - P Sommers
- Pennsylvania State University, University Park, Pennsylvania, USA
| | - J F Soriano
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
| | - R Squartini
- Observatorio Pierre Auger, Malargüe, Argentina
| | - M Stadelmaier
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - D Stanca
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - S Stanič
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - J Stasielak
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - P Stassi
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - A Streich
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | | | - T Sudholz
- University of Adelaide, Adelaide, S.A., Australia
| | - T Suomijärvi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - A D Supanitsky
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - Z Szadkowski
- University of Łódź, Faculty of High-Energy Astrophysics, Łódź, Poland
| | - A Tapia
- Universidad de Medellín, Medellín, Colombia
| | - C Taricco
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - C Timmermans
- IMAPP, Radboud University Nijmegen, Nijmegen, Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, Netherlands
| | - O Tkachenko
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - P Tobiska
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C J Todero Peixoto
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, SP, Brazil
| | - B Tomé
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - Z Torrès
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - A Travaini
- Observatorio Pierre Auger, Malargüe, Argentina
| | - P Travnicek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C Trimarelli
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - M Tueros
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - R Ulrich
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Unger
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - L Vaclavek
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - M Vacula
- Palacky University, RCPTM, Olomouc, Czech Republic
| | | | - L Valore
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
| | - E Varela
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | | | - D Veberič
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - C Ventura
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, RJ, Brazil
| | | | - V Verzi
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
| | - J Vicha
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Vink
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, Netherlands
| | - S Vorobiov
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - H Wahlberg
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - C Watanabe
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, RJ, Brazil
| | - A A Watson
- School of Physics and Astronomy, University of Leeds, Leeds, United Kingdom
| | - A Weindl
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - L Wiencke
- Colorado School of Mines, Golden, Colorado, USA
| | - H Wilczyński
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - D Wittkowski
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - B Wundheiler
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Yushkov
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - O Zapparrata
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - E Zas
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - D Zavrtanik
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - M Zavrtanik
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - L Zehrer
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| |
Collapse
|
7
|
Sánchez-Torres AM, Amoretti S, Enguita-Germán M, Mezquida G, Moreno-Izco L, Panadero-Gómez R, Rementería L, Toll A, Rodriguez-Jimenez R, Roldán A, Pomarol-Clotet E, Ibáñez Á, Usall J, Contreras F, Vieta E, López-Ilundain JM, Merchán-Naranjo J, González-Pinto A, Berrocoso E, Bernardo M, Cuesta MJ. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study. Eur Neuropsychopharmacol 2023; 67:53-65. [PMID: 36495858 DOI: 10.1016/j.euroneuro.2022.11.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2022] [Revised: 10/18/2022] [Accepted: 11/22/2022] [Indexed: 12/13/2022]
Abstract
Schizophrenia is frequently characterized by the presence of multiple relapses. Cognitive impairments are core features of schizophrenia. Cognitive reserve (CR) is the ability of the brain to compensate for damage caused by pathologies such as psychotic illness. As cognition is related to CR, the study of the relationship between relapse, cognition and CR may broaden our understanding of the course of the disease. We aimed to determine whether relapse was associated with cognitive impairment, controlling for the effects of CR. Ninety-nine patients with a remitted first episode of schizophrenia or schizophreniform disorder were administered a set of neuropsychological tests to assess premorbid IQ, attention, processing speed, working memory, verbal and visual memory, executive functions and social cognition. They were followed up for 3 years (n=53) or until they relapsed (n=46). Personal and familial CR was estimated from a principal component analysis of the premorbid information gathered. Linear mixed-effects models were applied to analyse the effect of time and relapse on cognitive function, with CR as covariate. Patients who relapsed and had higher personal CR showed less deterioration in attention, whereas those with higher CR (personal and familial CR) who did not relapse showed better performance in processing speed and visual memory. Taken together, CR seems to ameliorate the negative effects of relapse on attention performance and shows a positive effect on processing speed and visual memory in those patients who did not relapse. Our results add evidence for the protective effect of CR over the course of the illness.
Collapse
Affiliation(s)
- Ana M Sánchez-Torres
- Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain; Navarra Institute of Health Research (IdiSNA), Pamplona, Spain
| | - Silvia Amoretti
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, University of Barcelona, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Spain; Bipolar and Depressive Disorders Unit, Hospital Clinic of Barcelona, Institute of Neurosciences, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR); Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
| | - Mónica Enguita-Germán
- Navarra Institute of Health Research (IdiSNA), Pamplona, Spain; Unidad de Metodología. Navarrabiomed-CHN -UPNA. Pamplona
| | - Gisela Mezquida
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, University of Barcelona, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
| | - Lucía Moreno-Izco
- Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain; Navarra Institute of Health Research (IdiSNA), Pamplona, Spain
| | - Rocío Panadero-Gómez
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain
| | - Lide Rementería
- BIOARABA Health Research Institute. OSI Araba. University Hospital. University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - Alba Toll
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Hospital del Mar Medical Research Institute (IMIM)
| | - Roberto Rodriguez-Jimenez
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Department of Psychiatry. Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12); Universidad Complutense de Madrid (UCM), Plaza Ramón y Cajal, s/n, 28040 Madrid, Spain
| | - Alexandra Roldán
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Department of Psychiatry, Institut d'Investigació Biomèdica-Sant Pau (IIB-SANT PAU), Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - Edith Pomarol-Clotet
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain
| | - Ángela Ibáñez
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Department of Psychiatry, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid, Spain
| | - Judith Usall
- Parc Sanitari Sant Joan de Déu, Teaching, Research & Innovation Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat
| | - Fernando Contreras
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Psychiatric Department. Bellvitge Universitary Hospital. IDIBELL
| | - Eduard Vieta
- Bipolar and Depressive Disorders Unit, Hospital Clinic of Barcelona, Institute of Neurosciences, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
| | - Jose M López-Ilundain
- Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain; Navarra Institute of Health Research (IdiSNA), Pamplona, Spain
| | - Jessica Merchán-Naranjo
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain
| | - Ana González-Pinto
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; BIOARABA Health Research Institute. OSI Araba. University Hospital. University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - Esther Berrocoso
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Department of Psychology, University of Cadiz, Spain, Biomedical Research and Innovation Institute of Cádiz (INiBICA), Spain
| | - Miguel Bernardo
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, University of Barcelona, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
| | - Manuel J Cuesta
- Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain; Navarra Institute of Health Research (IdiSNA), Pamplona, Spain.
| | | |
Collapse
|
8
|
Saiz-Masvidal C, Contreras F, Soriano-Mas C, Mezquida G, Díaz-Caneja CM, Vieta E, Amoretti S, Lobo A, González-Pinto A, Janssen J, Sagué-Vilavella M, Castro-Fornieles J, Bergé D, Bioque M, Lois NG, Parellada M, Bernardo M. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis. Prog Neuropsychopharmacol Biol Psychiatry 2023; 120:110645. [PMID: 36181960 DOI: 10.1016/j.pnpbp.2022.110645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2022] [Revised: 09/07/2022] [Accepted: 09/22/2022] [Indexed: 11/30/2022]
Abstract
The relationship between structural brain alterations and prediction of clinical improvement in first-episode psychosis (FEP) has been scarcely studied. We investigated whether structural covariance, a well-established approach to identify abnormal patterns of volumetric correlation across distant brain regions, which allows incorporating network-level information to structural assessments, is associated with longitudinal clinical course. We assessed a sample of 74 individuals from a multicenter study. Magnetic resonance imaging scans were acquired at baseline, and clinical assessments at baseline and at a 2-year follow-up. Participants were split in two groups as a function of their clinical improvement after 2 years (i.e., ≥ < 40% reduction in psychotic symptom severity, (n = 29, n = 45)). We performed a seed-based approach and focused our analyses on 3 cortical and 4 subcortical regions of interest to identify alterations in cortical and cortico-subcortical networks. Improvers presented an increased correlation between the volumes of the right posterior cingulate cortex (PCC) and the left precentral gyrus, and between the left PCC and the left middle occipital gyrus. They also showed an increased correlation between right posterior hippocampus and left angular gyrus volumes. Our study provides a novel mean to identify structural correlates of clinical improvement in FEP, describing clinically-relevant anatomical differences in terms of large-scale brain networks, which is better aligned with prevailing neurobiological models of psychosis. The results involve brain regions considered to participate in the multisensory processing of bodily signals and the construction of bodily self-consciousness, which resonates with recent theoretical accounts in psychosis research.
Collapse
Affiliation(s)
- Cristina Saiz-Masvidal
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Spain
| | - Fernando Contreras
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain
| | - Carles Soriano-Mas
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Social Psychology and Quantitative Psychology, University of Barcelona, Spain.
| | - Gisela Mezquida
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain
| | - Covadonga M Díaz-Caneja
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón and School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Eduard Vieta
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Bipolar and Depressive Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, University of Barcelona, Barcelona, Spain
| | - Silvia Amoretti
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Bipolar and Depressive Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, University of Barcelona, Barcelona, Spain; Group of Psychiatry, Mental Health and Addictions, Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - Antonio Lobo
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Medicine and Psychiatry, Universidad de Zaragoza, Zaragoza, Spain; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain
| | - Ana González-Pinto
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Instituto de Investigación Sanitaria Bioaraba (BIOARABA), Vitoria, Spain; Department of Psychiatry, Hospital Universitario de Alava, Vitoria, Spain; Universidad del País Vasco/ Euskal Harriko Unibertsitatea (UPV/EHU), País Vasco, Spain
| | - Joost Janssen
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón and School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Maria Sagué-Vilavella
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Bipolar and Depressive Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, University of Barcelona, Barcelona, Spain
| | - Josefina Castro-Fornieles
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Child and Adolescent Psychiatry and Psychology, 2017SGR881, Institut Clínic de Neurociències, Hospital Clínic Universitari, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain
| | - Daniel Bergé
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Institute of Neuropsychiatry and Addiction of the Barcelona MAR Health Park, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; Department of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain
| | - Miquel Bioque
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain
| | - Noemi G Lois
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón and School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Mara Parellada
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón and School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Miguel Bernardo
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain
| | | |
Collapse
|
9
|
Pina-Camacho L, Martinez K, Diaz-Caneja CM, Mezquida G, Cuesta MJ, Moreno C, Amoretti S, González-Pinto A, Arango C, Vieta E, Castro-Fornieles J, Lobo A, Fraguas D, Bernardo M, Janssen J, Parellada M, Madero S, Gómez-Ramiro M, Rodriguez-Toscano E, Santonja J, Zorrilla I, González-Ortega I, Fayed N, Santabárbara J, Berge D, Toll A, Nacher J, Martí GG, Sague-Vilavella M, Sanchez-Moreno J, de la Serna E, Baeza I, Saiz-Masvidal C, Contreras F, González-Blanco L, Bobes-Bascarán T, Dompablo M, Rodriguez-Jimenez R, Usall J, Butjosa A, Pomarol-Clotet E, Sarró S. Cortical thinning over two years after first-episode psychosis depends on age of onset. Schizophr 2022; 8:20. [PMID: 35277520 PMCID: PMC8917180 DOI: 10.1038/s41537-021-00196-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Accepted: 11/10/2021] [Indexed: 11/09/2022]
Abstract
AbstractFirst-episode psychosis (FEP) patients show structural brain abnormalities at the first episode. Whether the cortical changes that follow a FEP are progressive and whether age at onset modulates these changes remains unclear. This is a multicenter MRI study in a deeply phenotyped sample of 74 FEP patients with a wide age range at onset (15–35 years) and 64 neurotypical healthy controls (HC). All participants underwent two MRI scans with a 2-year follow-up interval. We computed the longitudinal percentage of change (PC) for cortical thickness (CT), surface area (CSA) and volume (CV) for frontal, temporal, parietal and occipital lobes. We used general linear models to assess group differences in PC as a function of age at FEP. We conducted post-hoc analyses for metrics where PC differed as a function of age at onset. We found a significant age-by-diagnosis interaction effect for PC of temporal lobe CT (d = 0.54; p = 002). In a post-hoc-analysis, adolescent-onset (≤19 y) FEP showed more severe longitudinal cortical thinning in the temporal lobe than adolescent HC. We did not find this difference in adult-onset FEP compared to adult HC. Our study suggests that, in individuals with psychosis, CT changes that follow the FEP are dependent on the age at first episode, with those with an earlier onset showing more pronounced cortical thinning in the temporal lobe.
Collapse
|
10
|
Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, Stättermayer A, Cengiz M, Clayton-Chubb D, Lammert C, Bernsmeier C, Gül Ö, la Tijera FHD, Anders M, Lytvyak E, Akın M, Purnak T, Liberal R, Peralta M, Ebik B, Duman S, Demir N, Balaban Y, Urzua Á, Contreras F, Venturelli MG, Bilgiç Y, Medina A, Girala M, Günşar F, Londoño MC, Androutsakos T, Kisch A, Yurci A, Güzelbulut F, Çağın YF, Avcı E, Akyıldız M, Dindar-Demiray EK, Harputluoğlu M, Kumar R, Satapathy SK, Mendizabal M, Silva M, Fagiuoli S, Roberts SK, Soylu NK, Idilman R, Yoshida EM, Montano-Loza AJ, Dalekos GN, Ridruejo E, Schiano TD, Wahlin S. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 2022; 76:1576-1586. [PMID: 35567545 PMCID: PMC9348326 DOI: 10.1002/hep.32572] [Citation(s) in RCA: 45] [Impact Index Per Article: 22.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 05/04/2022] [Accepted: 05/05/2022] [Indexed: 12/12/2022]
Abstract
BACKGROUND AND AIMS A few case reports of autoimmune hepatitis-like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We evaluated clinical features, treatment response and outcomes of liver injury following SARS-CoV-2 vaccination in a large case series. APPROACH AND RESULTS We collected data from cases in 18 countries. The type of liver injury was assessed with the R-value. The study population was categorized according to features of immune-mediated hepatitis (positive autoantibodies and elevated immunoglobulin G levels) and corticosteroid therapy for the liver injury. We identified 87 patients (63%, female), median age 48 (range: 18-79) years at presentation. Liver injury was diagnosed a median 15 (range: 3-65) days after vaccination. Fifty-one cases (59%) were attributed to the Pfizer-BioNTech (BNT162b2) vaccine, 20 (23%) cases to the Oxford-AstraZeneca (ChAdOX1 nCoV-19) vaccine and 16 (18%) cases to the Moderna (mRNA-1273) vaccine. The liver injury was predominantly hepatocellular (84%) and 57% of patients showed features of immune-mediated hepatitis. Corticosteroids were given to 46 (53%) patients, more often for grade 3-4 liver injury than for grade 1-2 liver injury (88.9% vs. 43.5%, p = 0.001) and more often for patients with than without immune-mediated hepatitis (71.1% vs. 38.2%, p = 0.003). All patients showed resolution of liver injury except for one man (1.1%) who developed liver failure and underwent liver transplantation. Steroid therapy was withdrawn during the observation period in 12 (26%) patients after complete biochemical resolution. None had a relapse during follow-up. CONCLUSIONS SARS-CoV-2 vaccination can be associated with liver injury. Corticosteroid therapy may be beneficial in those with immune-mediated features or severe hepatitis. Outcome was generally favorable, but vaccine-associated liver injury led to fulminant liver failure in one patient.
Collapse
Affiliation(s)
- Cumali Efe
- Department of GastroenterologyHarran University HospitalŞanlıurfaTurkey
| | - Anand V Kulkarni
- Department of Hepatology and Liver TransplantationAsian Institute of Gastroenterology HospitalsHyderabadIndia
| | | | - Bianca Magro
- Gastroenterology Hepatology and TransplantationASST Papa Giovanni XXIII-BergamoBergamoItaly
| | - Albert Stättermayer
- Division of Gastroenterology and HepatologyDepartment of Internal Medicine IIIMedical University of ViennaViennaAustria
| | - Mustafa Cengiz
- Department of GastroenterologyGülhane Training and Research HospitalAnkaraTurkey
| | | | - Craig Lammert
- Department of Medicine IndianaUniversity School of MedicineIndianapolisIndianaUSA
| | - Christine Bernsmeier
- Department of BiomedicineUniversity of BaselBaselSwitzerland.,University Centre for Gastrointestinal and Liver DiseasesBaselSwitzerland
| | - Özlem Gül
- Department of GastroenterologyKırıkkale UniversityKırıkkaleTurkey
| | | | - Margarita Anders
- Hepatology and Liver Transplant UnitHospital AlemánCiudad Autónoma de Buenos AiresArgentina
| | - Ellina Lytvyak
- Division of Gastroenterology and Liver UnitUniversity of AlbertaEdmontonAlbertaCanada
| | - Mete Akın
- Department of GastroenterologyAkdeniz University Faculty of MedicineAntalyaTurkey
| | - Tugrul Purnak
- Division of GastroenterologyHepatology and NutritionMcGovern Medical SchoolHoustonTexasUSA
| | - Rodrigo Liberal
- Gastroenterology and Hepatology DepartmentCentro Hospitalar e Universitário de São JoãoPortoPortugal.,World Gastroenterology Organization (WGO) Porto Training CenterPortoPortugal
| | - Mirta Peralta
- Hepatology SectionHospital Francisco J MuñizCiudad Autónoma de Buenos AiresArgentina.,Latin American Liver Research Educational and Awareness Network (LALREAN)PilarArgentina
| | - Berat Ebik
- Department of GastroenterologyGazi Yaşargil Education and Research HospitalDiyarbakirTurkey
| | - Serkan Duman
- Department of GastroenterologyAnkara University Medical FacultyAnkaraTurkey
| | - Nurhan Demir
- Department of GastroenterologyHaseki Training and Research HospitalIstanbulTurkey
| | - Yasemin Balaban
- Department of GastroenterologyFaculty of MedicineHacettepe UniversityAnkaraTurkey
| | - Álvaro Urzua
- Gastroenterology and Hepatology UnitHospital Clínico Universidad de ChileSantiago de ChileChile
| | | | | | - Yılmaz Bilgiç
- Department of GastroenterologyInönü University School of MedicineMalatyaTurkey
| | - Adriana Medina
- Gastroenterology and Hepatology UnitHospital de Clínicas, Universidad Nacional de AsunciónSan LorenzoParaguay
| | - Marcos Girala
- Gastroenterology and Hepatology UnitHospital de Clínicas, Universidad Nacional de AsunciónSan LorenzoParaguay
| | - Fulya Günşar
- Department of GastroenterologyEge University School of MedicineİzmirTurkey
| | | | - Theodoros Androutsakos
- Department of PathophysiologyNational and Kapodistrian University of AthensMedical SchoolAthensGreece
| | - Ayelen Kisch
- Hepatology SectionHospital Bonorino UdaondoCiudad Autónoma de Buenos AiresArgentina
| | - Alper Yurci
- Department of GastroenterologyErciyes University School of MedicineKayseriTurkey
| | - Fatih Güzelbulut
- Department of GastroenterologyHaydarpaşa Numune Education and Research HospitalİstanbulTurkey
| | - Yasir Furkan Çağın
- Department of GastroenterologyInönü University School of MedicineMalatyaTurkey
| | - Enver Avcı
- Department of GastroenterologyKTO Karatay University Medical School Affiliated Konya Medicana HospitalKonyaTurkey
| | - Murat Akyıldız
- Department of GastroenterologyKoc University School of MedicineIstanbulTurkey
| | | | - Murat Harputluoğlu
- Department of GastroenterologyInönü University School of MedicineMalatyaTurkey
| | - Rahul Kumar
- Department of Gastroenterology and HepatologyChangi General HospitalMedicine Academic Clinical ProgrammeSing Health Duke-NUS Academic Medical CentreSingapore
| | - Sanjaya K Satapathy
- Department of Internal MedicineDonald and Barbara Zucker School of MedicineNorthwell HealthManhassetNew YorkUSA
| | - Manuel Mendizabal
- Latin American Liver Research Educational and Awareness Network (LALREAN)PilarArgentina.,Hepatology and Liver Transplant UnitHospital Universitario AustralPilarArgentina
| | - Marcelo Silva
- Latin American Liver Research Educational and Awareness Network (LALREAN)PilarArgentina.,Hepatology and Liver Transplant UnitHospital Universitario AustralPilarArgentina
| | - Stefano Fagiuoli
- Gastroenterology Hepatology and TransplantationASST Papa Giovanni XXIII-BergamoBergamoItaly
| | - Stuart K Roberts
- Department of GastroenterologyAlfred HealthMelbourneVictoriaAustralia.,Central Clinical SchoolDepartment of MedicineMonash UniversityMelbourneVictoriaAustralia
| | - Neşe Karadağ Soylu
- Department of PathologyInönü University Faculty of MedicineMalatyaTurkey
| | - Ramazan Idilman
- Department of GastroenterologyAnkara University Medical FacultyAnkaraTurkey
| | - Eric M Yoshida
- Division of GastroenterologyUniversity of British Columbia and Vancouver General HospitalVancouverBritish ColumbiaCanada
| | - Aldo J Montano-Loza
- Division of Gastroenterology and Liver UnitUniversity of AlbertaEdmontonAlbertaCanada
| | - George N Dalekos
- Department of Medicine and Research Laboratory of Internal MedicineNational Expertise Center of Greece in Autoimmune Liver DiseasesGeneral University Hospital of LarissaLarissaGreece.,European Reference Network on Hepatological Diseases (ERN RARE-LIVER)General University Hospital of LarissaLarissaGreece
| | - Ezequiel Ridruejo
- Latin American Liver Research Educational and Awareness Network (LALREAN)PilarArgentina.,Hepatology and Liver Transplant UnitHospital Universitario AustralPilarArgentina.,Hepatology SectionDepartment of MedicineCentro de Educación Médica e Investigaciones Clínicas, CEMICCiudad Autónoma de Buenos AiresArgentina
| | - Thomas D Schiano
- Division of Liver Diseasesthe Mount Sinai Medical CenterNew YorkNew YorkUSA
| | - Staffan Wahlin
- Hepatology Division, Department of Upper GI DiseasesKarolinska Institutet and Karolinska University HospitalStockholmSweden
| |
Collapse
|
11
|
Rodríguez N, Gassó P, Martínez-Pinteño A, Segura ÀG, Mezquida G, Moreno-Izco L, González-Peñas J, Zorrilla I, Martin M, Rodriguez-Jimenez R, Corripio I, Sarró S, Ibáñez A, Butjosa A, Contreras F, Bioque M, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M, Mas S, Amoretti S S, Moren C, Stella C, Gurriarán X, Alonso-Solís A, Grasa E, Fernandez J, Gonzalez-Ortega I, Casanovas F, Bulbuena A, Núñez-Doyle Á, Jiménez-Rodríguez O, Pomarol-Clotet E, Feria-Raposo I, Usall J, Muñoz-Samons D, Ilundain JL, Sánchez-Torres AM, Saiz-Ruiz J, López-Torres I, Nacher J, De-la-Cámara C, Gutiérrez M, Sáiz PA. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients. Schizophr 2022; 8:45. [PMID: 35853879 PMCID: PMC9261105 DOI: 10.1038/s41537-022-00215-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Accepted: 02/01/2022] [Indexed: 11/18/2022]
Abstract
A better understanding of schizophrenia subtypes is necessary to stratify the patients according to clinical attributes. To explore the genomic architecture of schizophrenia symptomatology, we analyzed blood co-expression modules and their association with clinical data from patients in remission after a first episode of schizophrenia. In total, 91 participants of the 2EPS project were included. Gene expression was assessed using the Clariom S Human Array. Weighted-gene co-expression network analysis (WGCNA) was applied to identify modules of co-expressed genes and to test its correlation with global functioning, clinical symptomatology, and premorbid adjustment. Among the 25 modules identified, six modules were significantly correlated with clinical data. These modules could be clustered in two groups according to their correlation with clinical data. Hub genes in each group showing overlap with risk genes for schizophrenia were enriched in biological processes related to metabolic processes, regulation of gene expression, cellular localization and protein transport, immune processes, and neurotrophin pathways. Our results indicate that modules with significant associations with clinical data showed overlap with gene sets previously identified in differential gene-expression analysis in brain, indicating that peripheral tissues could reveal pathogenic mechanisms. Hub genes involved in these modules revealed multiple signaling pathways previously related to schizophrenia, which may represent the complex interplay in the pathological mechanisms behind the disease. These genes could represent potential targets for the development of peripheral biomarkers underlying illness traits in clinical remission stages after a first episode of schizophrenia.
Collapse
|
12
|
Solanes A, Mezquida G, Janssen J, Amoretti S, Lobo A, González-Pinto A, Arango C, Vieta E, Castro-Fornieles J, Bergé D, Albacete A, Giné E, Parellada M, Bernardo M, Bioque M, Morén C, Pina-Camacho L, Díaz-Caneja CM, Zorrilla I, Corres EG, De-la-Camara C, Barcones F, Escarti MJ, Aguilar EJ, Legido T, Martin M, Verdolini N, Martinez-Aran A, Baeza I, de la Serna E, Contreras F, Bobes J, García-Portilla MP, Sanchez-Pastor L, Rodriguez-Jimenez R, Usall J, Butjosa A, Salgado-Pineda P, Salvador R, Pomarol-Clotet E, Radua J. Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis. Schizophr 2022; 8:100. [PMID: 36396933 PMCID: PMC9672064 DOI: 10.1038/s41537-022-00309-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Accepted: 10/28/2022] [Indexed: 11/18/2022]
Abstract
AbstractDetecting patients at high relapse risk after the first episode of psychosis (HRR-FEP) could help the clinician adjust the preventive treatment. To develop a tool to detect patients at HRR using their baseline clinical and structural MRI, we followed 227 patients with FEP for 18–24 months and applied MRIPredict. We previously optimized the MRI-based machine-learning parameters (combining unmodulated and modulated gray and white matter and using voxel-based ensemble) in two independent datasets. Patients estimated to be at HRR-FEP showed a substantially increased risk of relapse (hazard ratio = 4.58, P < 0.05). Accuracy was poorer when we only used clinical or MRI data. We thus show the potential of combining clinical and MRI data to detect which individuals are more likely to relapse, who may benefit from increased frequency of visits, and which are unlikely, who may be currently receiving unnecessary prophylactic treatments. We also provide an updated version of the MRIPredict software.
Collapse
|
13
|
Radaic A, Brody H, Contreras F, Hajfathalian M, Lucido L, Kamarajan P, Kapila YL. Nisin and Nisin Probiotic Disrupt Oral Pathogenic Biofilms and Restore Their Microbiome Composition towards Healthy Control Levels in a Peri-Implantitis Setting. Microorganisms 2022; 10:1336. [PMID: 35889055 PMCID: PMC9324437 DOI: 10.3390/microorganisms10071336] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2022] [Revised: 06/24/2022] [Accepted: 06/29/2022] [Indexed: 02/06/2023] Open
Abstract
Peri-implantitis is characterized by chronic inflammation of the peri-implant supporting tissues that progressively and irreversibly leads to bone loss and, consequently, implant loss. Similar to periodontal disease, oral dysbiosis is thought to be a driver of peri-implantitis. However, managing peri-implantitis with traditional treatment methods, such as nonsurgical debridement or surgery, is not always successful. Thus, novel strategies have been proposed to address these shortcomings. One strategy is the use of probiotics as antimicrobial agents since they are considered safe for humans and the environment. Specifically, the probiotic Lactococcus lactis produces nisin, which has been used worldwide for food preservation. The objective of this study was to determine whether nisin and the wild-type (WT) nisin-producing L. lactis probiotic can disrupt oral pathogenic biofilms and promote a healthier oral microbiome within these oral biofilms on titanium discs. Using confocal imaging and 16S rRNA sequencing, this study revealed that nisin and WT L. lactis probiotic disrupt oral pathogenic biofilms in a peri-implantitis setting in vitro. More specifically, nisin decreased the viability of the pathogen-spiked biofilms dose-dependently from 62.53 ± 3.69% to 54.26 ± 3.35% and 44.88 ± 2.98%, respectively. Similarly, 105 CFU/mL of WT L. lactis significantly decreased biofilm viability to 52.45 ± 3.41%. Further, both treatments shift the composition, relative abundance, and diversity levels of these biofilms towards healthy control levels. A total of 1 µg/mL of nisin and 103 CFU/mL of WT L. lactis were able to revert the pathogen-mediated changes in the Proteobacteria (from 80.5 ± 2.9% to 75.6 ± 2.0%, 78.0 ± 2.8%, and 75.1 ± 5.3%, respectively) and Firmicutes (from 11.6 ± 1.6% to 15.4 ± 1.3%, 13.8 ± 1.8%, and 13.7 ± 2.6%, respectively) phyla back towards control levels. Thus, nisin and its nisin-producing L. lactis probiotic may be useful in treating peri-implantitis by promoting healthier oral biofilms, which may be useful for improving patient oral health.
Collapse
Affiliation(s)
- Allan Radaic
- Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA 94143, USA; (A.R.); (H.B.); (F.C.); (M.H.); (L.L.); (P.K.)
| | - Hanna Brody
- Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA 94143, USA; (A.R.); (H.B.); (F.C.); (M.H.); (L.L.); (P.K.)
| | - Fernando Contreras
- Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA 94143, USA; (A.R.); (H.B.); (F.C.); (M.H.); (L.L.); (P.K.)
| | - Maryam Hajfathalian
- Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA 94143, USA; (A.R.); (H.B.); (F.C.); (M.H.); (L.L.); (P.K.)
- Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Luke Lucido
- Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA 94143, USA; (A.R.); (H.B.); (F.C.); (M.H.); (L.L.); (P.K.)
| | - Pachiyappan Kamarajan
- Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA 94143, USA; (A.R.); (H.B.); (F.C.); (M.H.); (L.L.); (P.K.)
| | - Yvonne L. Kapila
- Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA 94143, USA; (A.R.); (H.B.); (F.C.); (M.H.); (L.L.); (P.K.)
- Division of Oral and Systemic Health Sciences, Sections of Biosystems and Function and Periodontics, School of Dentistry, University of California, Los Angeles, Los Angeles, CA 90095, USA
| |
Collapse
|
14
|
Ospina Serrano AV, Contreras F, Triana I, Ortiz Diaz JD, Ramos P, Vargas C, Arango N, Idrobo H, Munevar I, Yepes A, Mantilla W, Jimenez P, Rivas Tafurt GP, Lema-Medina M, Alcala M, Gomez D, Chinchia I, Barrero A, Sanchez-Vanegas G. Prognostic factors for recurrence and mortality in patients with localized malignant melanoma: Analysis of the Epidemiological Registry of Malignant Melanoma in Colombia REMMEC ACHO. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.16_suppl.e21572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e21572 Background: Malignant melanoma is the skin cancer with the highest mortality rate. In early stages, it may have a better prognosis and some possibility of cure. In Colombia, given the increase in cases, a national registry of the disease has been initiated with the aim of characterizing the population and establishing the prognostic factors in the local context. Methods: Cohort study based on data from the Epidemiological Registry of Malignant Melanoma in Colombia (REMMEC). For this first phase,data from January 2011 to December 2021 were analyzed. Patients were older than 18 years, with confirmed diagnosis of localized melanoma. Mortality and recurrence incidence rates were calculated using the Kaplan-Meier method, overall survival was estimated at 5 years of follow-up for each stage. Finally, a prognostic model was made for the mortality outcome, using the Cox proportional hazards method. Results: 759 patients were included, the mean age was 66 years (SD: 15.6), 57% women (n = 431), 29% phototype I or II (n = 219), and the most frequent histological subtype was acral lentiginous (n = 211; 36%). In relation to the stage, 13.9% with stage 0 (n = 106), 24.2% in stage I (n = 184), 30% in stage II (n = 228), and 31.7% in stage III (n = 241). ECOG-3-4 in 1.05% (n = 8). Regarding the health regimen, the subsidized patients were 199 (26%), and the contributive 560 (73.8%), of which 35 and 30.6% had stage III, respectively. 92% of all patients underwent local surgery (n = 699) and 30% (n = 226) local lymphadenectomy. The median follow-up time was 36 months (IQR: 17-72). The mortality incidence rate was 3.6 cases per 100 person-years (95% CI: 2.9-4.3), and the recurrence rate was 6.8 cases per 100 person-years (95% CI: 5.9 -7.8). Overall survival at five years for patients in stage 0 and I was 97% (95% CI: 89-99), for stage II it was 80% (95% CI: 72.6-86.6); for stage III 65% (95% CI: 57-72). 22.4% (n = 170) received adjuvant treatment . 26.2% (n = 199) had metastatic recurrence. The prognostic factors for mortality are presented in Table. Conclusions: In the Colombian context, in patients with localized melanoma, ECOG 3 or 4, stage III at the time of diagnosis, receiving radiotherapy, the presence of ulceration, chronic sun exposure, and the subsidized health regimen are poor prognostic factors.[Table: see text]
Collapse
Affiliation(s)
- Aylen Vanessa Ospina Serrano
- ICCAL Hospital Universitario Fundacion Santa Fe de Bogota, Asociacion Colombiana de Hematologia y Oncologia ACHO, Bogotá, Colombia
| | - Fernando Contreras
- Instituto Nacional de Cancerologia, Universidad El Bosque, Bogota, Colombia
| | - Ivan Triana
- ICCAL fundacion Santa Fe de Bogota, Bogotá, Colombia
| | | | - Pedro Ramos
- Clínica Universitaria Colombia, Sanitas, Oncocare, Bogota, Colombia
| | | | | | - Henry Idrobo
- Centro Médico Julián Coronel, Universidad del Valle, Cali, Colombia
| | - Isabel Munevar
- Hospital Militar Central, Fundación Cardioinfantil, Hemato Oncólogos Asociados., Bogota, Colombia
| | - Andres Yepes
- Hospital Universitario San Vicente Fundación, Medellin, Colombia
| | - William Mantilla
- Fundación Cardioinfantil, Universidad del Rosario, Grupo ICAROS., Bogota, Colombia
| | - Paola Jimenez
- Clínica Los Cobos MC, Hemato Oncólogos Asociados, Bogota, Colombia
| | | | | | | | - Diego Gomez
- FCV, Hospital Internacional de Colombia, Bucaramanga, Colombia
| | | | | | | |
Collapse
|
15
|
Bernardo M, Anmella G, Verdolini N, Saiz-Masvidal C, Casals S, Contreras F, Garrido I, Pérez F, Safont G, Mas S, Rodriguez N, Meseguer A, Pons-Cabrera MT, Vieta E, Amoretti S. Assessing cognitive reserve outcomes and biomarkers in first episode of psychosis: rationale, objectives, protocol and preliminary results of the CRASH Project. Revista de Psiquiatría y Salud Mental 2022. [DOI: 10.1016/j.rpsm.2022.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
16
|
Forero YJ, Zapata Laguado MI, Briceño X, Brugés RE, Contreras F. Peripheral Neural Sheath Breast Sarcoma: Case Report and Literature Review. Case Rep Oncol 2022; 15:403-412. [PMID: 35702560 PMCID: PMC9149436 DOI: 10.1159/000523811] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2021] [Accepted: 02/17/2022] [Indexed: 11/25/2022] Open
Abstract
Primary sarcomas of the breast are heterogeneous neoplasms derived from the non-epithelial elements of the mammary gland. Malignant peripheral nerve sheath tumors comprise 5–10% of all malignant soft tissue sarcomas. Its heterogeneity and low incidence (1 in 100,000) limit the performance of prospective studies. Therefore, most published articles include individual reports and case series with a small number of patients, making it impossible to determine clear treatment standards in this scenario. A 36-year-old young woman with no personal history consulted the National Cancer Institute of Colombia with a 1-year progression of a rapidly growing mass in her left breast until reaching an approximate tumor size of 20 × 20 cm. Histopathological analysis with a tru-cut biopsy taken from the lesion revealed the presence of a breast sarcoma with positive staining for SOX-10 and S-100. A radical mastectomy as her first treatment included the resection of a costal arch and, therefore, the reconstruction of the chest wall with coverage of the defect with an extended latissimus dorsi flap followed by consolidation therapy with adjuvant radiotherapy (RT) and chemotherapy. Evidence regarding malignant peripheral nerve sheath sarcoma of the breast treatment corresponds to retrospective analyses and case reports with high heterogeneity and variability about strategies in surgical procedures and adjunctive therapy such as complementary chemotherapy and RT; therapeutic approach should always include a multidisciplinary team.
Collapse
Affiliation(s)
- Yency Johana Forero
- Clínical Epidemiology, Universidad del Rosario, Bogotá, Colombia
- *Yency Johana Forero,
| | | | - Ximena Briceño
- National Institute of Cancer, Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia
| | | | | |
Collapse
|
17
|
Bessone F, Hernandez N, Tagle M, Arrese M, Parana R, Méndez-Sánchez N, Ridruejo E, Mendizabal M, Dagher L, Contreras F, Fassio E, Pessoa M, Brahm J, Silva M. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver. Ann Hepatol 2022; 24:100321. [PMID: 33609753 DOI: 10.1016/j.aohep.2021.100321] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/27/2020] [Revised: 01/18/2021] [Accepted: 01/18/2021] [Indexed: 02/06/2023]
Abstract
Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) is an uncommon cause of liver disease presenting with a wide range of phenotypes and disease severity, acute hepatitis mimicking viral hepatitis to autoimmune hepatitis, steatosis, fibrosis or rare chronic vascular syndromes. Disease severity ranges from asymptomatic liver test abnormalities to acute liver failure. DILI has been traditionally classified in predictable or intrinsic (dose-related) or unpredictable (not dose-related) mechanisms. Few prospective studies are assessing the real prevalence and incidence of hepatotoxicity in the general population. DILI registries represent useful networks used for the study of liver toxicity, aimed at improving the understanding of causes, phenotypes, natural history, and standardized definitions of hepatotoxicity. Although most of the registries do not carry out population-based studies, they may provide important data related to the prevalence of DILI, and also may be useful to compare features from different countries. With the support of the Spanish Registry of Hepatotoxicity, our Latin American Registry (LATINDILI) was created in 2011, and more than 350 DILI patients have been recruited to date. This position paper describes the more frequent drugs and herbs-induced DILI in Latin America, mainly focusing on several features of responsible medicaments. Also, we highlighted the most critical points on the management of hepatotoxicity in general and those based on findings from our Latin American experience in particular.
Collapse
Affiliation(s)
- Fernando Bessone
- Hospital Provincial del Centenario, Facultad de Medicina, Universidad Nacional de Rosario, Rosario, Argentina.
| | | | - Martin Tagle
- Universidad Peruana Cayetano Heredia, Lima, Peru
| | - Marco Arrese
- Pontificia Universidad Católica de chile, Santiago de Chile, Chile
| | | | - Nahum Méndez-Sánchez
- Liver Research Unit, Medica Sur Clinic & Foundation, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico; Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Ezequiel Ridruejo
- Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno "CEMIC", Buenos Aires, Argentina
| | | | - Lucy Dagher
- Policlínica Metropolitana y CMDLT, Caracas, Venezuela
| | | | - Eduardo Fassio
- Hospital Nacional Prof. Alejandro Posadas, Provincia de Buenos Aires, Argentina
| | | | | | | |
Collapse
|
18
|
Niklander S, Guerra D, Contreras F, González-Arriagada W, Marín C. MicroRNAs and their role in the malignant transformation of oral leukoplakia: a scoping review. Med Oral Patol Oral Cir Bucal 2022; 27:e77-e84. [PMID: 34564679 PMCID: PMC8719793 DOI: 10.4317/medoral.24975] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Accepted: 09/06/2021] [Indexed: 11/18/2022] Open
Abstract
Background MiRNAs are small non-coding RNAs that regulate gene expression at the post-transcriptional level and have been associated with malignant transformation of oral epithelial precursor lesions such as oral leukoplakia. The aim was to perform a scoping review of the contemporary literature about the different roles of miRNAs during the malignant transformation of oral leukoplakia. Material and Methods We conducted a systematic search with the following MeSH terms: ‘oral leukoplakia’, ‘carcinoma in situ’, ‘microRNAs’, ‘mouth neoplasms’ and ‘epithelial–mesenchymal transition’ in PubMed/MEDLINE, EMBASE and SpringerLink. Results Fifteen articles were included for analysis, among which in vivo and in vitro articles were included. A total of 21 different miRNAs were found to be involved in the malignant transformation process of oral leukoplakia. Regarding their possible effects, 6 miRNAs were classified as oncogenic, 5 as tumour suppressors and 10 were related to epithelial–mesenchymal transition, invasion and migration. Conclusions Based on the current review, we concluded that miRNAs-21, 345, 181-b and 31* seem to be potential markers of malignant transformation of oral leukoplakia. However, further clinical prospective studies are needed in order to validate their utility as prognostic biomarkers. Key words:miRNAs, oral leukoplakia, oral squamous cell carcinoma, biomarkers, malignant transformation.
Collapse
Affiliation(s)
- S Niklander
- Departamento de Patología y Medicina Oral Universidad Andres Bello Postcode: 2520000. Quillota 980, Viña del Mar, Chile
| | | | | | | | | |
Collapse
|
19
|
Ospina AV, Bruges R, Mantilla W, Triana I, Ramos P, Aruachan S, Quiroga A, Munevar I, Ortiz J, Llinás N, Pinilla P, Vargas H, Idrobo H, Russi A, Kopp RM, Rivas G, González H, Santa D, Insuasty J, Bernal L, Otero J, Vargas C, Pacheco J, Alcalá C, Jiménez P, Lombana M, Contreras F, Segovia J, Pino L, Lobatón J, González M, Cuello J, Bogoya J, Barrero A, de Lima Lopes G. Impact of COVID-19 Infection on Patients with Cancer: Experience in a Latin American Country: The ACHOCC-19 Study. Oncologist 2021; 26:e1761-e1773. [PMID: 34132449 PMCID: PMC8441790 DOI: 10.1002/onco.13861] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Accepted: 06/01/2021] [Indexed: 01/08/2023] Open
Abstract
INTRODUCTION The ACHOCC-19 study was performed to characterize COVID-19 infection in a Colombian oncological population. METHODOLOGY Analytical cohort study of patients with cancer and COVID-19 infection in Colombia. From April 1 to October 31, 2020. Demographic and clinical variables related to cancer and COVID-19 infection were collected. The primary outcome was 30-day mortality from all causes. The association between the outcome and the prognostic variables was analyzed using logistic regression models and survival analysis with Cox regression. RESULTS The study included 742 patients; 72% were >51 years. The most prevalent neoplasms were breast (132, 17.77%), colorectal (92, 12.34%), and prostate (81, 10.9%). Two hundred twenty (29.6%) patients were asymptomatic and 96 (26.3%) died. In the bivariate descriptive analysis, higher mortality occurred in patients who were >70 years, patients with lung cancer, ≥2 comorbidities, former smokers, receiving antibiotics, corticosteroids, and anticoagulants, residents of rural areas, low socioeconomic status, and increased acute-phase reactants. In the logistic regression analysis, higher mortality was associated with Eastern Cooperative Oncology Group performance status (ECOG PS) 3 (odds ratio [OR] 28.67; 95% confidence interval [CI], 8.2-99.6); ECOG PS 4 (OR 20.89; 95% CI, 3.36-129.7); two complications from COVID-19 (OR 5.3; 95% CI, 1.50-18.1); and cancer in progression (OR 2.08; 95% CI, 1.01-4.27). In the Cox regression analysis, the statistically significant hazard ratios (HR) were metastatic disease (HR 1.58; 95% CI, 1.16-2.16), cancer in progression (HR 1.08; 95% CI, 1.24-2.61) cancer in partial response (HR 0.31; 95% CI, 0.11-0.88), use of steroids (HR 1.44; 95% CI, 1.01-2.06), and use of antibiotics (HR 2.11; 95% CI, 1.47-2.95). CONCLUSION In our study, patients with cancer have higher mortality due to COVID-19 infection if they have active cancer, metastatic or progressive cancer, ECOG PS >2, and low socioeconomic status. IMPLICATIONS FOR PRACTICE This study's findings raise the need to carefully evaluate patients with metastatic cancer, in progression, and with impaired Eastern Cooperative Oncology Group status to define the relevance of cancer treatment during the pandemic, consider the risk/benefit of the interventions, and establish clear and complete communication with the patients and their families about the risk of complications. There is also the importance of offering additional support to patients with low income and residence in rural areas so that they can have more support during cancer treatment.
Collapse
Affiliation(s)
- Aylen Vanessa Ospina
- ICCAL Instituto de Cancer Carlos Ardila Lulle Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes, Asociación Colombiana de Hematología y Oncología ACHOBogotáColombia
| | - Ricardo Bruges
- Instituto Nacional de Cancerología. Pontificia Universidad Javeriana, Universidad El Bosque, Asociación Colombiana de Hematología y OncologíaBogotáColombia
| | - William Mantilla
- Fundación Cardioinfantil, Asociación Colombiana de Hematología y OncologíaBogotáColombia
| | - Iván Triana
- ICCAL Instituto de Cancer Carlos Ardila Lulle Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes, Asociación Colombiana de Hematología y Oncología ACHOBogotáColombia
| | - Pedro Ramos
- Clínica Universitaria ColombiaBogotáColombia
| | | | | | | | - Juan Ortiz
- Hospital Universitario del ValleCaliColombia
| | | | - Paola Pinilla
- Hospital Universitario San Ignacio, Centro Javeriano de OncologíaBogotáColombia
| | | | - Henry Idrobo
- Universidad del ValleChristus Sinergia, CaliColombia
| | - Andrea Russi
- Hospital Universitario San Ignacio, Centro Javeriano de OncologíaBogotáColombia
| | - Ray Manneh Kopp
- Sociedad de Oncología y Hematología del CesarValleduparColombia
| | | | | | | | - Jesús Insuasty
- Hospital Universitario de Santander, Universidad Industrial de SantanderBucaramangaColombia
| | | | - Jorge Otero
- ICCAL Instituto de Cancer Carlos Ardila Lulle Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes, Asociación Colombiana de Hematología y Oncología ACHOBogotáColombia
| | | | - Javier Pacheco
- Fundación Universitaria de Ciencias de la Salud‐Hospital San JoséBogotáColombia
| | | | | | | | | | - Javier Segovia
- ICCAL Instituto de Cancer Carlos Ardila Lulle Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes, Asociación Colombiana de Hematología y Oncología ACHOBogotáColombia
| | - Luis Pino
- ICCAL Instituto de Cancer Carlos Ardila Lulle Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes, Asociación Colombiana de Hematología y Oncología ACHOBogotáColombia
| | | | | | | | | | | | | |
Collapse
|
20
|
Saigal G, Pisani L, Allakhverdieva E, Aristizabal J, Lehmkuhl D, Contreras F, Bhatia R, Sidani C, Quencer R. Utility of Microhemorrhage as a Diagnostic Tool in Distinguishing Vestibular Schwannomas from other Cerebellopontine Angle (CPA) Tumors. Indian J Otolaryngol Head Neck Surg 2021; 73:321-326. [PMID: 34471620 DOI: 10.1007/s12070-021-02372-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Accepted: 01/04/2021] [Indexed: 11/24/2022] Open
Abstract
Although a majority of tumors in the Cerebellopontine Angle (CPA) are vestibular schwannomas (VS), other masses can also be seen in the region and differentiation of various CPA tumors, particularly meningiomas can be difficult on imaging alone. Treatment options may vary based on specific pathology of the CPA tumor. In this study, the presence of microhemorrhage (MH) and other imaging features such as size of lesion, cystic features and pattern of IAC extension, were evaluated as a tool in distinguishing VS from other CPA masses. A review of CPA masses in the last 11 years at our institution was performed. All the pathology proven tumors with at least 1 pre-operative MRI were considered for analysis. A T2* GRE or SWI sequence was used to assess presence of MH within the lesion. Pattern of IAC extension ('centric' versus 'eccentric') of tumor was also evaluated. A total of 147 patients were reviewed out of which 102 patients (with T2* GRE or SWI) were included for analysis of MH. 57 patients (56%) had VS as the final histopathological diagnosis and 45 patients (44%) had other types of tumor. A sensitivity of 82% and a specificity of 98% was noted for the presence of MH favoring the diagnosis of VS from other tumors (p < 0.001). All meningiomas with IAC extension (25/31) showed an 'eccentric' pattern of extension into the canal. Visualization of MH and pattern of IAC extension is useful in the differentiation of schwannomas from other CPA masses, particularly meningiomas.
Collapse
Affiliation(s)
- G Saigal
- Department of Radiology, WW279, University of Miami Miller School of Medicine, 1611 NW 12th Avenue, Miami, FL 33136 USA
| | - L Pisani
- Emory University, 1364 Clifton Road Northeast, Atlanta, GA 30322 USA
| | - E Allakhverdieva
- Department of Radiology, WW279, University of Miami Miller School of Medicine, 1611 NW 12th Avenue, Miami, FL 33136 USA.,Jackson Memorial Hospital, 1611 NW 12th Avenue, Miami, FL 33136 USA
| | - J Aristizabal
- University of Antioquia, Cl. 67 ##53-108, Medellín, Antioquia, , CO USA
| | - D Lehmkuhl
- Department of Radiology, WW279, University of Miami Miller School of Medicine, 1611 NW 12th Avenue, Miami, FL 33136 USA.,Jackson Memorial Hospital, 1611 NW 12th Avenue, Miami, FL 33136 USA
| | - F Contreras
- Department of Radiology, WW279, University of Miami Miller School of Medicine, 1611 NW 12th Avenue, Miami, FL 33136 USA.,Jackson Memorial Hospital, 1611 NW 12th Avenue, Miami, FL 33136 USA
| | - R Bhatia
- Department of Radiology, WW279, University of Miami Miller School of Medicine, 1611 NW 12th Avenue, Miami, FL 33136 USA
| | - C Sidani
- Department of Radiology, WW279, University of Miami Miller School of Medicine, 1611 NW 12th Avenue, Miami, FL 33136 USA
| | - R Quencer
- Department of Radiology, WW279, University of Miami Miller School of Medicine, 1611 NW 12th Avenue, Miami, FL 33136 USA
| |
Collapse
|
21
|
Bernardo M, Amoretti S, Cuesta MJ, Parellada M, Mezquida G, González-Pinto A, Bergé D, Lobo A, Aguilar EJ, Usall J, Corripio I, Bobes J, Rodríguez-Jiménez R, Sarró S, Contreras F, Ibáñez Á, Gutiérrez M, Micó JA. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design. Rev Psiquiatr Salud Ment (Engl Ed) 2021; 14:164-176. [PMID: 34456031 DOI: 10.1016/j.rpsmen.2021.08.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Accepted: 07/15/2020] [Indexed: 12/16/2022]
Abstract
Up to 80% of first-episode psychosis patients suffer a relapse within five years of the remission. Relapse should be an important focus of prevention given the potential harm to the patient and family. It threatens to disrupt their psychosocial recovery, increases the risk of resistance to treatment and has been associated with greater direct and indirect costs for society. Based on a previous project entitled "Genotype-phenotype and environment. Application to a predictive model in first psychotic episodes" (PEPs Project), the project "Clinical and neurobiological determinants of second episodes of schizophrenia. Longitudinal study of first episode of psychosis" was designed, also known as the 2EPs Project. It aimed to identify and characterize those factors that predict a relapse within the years immediately following a first episode. This project has focused on following the clinical course, with neuropsychological assessments, biological and neuroanatomical measures, genetic adherence and physical health monitoring in order to compare a subgroup of patients with a second episode to another group of patients which remains in remission. The main objective of the present article is to describe the rationale of the 2EPs Project, explaining the measurement approach adopted and providing an overview of the selected clinical and functional measures. 2EPs Project is a multicenter, coordinated, naturalistic, longitudinal follow-up study over three years in a Spanish sample of patients in remission after a first-psychotic episode of schizophrenia. It is closely monitoring the clinical course of the cases recruited to compare the subgroup of patients with a second episode to that which remains in remission. The sample is composed of 223 subjects recruited from 15 clinical centres in Spain with experience of the preceding PEPs Study project, albeit 2EPs being an expanded version with new basic groups in biological research. From the total sample recruited, 63 patients presented a relapse (44%). 2EPs arose to characterize first episodes in an exhaustive, novel and multimodal way, thus contributing towards the development of a predictive model of relapse. Identifying the characteristics of patients who relapse could improve early detection and intervention.
Collapse
Affiliation(s)
- Miguel Bernardo
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Barcelona, Spain; Departament de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain; August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
| | - Silvia Amoretti
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Barcelona, Spain; Departament de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain; August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
| | - Manuel Jesús Cuesta
- Departamento de Psiquiatría, Complejo Hospitalario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, Spain
| | - Mara Parellada
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain; Servicio de Psiquiatría del Niño y del Adolescente, Hospital General Universitario Gregorio Marañón (IiSGM), Facultad de Medicina, Universidad Complutense, CIBERSAM, Madrid, España
| | - Gisela Mezquida
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Barcelona, Spain; Departament de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain; August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
| | - Ana González-Pinto
- Department of Psychiatry, Araba University Hospital, Bioaraba Research Institute, Department of Neurociences, University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - Daniel Bergé
- Department of Neurosciences and Psychiatry, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
| | - Antonio Lobo
- Department of Medicine and Psychiatry. Universidad de Zaragoza. Instituto de Investigación Aragón, CIBERSAM, Zaragoza, Spain
| | - Eduardo J Aguilar
- Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, CIBERSAM, Valencia, Spain
| | - Judith Usall
- Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, SantBoi de Llobregat; Fundació Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
| | - Iluminada Corripio
- Department of Psychiatry, Biomedical Research Institute Sant Pau (IIB-SANT PAU), Santa Creu and Sant Pau Hospital; Autonomous University of Barcelona (UAB), CIBERSAM, Barcelona, Spain
| | - Julio Bobes
- Área de Psiquiatría, Universidad de Oviedo, Servicio de Salud del Principado de Asturias, Instituto de Neurociencias del Principado de Asturias (INEUROPA), CIBERSAM, Oviedo, Asturias, Spain
| | - Roberto Rodríguez-Jiménez
- Departamento de Psiquiatría, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), CogPsy-Group, Universidad Complutense de Madrid (UCM), CIBERSAM, Madrid, Spain
| | - Salvador Sarró
- FIDMAG Research Foundation Germanes Hospitalàries, CIBERSAM, Barcelona, Spain
| | - Fernando Contreras
- Psychiatry Department, Bellvitge University Hospital-IDIBELL, Barcelona, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain
| | - Ángela Ibáñez
- Departamento de Psiquiatría, Hospital Ramon y Cajal, Universidad de Alcalá, IRYCIS, CIBERSAM, Madrid, Spain
| | - Miguel Gutiérrez
- Department of Psychiatry, Hospital Santiago Apóstol, University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - Juan Antonio Micó
- Grupo de Investigación en Neuropsicofarmacología y Psicobiología, Departamento de Neurociencias, Universidad de Cádiz, Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz, INiBICA, Hospital Universitario Puerta del Mar, CIBERSAM, Cádiz, Spain
| |
Collapse
|
22
|
Aab A, Abreu P, Aglietta M, Albury JM, Allekotte I, Almela A, Alvarez-Muñiz J, Alves Batista R, Anastasi GA, Anchordoqui L, Andrada B, Andringa S, Aramo C, Araújo Ferreira PR, Asorey H, Assis P, Avila G, Badescu AM, Bakalova A, Balaceanu A, Barbato F, Barreira Luz RJ, Becker KH, Bellido JA, Berat C, Bertaina ME, Bertou X, Biermann PL, Bister T, Biteau J, Blazek J, Bleve C, Boháčová M, Boncioli D, Bonifazi C, Bonneau Arbeletche L, Borodai N, Botti AM, Brack J, Bretz T, Briechle FL, Buchholz P, Bueno A, Buitink S, Buscemi M, Caballero-Mora KS, Caccianiga L, Cancio A, Canfora F, Caracas I, Carceller JM, Caruso R, Castellina A, Catalani F, Cataldi G, Cazon L, Cerda M, Chinellato JA, Choi K, Chudoba J, Chytka L, Clay RW, Cobos Cerutti AC, Colalillo R, Coleman A, Coluccia MR, Conceição R, Condorelli A, Consolati G, Contreras F, Convenga F, Covault CE, Dasso S, Daumiller K, Dawson BR, Day JA, de Almeida RM, de Jesús J, de Jong SJ, De Mauro G, de Mello Neto JRT, De Mitri I, de Oliveira J, de Oliveira Franco D, de Souza V, De Vito E, Debatin J, Del Río M, Deligny O, Dembinski H, Dhital N, Di Matteo A, Dobrigkeit C, D'Olivo JC, Dos Anjos RC, Dova MT, Ebr J, Engel R, Epicoco I, Erdmann M, Escobar CO, Etchegoyen A, Falcke H, Farmer J, Farrar G, Fauth AC, Fazzini N, Feldbusch F, Fenu F, Fick B, Figueira JM, Filipčič A, Fodran T, Freire MM, Fujii T, Fuster A, Galea C, Galelli C, García B, Garcia Vegas AL, Gemmeke H, Gesualdi F, Gherghel-Lascu A, Ghia PL, Giaccari U, Giammarchi M, Giller M, Glombitza J, Gobbi F, Gollan F, Golup G, Gómez Berisso M, Gómez Vitale PF, Gongora JP, González N, Goos I, Góra D, Gorgi A, Gottowik M, Grubb TD, Guarino F, Guedes GP, Guido E, Hahn S, Halliday R, Hampel MR, Hansen P, Harari D, Harvey VM, Haungs A, Hebbeker T, Heck D, Hill GC, Hojvat C, Hörandel JR, Horvath P, Hrabovský M, Huege T, Hulsman J, Insolia A, Isar PG, Johnsen JA, Jurysek J, Kääpä A, Kampert KH, Keilhauer B, Kemp J, Klages HO, Kleifges M, Kleinfeller J, Köpke M, Kukec Mezek G, Lago BL, LaHurd D, Lang RG, Langner N, Leigui de Oliveira MA, Lenok V, Letessier-Selvon A, Lhenry-Yvon I, Lo Presti D, Lopes L, López R, Lorek R, Luce Q, Lucero A, Lundquist JP, Machado Payeras A, Mancarella G, Mandat D, Manning BC, Manshanden J, Mantsch P, Marafico S, Mariazzi AG, Mariş IC, Marsella G, Martello D, Martinez H, Martínez Bravo O, Mastrodicasa M, Mathes HJ, Matthews J, Matthiae G, Mayotte E, Mazur PO, Medina-Tanco G, Melo D, Menshikov A, Merenda KD, Michal S, Micheletti MI, Miramonti L, Mollerach S, Montanet F, Morello C, Mostafá M, Müller AL, Muller MA, Mulrey K, Mussa R, Muzio M, Namasaka WM, Nellen L, Niculescu-Oglinzanu M, Niechciol M, Nitz D, Nosek D, Novotny V, Nožka L, Nucita A, Núñez LA, Palatka M, Pallotta J, Papenbreer P, Parente G, Parra A, Pech M, Pedreira F, Pȩkala J, Pelayo R, Peña-Rodriguez J, Perez Armand J, Perlin M, Perrone L, Petrera S, Pierog T, Pimenta M, Pirronello V, Platino M, Pont B, Pothast M, Privitera P, Prouza M, Puyleart A, Querchfeld S, Rautenberg J, Ravignani D, Reininghaus M, Ridky J, Riehn F, Risse M, Ristori P, Rizi V, Rodrigues de Carvalho W, Rodriguez Rojo J, Roncoroni MJ, Roth M, Roulet E, Rovero AC, Ruehl P, Saffi SJ, Saftoiu A, Salamida F, Salazar H, Salina G, Sanabria Gomez JD, Sánchez F, Santos EM, Santos E, Sarazin F, Sarmento R, Sarmiento-Cano C, Sato R, Savina P, Schäfer CM, Scherini V, Schieler H, Schimassek M, Schimp M, Schlüter F, Schmidt D, Scholten O, Schovánek P, Schröder FG, Schröder S, Schulte J, Sciutto SJ, Scornavacche M, Shellard RC, Sigl G, Silli G, Sima O, Šmída R, Sommers P, Soriano JF, Souchard J, Squartini R, Stadelmaier M, Stanca D, Stanič S, Stasielak J, Stassi P, Streich A, Suárez-Durán M, Sudholz T, Suomijärvi T, Supanitsky AD, Šupík J, Szadkowski Z, Taboada A, Tapia A, Timmermans C, Tkachenko O, Tobiska P, Todero Peixoto CJ, Tomé B, Torralba Elipe G, Travaini A, Travnicek P, Trimarelli C, Trini M, Tueros M, Ulrich R, Unger M, Vaclavek L, Vacula M, Valdés Galicia JF, Valiño I, Valore L, Varela E, Varma K C V, Vásquez-Ramírez A, Veberič D, Ventura C, Vergara Quispe ID, Verzi V, Vicha J, Vink J, Vorobiov S, Wahlberg H, Watson AA, Weber M, Weindl A, Wiencke L, Wilczyński H, Winchen T, Wirtz M, Wittkowski D, Wundheiler B, Yushkov A, Zapparrata O, Zas E, Zavrtanik D, Zavrtanik M, Zehrer L, Zepeda A. Measurement of the Fluctuations in the Number of Muons in Extensive Air Showers with the Pierre Auger Observatory. Phys Rev Lett 2021; 126:152002. [PMID: 33929235 DOI: 10.1103/physrevlett.126.152002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/04/2020] [Revised: 01/28/2021] [Accepted: 02/12/2021] [Indexed: 06/12/2023]
Abstract
We present the first measurement of the fluctuations in the number of muons in extensive air showers produced by ultrahigh energy cosmic rays. We find that the measured fluctuations are in good agreement with predictions from air shower simulations. This observation provides new insights into the origin of the previously reported deficit of muons in air shower simulations and constrains models of hadronic interactions at ultrahigh energies. Our measurement is compatible with the muon deficit originating from small deviations in the predictions from hadronic interaction models of particle production that accumulate as the showers develop.
Collapse
Affiliation(s)
- A Aab
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - P Abreu
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Aglietta
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - J M Albury
- University of Adelaide, Adelaide, South Australia, Australia
| | - I Allekotte
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - A Almela
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - J Alvarez-Muñiz
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - R Alves Batista
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - G A Anastasi
- INFN, Sezione di Torino, Torino, Italy
- Dipartimento di Fisica, Università Torino, Torino, Italy
| | - L Anchordoqui
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
| | - B Andrada
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - S Andringa
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - C Aramo
- INFN, Sezione di Napoli, Napoli, Italy
| | | | - H Asorey
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - P Assis
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - G Avila
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - A M Badescu
- University Politehnica of Bucharest, Bucharest, Romania
| | - A Bakalova
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Balaceanu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - F Barbato
- INFN, Sezione di Napoli, Napoli, Italy
- Dipartimento di Fisica "Ettore Pancini," Università di Napoli "Federico II," Napoli, Italy
| | - R J Barreira Luz
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - K H Becker
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - J A Bellido
- University of Adelaide, Adelaide, South Australia, Australia
| | - C Berat
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - M E Bertaina
- INFN, Sezione di Torino, Torino, Italy
- Dipartimento di Fisica, Università Torino, Torino, Italy
| | - X Bertou
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - P L Biermann
- Max-Planck-Institut für Radioastronomie, Bonn, Germany
| | - T Bister
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - J Biteau
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - J Blazek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C Bleve
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - M Boháčová
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - D Boncioli
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - C Bonifazi
- Instituto de Física, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | | | - N Borodai
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - A M Botti
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - J Brack
- Colorado State University, Fort Collins, Colorado, USA
| | - T Bretz
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - F L Briechle
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - P Buchholz
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - A Bueno
- Universidad de Granada and C.A.F.P.E., Granada, Spain
| | - S Buitink
- Vrije Universiteit Brussels, Brussels, Belgium
| | - M Buscemi
- Dipartimento di Fisica e Astronomia, Università di Catania, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | | | - L Caccianiga
- Dipartimento di Fisica, Università di Milano, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - A Cancio
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - F Canfora
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - I Caracas
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - J M Carceller
- Universidad de Granada and C.A.F.P.E., Granada, Spain
| | - R Caruso
- Dipartimento di Fisica e Astronomia, Università di Catania, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - A Castellina
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - F Catalani
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
| | - G Cataldi
- INFN, Sezione di Lecce, Lecce, Italy
| | - L Cazon
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Cerda
- Observatorio Pierre Auger, Malargüe, Argentina
| | - J A Chinellato
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
| | - K Choi
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - J Chudoba
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - L Chytka
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - R W Clay
- University of Adelaide, Adelaide, South Australia, Australia
| | - A C Cobos Cerutti
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
| | - R Colalillo
- INFN, Sezione di Napoli, Napoli, Italy
- Dipartimento di Fisica "Ettore Pancini," Università di Napoli "Federico II," Napoli, Italy
| | - A Coleman
- Department of Physics and Astronomy, Bartol Research Institute, University of Delaware, Newark, Delaware, USA
| | - M R Coluccia
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
| | - R Conceição
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - A Condorelli
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Gran Sasso Science Institute, L'Aquila, Italy
| | - G Consolati
- INFN, Sezione di Milano, Milano, Italy
- Dipartimento di Scienze e Tecnologie Aerospaziali, Politecnico di Milano, Milano, Italy
| | - F Contreras
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - F Convenga
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
| | - C E Covault
- Case Western Reserve University, Cleveland, Ohio, USA
| | - S Dasso
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
| | - K Daumiller
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - B R Dawson
- University of Adelaide, Adelaide, South Australia, Australia
| | - J A Day
- University of Adelaide, Adelaide, South Australia, Australia
| | - R M de Almeida
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
| | - J de Jesús
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - S J de Jong
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - G De Mauro
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - J R T de Mello Neto
- Instituto de Física, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Brazil
| | - I De Mitri
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Gran Sasso Science Institute, L'Aquila, Italy
| | - J de Oliveira
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
| | | | - V de Souza
- Instituto de Física de São Carlos, Universidade de São Paulo, São Carlos, São Paulo, Brazil
| | - E De Vito
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
| | - J Debatin
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - M Del Río
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - O Deligny
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | - H Dembinski
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - N Dhital
- Institute of Nuclear Physics PAN, Krakow, Poland
| | | | - C Dobrigkeit
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
| | - J C D'Olivo
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
| | - R C Dos Anjos
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
| | - M T Dova
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - J Ebr
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - R Engel
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - I Epicoco
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
| | - M Erdmann
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - C O Escobar
- Fermi National Accelerator Laboratory, Batavia, Illinois, USA
| | - A Etchegoyen
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - H Falcke
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
| | - J Farmer
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - G Farrar
- New York University, New York, New York, USA
| | - A C Fauth
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
| | - N Fazzini
- Fermi National Accelerator Laboratory, Fermilab, Batavia, Illinois, USA
| | - F Feldbusch
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - F Fenu
- INFN, Sezione di Torino, Torino, Italy
- Dipartimento di Fisica, Università Torino, Torino, Italy
| | - B Fick
- Michigan Technological University, Houghton, Michigan, USA
| | - J M Figueira
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Filipčič
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - T Fodran
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - M M Freire
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas Universidad Nacional de Rosario, Rosario, Argentina
| | - T Fujii
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - A Fuster
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - C Galea
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - C Galelli
- Dipartimento di Fisica, Università di Milano, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - B García
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
| | - A L Garcia Vegas
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - H Gemmeke
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - F Gesualdi
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - A Gherghel-Lascu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - P L Ghia
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | - U Giaccari
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | | | - M Giller
- Faculty of Astrophysics, University of Łódź, Łódź, Poland
| | - J Glombitza
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - F Gobbi
- Observatorio Pierre Auger, Malargüe, Argentina
| | - F Gollan
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - G Golup
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - M Gómez Berisso
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - P F Gómez Vitale
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - J P Gongora
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - N González
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - I Goos
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - D Góra
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - A Gorgi
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - M Gottowik
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - T D Grubb
- University of Adelaide, Adelaide, South Australia, Australia
| | - F Guarino
- INFN, Sezione di Napoli, Napoli, Italy
- Dipartimento di Fisica "Ettore Pancini," Università di Napoli "Federico II," Napoli, Italy
| | - G P Guedes
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
| | - E Guido
- INFN, Sezione di Torino, Torino, Italy
- Dipartimento di Fisica, Università Torino, Torino, Italy
| | - S Hahn
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - R Halliday
- Case Western Reserve University, Cleveland, Ohio, USA
| | - M R Hampel
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - P Hansen
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - D Harari
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - V M Harvey
- University of Adelaide, Adelaide, South Australia, Australia
| | - A Haungs
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - T Hebbeker
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - D Heck
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - G C Hill
- University of Adelaide, Adelaide, South Australia, Australia
| | - C Hojvat
- Fermi National Accelerator Laboratory, Fermilab, Batavia, Illinois, USA
| | - J R Hörandel
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - P Horvath
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - M Hrabovský
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - T Huege
- Vrije Universiteit Brussels, Brussels, Belgium
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - J Hulsman
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - A Insolia
- Dipartimento di Fisica e Astronomia, Università di Catania, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - P G Isar
- Institute of Space Science, Bucharest-Magurele, Romania
| | - J A Johnsen
- Colorado School of Mines, Golden, Colorado, USA
| | - J Jurysek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Kääpä
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - K H Kampert
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - B Keilhauer
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - J Kemp
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - H O Klages
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M Kleifges
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | | | - M Köpke
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - G Kukec Mezek
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - B L Lago
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Nova Friburgo, Brazil
| | - D LaHurd
- Case Western Reserve University, Cleveland, Ohio, USA
| | - R G Lang
- Instituto de Física de São Carlos, Universidade de São Paulo, São Carlos, São Paulo, Brazil
| | - N Langner
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | | | - V Lenok
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - A Letessier-Selvon
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
| | - I Lhenry-Yvon
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | - D Lo Presti
- Dipartimento di Fisica e Astronomia, Università di Catania, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - L Lopes
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - R López
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - R Lorek
- Case Western Reserve University, Cleveland, Ohio, USA
| | - Q Luce
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - A Lucero
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - J P Lundquist
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - A Machado Payeras
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
| | - G Mancarella
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
| | - D Mandat
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - B C Manning
- University of Adelaide, Adelaide, South Australia, Australia
| | - J Manshanden
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
| | - P Mantsch
- Fermi National Accelerator Laboratory, Fermilab, Batavia, Illinois, USA
| | - S Marafico
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | - A G Mariazzi
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - I C Mariş
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - G Marsella
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
| | - D Martello
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
| | - H Martinez
- Instituto de Física de São Carlos, Universidade de São Paulo, São Carlos, São Paulo, Brazil
| | | | - M Mastrodicasa
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - H J Mathes
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - J Matthews
- Louisiana State University, Baton Rouge, Louisiana, USA
| | - G Matthiae
- Dipartimento di Fisica, Università di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
| | - E Mayotte
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - P O Mazur
- Fermi National Accelerator Laboratory, Fermilab, Batavia, Illinois, USA
| | - G Medina-Tanco
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
| | - D Melo
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Menshikov
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - K-D Merenda
- Colorado School of Mines, Golden, Colorado, USA
| | - S Michal
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - M I Micheletti
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas Universidad Nacional de Rosario, Rosario, Argentina
| | - L Miramonti
- Dipartimento di Fisica, Università di Milano, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - S Mollerach
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - F Montanet
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - C Morello
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - M Mostafá
- Pennsylvania State University, University Park, Pennsylvania, USA
| | - A L Müller
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M A Muller
- Instituto de Física, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
| | - K Mulrey
- Vrije Universiteit Brussels, Brussels, Belgium
| | - R Mussa
- INFN, Sezione di Torino, Torino, Italy
| | - M Muzio
- New York University, New York, New York, USA
| | - W M Namasaka
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - L Nellen
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
| | - M Niculescu-Oglinzanu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - M Niechciol
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - D Nitz
- Michigan Technological University, Houghton, Michigan, USA
| | - D Nosek
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - V Novotny
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - L Nožka
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - A Nucita
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
| | - L A Núñez
- Universidad Industrial de Santander, Bucaramanga, Colombia
| | - M Palatka
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Pallotta
- Centro de Investigaciones en Láseres y Aplicaciones, CITEDEF and CONICET, Villa Martelli, Argentina
| | - P Papenbreer
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - G Parente
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Parra
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - M Pech
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Pedreira
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Pȩkala
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - R Pelayo
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
| | | | - J Perez Armand
- Instituto de Física, Universidade de São Paulo, São Paulo, Brazil
| | - M Perlin
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - L Perrone
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
| | - S Petrera
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Gran Sasso Science Institute, L'Aquila, Italy
| | - T Pierog
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M Pimenta
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - V Pirronello
- Dipartimento di Fisica e Astronomia, Università di Catania, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - M Platino
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - B Pont
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - M Pothast
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - P Privitera
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - M Prouza
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Puyleart
- Michigan Technological University, Houghton, Michigan, USA
| | - S Querchfeld
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - J Rautenberg
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - D Ravignani
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - M Reininghaus
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - J Ridky
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Riehn
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Risse
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - P Ristori
- Centro de Investigaciones en Láseres y Aplicaciones, CITEDEF and CONICET, Villa Martelli, Argentina
| | - V Rizi
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | | | - J Rodriguez Rojo
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - M J Roncoroni
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - M Roth
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - E Roulet
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - A C Rovero
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
| | - P Ruehl
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - S J Saffi
- University of Adelaide, Adelaide, South Australia, Australia
| | - A Saftoiu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - F Salamida
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - H Salazar
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - G Salina
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
| | | | - F Sánchez
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - E M Santos
- Instituto de Física, Universidade de São Paulo, São Paulo, Brazil
| | - E Santos
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Sarazin
- Colorado School of Mines, Golden, Colorado, USA
| | - R Sarmento
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - C Sarmiento-Cano
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - R Sato
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - P Savina
- INFN, Sezione di Lecce, Lecce, Italy
- Dipartimento di Matematica e Fisica "E. De Giorgi," Università del Salento, Lecce, Italy
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | - C M Schäfer
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | | | - H Schieler
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M Schimassek
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - M Schimp
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - F Schlüter
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - D Schmidt
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - O Scholten
- Vrije Universiteit Brussels, Brussels, Belgium
- KVI-Center for Advanced Radiation Technology, University of Groningen, Groningen, The Netherlands
| | - P Schovánek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F G Schröder
- Department of Physics and Astronomy, Bartol Research Institute, University of Delaware, Newark, Delaware, USA
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - S Schröder
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - J Schulte
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - S J Sciutto
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - M Scornavacche
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - R C Shellard
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Brazil
| | - G Sigl
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
| | - G Silli
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - O Sima
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - R Šmída
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - P Sommers
- Pennsylvania State University, University Park, Pennsylvania, USA
| | - J F Soriano
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
| | - J Souchard
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - R Squartini
- Observatorio Pierre Auger, Malargüe, Argentina
| | - M Stadelmaier
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - D Stanca
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - S Stanič
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - J Stasielak
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - P Stassi
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - A Streich
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - M Suárez-Durán
- Universidad Industrial de Santander, Bucaramanga, Colombia
| | - T Sudholz
- University of Adelaide, Adelaide, South Australia, Australia
| | - T Suomijärvi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - A D Supanitsky
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - J Šupík
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - Z Szadkowski
- Faculty of High-Energy Astrophysics, University of Łódź, Łódź, Poland
| | - A Taboada
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - A Tapia
- Universidad de Medellín, Medellín, Colombia
| | - C Timmermans
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - O Tkachenko
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - P Tobiska
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C J Todero Peixoto
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
| | - B Tomé
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - G Torralba Elipe
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Travaini
- Observatorio Pierre Auger, Malargüe, Argentina
| | - P Travnicek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C Trimarelli
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - M Trini
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - M Tueros
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - R Ulrich
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M Unger
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - L Vaclavek
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - M Vacula
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - J F Valdés Galicia
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
| | - I Valiño
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Gran Sasso Science Institute, L'Aquila, Italy
| | - L Valore
- INFN, Sezione di Napoli, Napoli, Italy
- Dipartimento di Fisica "Ettore Pancini," Università di Napoli "Federico II," Napoli, Italy
| | - E Varela
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - V Varma K C
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | | | - D Veberič
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - C Ventura
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Brazil
| | | | - V Verzi
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
| | - J Vicha
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Vink
- Faculty of Science, Universiteit van Amsterdam, Amsterdam, The Netherlands
| | - S Vorobiov
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - H Wahlberg
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - A A Watson
- School of Physics and Astronomy, University of Leeds, Leeds, United Kingdom
| | - M Weber
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - A Weindl
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - L Wiencke
- Colorado School of Mines, Golden, Colorado, USA
| | - H Wilczyński
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - T Winchen
- Vrije Universiteit Brussels, Brussels, Belgium
| | - M Wirtz
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - D Wittkowski
- Department of Physics, Bergische Universität Wuppertal, Wuppertal, Germany
| | - B Wundheiler
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Yushkov
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - O Zapparrata
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - E Zas
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - D Zavrtanik
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - M Zavrtanik
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - L Zehrer
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - A Zepeda
- Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV), México, Distrito Federal, México
| |
Collapse
|
23
|
Mendizabal M, Ridruejo E, Piñero F, Anders M, Padilla M, Toro LG, Torre A, Montes P, Urzúa A, Gonzalez Ballerga E, Silveyra MD, Michelato D, Díaz J, Peralta M, Pages J, García SR, Gutierrez Lozano I, Macias Y, Cocozzella D, Chavez-Tapia N, Tagle M, Dominguez A, Varón A, Vera Pozo E, Higuera-de la Tijera F, Bustios C, Conte D, Escajadillo N, Gómez AJ, Tenorio L, Castillo Barradas M, Schinoni MI, Bessone F, Contreras F, Nazal L, Sanchez A, García M, Brutti J, Cabrera MC, Miranda-Zazueta G, Rojas G, Cattaneo M, Castro-Narro G, Rubinstein F, Silva MO. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection. Ann Hepatol 2021; 25:100350. [PMID: 33864948 PMCID: PMC8045426 DOI: 10.1016/j.aohep.2021.100350] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/11/2021] [Revised: 03/01/2021] [Accepted: 03/05/2021] [Indexed: 02/06/2023]
Abstract
INTRODUCTION AND OBJECTIVES Viral infections have been described to increase the risk of decompensation in patients with cirrhosis. We aimed to determine the effect of SARS-CoV-2 infection on outcome of hospitalized patients with cirrhosis and to compare the performance of different prognostic models for predicting mortality. PATIENTS We performed a prospective cohort study including 2211 hospitalized patients with confirmed SARS-CoV-2 infection from April 15, 2020 through October 1, 2020 in 38 Hospitals from 11 Latin American countries. We registered clinical and laboratory parameters of patients with and without cirrhosis. All patients were followed until discharge or death. We evaluated the prognostic performance of different scoring systems to predict mortality in patients with cirrhosis using ROC curves. RESULTS Overall, 4.6% (CI 3.7-5.6) subjects had cirrhosis (n = 96). Baseline Child-Turcotte-Pugh (CTP) class was assessed: CTP-A (23%), CTP-B (45%) and CTP-C (32%); median MELD-Na score was 19 (IQR 14-25). Mortality was 47% in patients with cirrhosis and 16% in patients without cirrhosis (P < .0001). Cirrhosis was independently associated with death [OR 3.1 (CI 1.9-4.8); P < .0001], adjusted by age, gender, and body mass index >30. The areas under the ROC curves for performance evaluation in predicting 28-days mortality for Chronic Liver Failure Consortium (CLIF-C), North American Consortium for the Study of End-Stage Liver Disease (NACSELD), CTP score and MELD-Na were 0.85, 0.75, 0.69, 0.67; respectively (P < .0001). CONCLUSIONS SARS-CoV-2 infection is associated with elevated mortality in patients with cirrhosis. CLIF-C had better performance in predicting mortality than NACSELD, CTP and MELD-Na in patients with cirrhosis and SARS-CoV-2 infection. Clinicaltrials.gov:NCT04358380.
Collapse
Affiliation(s)
- Manuel Mendizabal
- Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Universidad Austral, Pilar, Argentina; Latin American Liver Research Educational and Awareness Network (LALREAN).
| | - Ezequiel Ridruejo
- Latin American Liver Research Educational and Awareness Network (LALREAN); Liver Section, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina
| | - Federico Piñero
- Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Universidad Austral, Pilar, Argentina; Latin American Liver Research Educational and Awareness Network (LALREAN)
| | - Margarita Anders
- Latin American Liver Research Educational and Awareness Network (LALREAN); Hepatology and Liver Transplant Unit, Hospital Alemán, Buenos Aires, Argentina
| | - Martín Padilla
- Gastroenterology Unit, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Perú
| | - Luis G Toro
- Hepatology and Liver Transplant Unit, Hospitales de San Vicente Fundación de Medellín y Rionegro, Medellín, Colombia
| | - Aldo Torre
- Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición, Ciudad de México, México
| | - Pedro Montes
- Gastroenterology Unit, Hospital Nacional Daniel A. Carrión, Callao, Perú
| | - Alvaro Urzúa
- Gastroenterology Section, Internal Medicine Department, Hospital Clínico de la Universidad de Chile, Santiago, Chile
| | - Esteban Gonzalez Ballerga
- Department of Gastroenterology, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires, Argentina
| | | | - Douglas Michelato
- Hospital Especializado en Enfermedades Infecciosas Instituto Couto Maia, Salvador de Bahía, Brazil
| | - Javier Díaz
- Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú
| | - Mirta Peralta
- Latin American Liver Research Educational and Awareness Network (LALREAN); Intensive Care Unit, Hospital de Infecciosas Francisco J Muñiz, Buenos Aires, Argentina
| | - Josefina Pages
- Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Universidad Austral, Pilar, Argentina; Latin American Liver Research Educational and Awareness Network (LALREAN)
| | - Sandro Ruiz García
- Gastroenterology Unit, Hospital de Víctor Lazarte Echegaray, Trujillo, Perú
| | | | - Yuridia Macias
- Department of Medicine, IMSS Hospital General Regional No. 1 "Dr. Carlos Mc Gregor Sánchez", Ciudad de México, Mexico
| | - Daniel Cocozzella
- Latin American Liver Research Educational and Awareness Network (LALREAN); Department of Gastroenterology, Hospital Italiano de La Plata, La Plata, Argentina
| | | | - Martín Tagle
- Gastroenterology Unit, Clínica Anglo-Americana, Lima, Perú
| | | | - Adriana Varón
- Latin American Liver Research Educational and Awareness Network (LALREAN); Liver Unit, Fundación Cardio-Infantil, Bogotá, Colombia
| | - Emilia Vera Pozo
- Hospital Regional Dr. Teodoro Maldonado Carbo del IESS, Guayaquil, Ecuador
| | - Fátima Higuera-de la Tijera
- Department of Gastroenterology and Hepatology, Hospital General de México "Dr. Eduardo Liceaga", Ciudad de México, México
| | | | - Damián Conte
- Unidad de Hígado, Hospital Privado de Córdoba, Córdoba, Argentina
| | - Nataly Escajadillo
- Gastroenterology Unit, Hospital Nacional Almanzor Aguinaga Asenjo, Chiclayo, Perú
| | - Andrés J Gómez
- Endoscopy and Transplant Service, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - Laura Tenorio
- Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú
| | - Mauricio Castillo Barradas
- Gastroenterology Unit, Hospital de Especialidades del Centro Médico Nacional La Raza IMSS, Ciudad de México, México
| | - Maria Isabel Schinoni
- Latin American Liver Research Educational and Awareness Network (LALREAN); Department of Gastroenterology, Hospital Alianza, Bahía, Brazil
| | - Fernando Bessone
- Department of Gastroenterology, Hospital Provincial del Centenario, Rosario, Argentina
| | - Fernando Contreras
- Department of Gastroenterology, CEDIMAT, Santo Domingo, Dominican Republic
| | - Leyla Nazal
- Department of Gastroenterology, Clínica Las Condes, Santiago, Chile
| | - Abel Sanchez
- Department of Gastroenterology, Hospital Roosevelt, Ciudad de Guatemala, Guatemala
| | - Matías García
- Liver Section, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina
| | - Julia Brutti
- Department of Internal Medicine, Sanatorio Anchorena, Buenos Aires, Argentina
| | | | - Godolfino Miranda-Zazueta
- Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición, Ciudad de México, México
| | - German Rojas
- Department of Gastroenterology, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Maximo Cattaneo
- Gastroenterology Section, Internal Medicine Department, Hospital Clínico de la Universidad de Chile, Santiago, Chile
| | | | | | - Marcelo O Silva
- Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Universidad Austral, Pilar, Argentina; Latin American Liver Research Educational and Awareness Network (LALREAN)
| |
Collapse
|
24
|
González-Ortega I, González-Pinto A, Alberich S, Echeburúa E, Bernardo M, Cabrera B, Amoretti S, Lobo A, Arango C, Corripio I, Vieta E, de la Serna E, Rodriguez-Jimenez R, Segarra R, López-Ilundain JM, Sánchez-Torres AM, Cuesta MJ, Zorrilla I, López P, Bioque M, Mezquida G, Barcones F, De-la-Cámara C, Parellada M, Espliego A, Alonso-Solís A, Grasa EM, Varo C, Montejo L, Castro-Fornieles J, Baeza I, Dompablo M, Torio I, Zabala A, Eguiluz JI, Moreno-Izco L, Sanjuan J, Guirado R, Cáceres I, Garnier P, Contreras F, Bobes J, Al-Halabí S, Usall J, Butjosa A, Sarró S, Landin-Romero R, Ibáñez A, Selva G. Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis. Psychol Med 2020; 50:2702-2710. [PMID: 31637990 DOI: 10.1017/s0033291719002794] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
BACKGROUND Social cognition has been associated with functional outcome in patients with first episode psychosis (FEP). Social cognition has also been associated with neurocognition and cognitive reserve. Although cognitive reserve, neurocognitive functioning, social cognition, and functional outcome are related, the direction of their associations is not clear. Therefore, the main aim of this study was to analyze the influence of social cognition as a mediator between cognitive reserve and cognitive domains on functioning in FEP both at baseline and at 2 years. METHODS The sample of the study was composed of 282 FEP patients followed up for 2 years. To analyze whether social cognition mediates the influence of cognitive reserve and cognitive domains on functioning, a path analysis was performed. The statistical significance of any mediation effects was evaluated by bootstrap analysis. RESULTS At baseline, as neither cognitive reserve nor the cognitive domains studied were related to functioning, the conditions for mediation were not satisfied. Nevertheless, at 2 years of follow-up, social cognition acted as a mediator between cognitive reserve and functioning. Likewise, social cognition was a mediator between verbal memory and functional outcome. The results of the bootstrap analysis confirmed these significant mediations (95% bootstrapped CI (-10.215 to -0.337) and (-4.731 to -0.605) respectively). CONCLUSIONS Cognitive reserve and neurocognition are related to functioning, and social cognition mediates in this relationship.
Collapse
Affiliation(s)
- I González-Ortega
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Araba University Hospital, Bioaraba Research Institute, Vitoria, Spain
- Department of Neurosciences, University of the Basque Country, Bizkaia, Spain
- The National Distance Education University (UNED), Vitoria, Spain
| | - A González-Pinto
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Araba University Hospital, Bioaraba Research Institute, Vitoria, Spain
- Department of Neurosciences, University of the Basque Country, Bizkaia, Spain
| | - S Alberich
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Araba University Hospital, Bioaraba Research Institute, Vitoria, Spain
- Department of Neurosciences, University of the Basque Country, Bizkaia, Spain
- The National Distance Education University (UNED), Vitoria, Spain
| | - E Echeburúa
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Personality, Assessment and Psychological Treatment, University of the Basque Country, San Sebastián, Spain
| | - M Bernardo
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain
| | - B Cabrera
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain
| | - S Amoretti
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain
| | - A Lobo
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Medicine and Psychiatry, University of Zaragoza, Aragon Institute for Health Sciences (IIS Aragón), Zaragoza, Spain
| | - C Arango
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Child and Adolescent Psychiatry Department, Gregorio Marañón General University Hospital, School of Medicine, Universidad Complutense, IiSGM, Madrid, Spain
| | - I Corripio
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Institut d'Investigació Biomèdica-Sant Pau (IIB-SANT PAU), Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - E Vieta
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Bipolar Disorders Unit, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain
| | - E de la Serna
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Child and Adolescent Psychiatry Service, Hospital Clinic of Barcelona, Barcelona, Spain
| | - R Rodriguez-Jimenez
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- 12 de Octubre Hospital Research Institute (i+12), Madrid, Spain
| | - R Segarra
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Neurosciences, University of the Basque Country, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Vizcaya, Spain
| | - J M López-Ilundain
- Department of Psychiatry, Navarre Hospital Complex, IdiSNA, Navarre Institute for Health Research, Pamplona, Spain
| | - A M Sánchez-Torres
- Department of Psychiatry, Navarre Hospital Complex, IdiSNA, Navarre Institute for Health Research, Pamplona, Spain
| | - M J Cuesta
- Department of Psychiatry, Navarre Hospital Complex, IdiSNA, Navarre Institute for Health Research, Pamplona, Spain
| | - I Zorrilla
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Araba University Hospital, Bioaraba Research Institute, Vitoria, Spain
- Department of Neurosciences, University of the Basque Country, Bizkaia, Spain
| | - P López
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Araba University Hospital, Bioaraba Research Institute, Vitoria, Spain
- Department of Neurosciences, University of the Basque Country, Bizkaia, Spain
| | - M Bioque
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain
| | - G Mezquida
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain
| | - F Barcones
- Department of Medicine and Psychiatry, University of Zaragoza, Aragon Institute for Health Sciences (IIS Aragón), Zaragoza, Spain
- Department of Family Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - C De-la-Cámara
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Medicine and Psychiatry, University of Zaragoza, Aragon Institute for Health Sciences (IIS Aragón), Zaragoza, Spain
| | - M Parellada
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Child and Adolescent Psychiatry Department, Gregorio Marañón General University Hospital, School of Medicine, Universidad Complutense, IiSGM, Madrid, Spain
| | - A Espliego
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Child and Adolescent Psychiatry Department, Gregorio Marañón General University Hospital, School of Medicine, Universidad Complutense, IiSGM, Madrid, Spain
| | - A Alonso-Solís
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Institut d'Investigació Biomèdica-Sant Pau (IIB-SANT PAU), Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - E M Grasa
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Institut d'Investigació Biomèdica-Sant Pau (IIB-SANT PAU), Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - C Varo
- Bipolar Disorders Unit, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain
| | - L Montejo
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Bipolar Disorders Unit, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain
| | - J Castro-Fornieles
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Child and Adolescent Psychiatry Service, Hospital Clinic of Barcelona, Barcelona, Spain
| | - I Baeza
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Child and Adolescent Psychiatry Service, Hospital Clinic of Barcelona, Barcelona, Spain
| | - M Dompablo
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- 12 de Octubre Hospital Research Institute (i+12), Madrid, Spain
| | - I Torio
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- 12 de Octubre Hospital Research Institute (i+12), Madrid, Spain
| | - A Zabala
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Neurosciences, University of the Basque Country, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Vizcaya, Spain
| | - J I Eguiluz
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Department of Neurosciences, University of the Basque Country, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Vizcaya, Spain
| | - L Moreno-Izco
- Department of Psychiatry, Navarre Hospital Complex, IdiSNA, Navarre Institute for Health Research, Pamplona, Spain
| | - J Sanjuan
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- INCLIVA, University of Valencia, Hospital Clinico Universitario of Valencia, Spain
| | - R Guirado
- Neurobiology Unit, Department of Cell Biology, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Valencia, Spain
| | - I Cáceres
- Department of Psychiatry, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
| | - P Garnier
- Department of Psychiatry, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
| | - F Contreras
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Psychiatry Department, Bellvitge University Hospital-IDIBELL, Barcelona, Spain
- Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain
| | - J Bobes
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Psychiatry Department, University of Oviedo, Oviedo, Spain
| | - S Al-Halabí
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Psychiatry Department, University of Oviedo, Oviedo, Spain
- Institute of Neurosciences of the Principality of Asturias, INEUROPA, Oviedo, Spain
| | - J Usall
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Research Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona (UB), Sant Boi de Llobregat, Barcelona, Spain
| | - A Butjosa
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Research Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona (UB), Sant Boi de Llobregat, Barcelona, Spain
| | - S Sarró
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain
| | - R Landin-Romero
- FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain
| | - A Ibáñez
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Psychiatry Department, Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRyCIS), University of Alcalá, Madrid, Spain
| | - G Selva
- Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain
- Teaching Unit of Psychiatry and Psychological Medicine, Department of Medicine, University of Valencia, INCLIVA Health Research Institute, Valencia, Spain
| |
Collapse
|
25
|
Bernardo M, Amoretti S, Cuesta MJ, Parellada M, Mezquida G, González-Pinto A, Bergé D, Lobo A, Aguilar EJ, Usall J, Corripio I, Bobes J, Rodríguez-Jiménez R, Sarró S, Contreras F, Ibáñez Á, Gutiérrez M, Micó JA. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design. Rev Psiquiatr Salud Ment 2020. [PMID: 33020032 DOI: 10.1016/j.rpsm.2020.07.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Up to 80% of first-episode psychosis patients suffer a relapse within five years of the remission. Relapse should be an important focus of prevention given the potential harm to the patient and family. It threatens to disrupt their psychosocial recovery, increases the risk of resistance to treatment and has been associated with greater direct and indirect costs for society. Based on a previous project entitled "Genotype-phenotype and environment. Application to a predictive model in first psychotic episodes" (PEPs Project), the project "Clinical and neurobiological determinants of second episodes of schizophrenia. Longitudinal study of first episode of psychosis" was designed, also known as the 2EPs Project. It aimed to identify and characterize those factors that predict a relapse within the years immediately following a first episode. This project has focused on following the clinical course, with neuropsychological assessments, biological and neuroanatomical measures, genetic adherence and physical health monitoring in order to compare a subgroup of patients with a second episode to another group of patients which remains in remission. The main objective of the present article is to describe the rationale of the 2EPs Project, explaining the measurement approach adopted and providing an overview of the selected clinical and functional measures. 2EPs Project is a multicenter, coordinated, naturalistic, longitudinal follow-up study over three years in a Spanish sample of patients in remission after a first-psychotic episode of schizophrenia. It is closely monitoring the clinical course of the cases recruited to compare the subgroup of patients with a second episode to that which remains in remission. The sample is composed of 223 subjects recruited from 15 clinical centres in Spain with experience of the preceding PEPs Study project, albeit 2EPs being an expanded version with new basic groups in biological research. From the total sample recruited, 63 patients presented a relapse (44%). 2EPs arose to characterize first episodes in an exhaustive, novel and multimodal way, thus contributing towards the development of a predictive model of relapse. Identifying the characteristics of patients who relapse could improve early detection and intervention.
Collapse
Affiliation(s)
- Miguel Bernardo
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Barcelona, Spain; Departament de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain; August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
| | - Silvia Amoretti
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Barcelona, Spain; Departament de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain; August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
| | - Manuel Jesús Cuesta
- Departamento de Psiquiatría, Complejo Hospitalario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, Spain
| | - Mara Parellada
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain; Servicio de Psiquiatría del Niño y del Adolescente, Hospital General Universitario Gregorio Marañón (IiSGM), Facultad de Medicina, Universidad Complutense, CIBERSAM, Madrid, España
| | - Gisela Mezquida
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Barcelona, Spain; Departament de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain; August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
| | | | | | - Ana González-Pinto
- Department of Psychiatry, Araba University Hospital, Bioaraba Research Institute, Department of Neurociences, University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - Daniel Bergé
- Department of Neurosciences and Psychiatry, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
| | - Antonio Lobo
- Department of Medicine and Psychiatry. Universidad de Zaragoza. Instituto de Investigación Aragón, CIBERSAM, Zaragoza, Spain
| | - Eduardo J Aguilar
- Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, CIBERSAM, Valencia, Spain
| | - Judith Usall
- Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, SantBoi de Llobregat; Fundació Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
| | - Iluminada Corripio
- Department of Psychiatry, Biomedical Research Institute Sant Pau (IIB-SANT PAU), Santa Creu and Sant Pau Hospital; Autonomous University of Barcelona (UAB), CIBERSAM, Barcelona, Spain
| | - Julio Bobes
- Área de Psiquiatría, Universidad de Oviedo, Servicio de Salud del Principado de Asturias, Instituto de Neurociencias del Principado de Asturias (INEUROPA), CIBERSAM, Oviedo, Asturias, Spain
| | - Roberto Rodríguez-Jiménez
- Departamento de Psiquiatría, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), CogPsy-Group, Universidad Complutense de Madrid (UCM), CIBERSAM, Madrid, Spain
| | - Salvador Sarró
- FIDMAG Research Foundation Germanes Hospitalàries, CIBERSAM, Barcelona, Spain
| | - Fernando Contreras
- Psychiatry Department, Bellvitge University Hospital-IDIBELL, Barcelona, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain
| | - Ángela Ibáñez
- Departamento de Psiquiatría, Hospital Ramon y Cajal, Universidad de Alcalá, IRYCIS, CIBERSAM, Madrid, Spain
| | - Miguel Gutiérrez
- Department of Psychiatry, Hospital Santiago Apóstol, University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - Juan Antonio Micó
- Grupo de Investigación en Neuropsicofarmacología y Psicobiología, Departamento de Neurociencias, Universidad de Cádiz, Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz, INiBICA, Hospital Universitario Puerta del Mar, CIBERSAM, Cádiz, Spain
| |
Collapse
|
26
|
Aab A, Abreu P, Aglietta M, Albury JM, Allekotte I, Almela A, Alvarez Castillo J, Alvarez-Muñiz J, Alves Batista R, Anastasi GA, Anchordoqui L, Andrada B, Andringa S, Aramo C, Araújo Ferreira PR, Asorey H, Assis P, Avila G, Badescu AM, Bakalova A, Balaceanu A, Barbato F, Barreira Luz RJ, Becker KH, Bellido JA, Berat C, Bertaina ME, Bertou X, Biermann PL, Bister T, Biteau J, Blanco A, Blazek J, Bleve C, Boháčová M, Boncioli D, Bonifazi C, Bonneau Arbeletche L, Borodai N, Botti AM, Brack J, Bretz T, Briechle FL, Buchholz P, Bueno A, Buitink S, Buscemi M, Caballero-Mora KS, Caccianiga L, Calcagni L, Cancio A, Canfora F, Caracas I, Carceller JM, Caruso R, Castellina A, Catalani F, Cataldi G, Cazon L, Cerda M, Chinellato JA, Choi K, Chudoba J, Chytka L, Clay RW, Cobos Cerutti AC, Colalillo R, Coleman A, Coluccia MR, Conceição R, Condorelli A, Consolati G, Contreras F, Convenga F, Covault CE, Dasso S, Daumiller K, Dawson BR, Day JA, de Almeida RM, de Jesús J, de Jong SJ, De Mauro G, de Mello Neto JRT, De Mitri I, de Oliveira J, de Oliveira Franco D, de Souza V, De Vito E, Debatin J, Del Río M, Deligny O, Dembinski H, Dhital N, Di Giulio C, Di Matteo A, Díaz Castro ML, Dobrigkeit C, D'Olivo JC, Dorosti Q, Dos Anjos RC, Dova MT, Ebr J, Engel R, Epicoco I, Erdmann M, Escobar CO, Etchegoyen A, Falcke H, Farmer J, Farrar G, Fauth AC, Fazzini N, Feldbusch F, Fenu F, Fick B, Figueira JM, Filipčič A, Fodran T, Freire MM, Fujii T, Fuster A, Galea C, Galelli C, García B, Garcia Vegas AL, Gemmeke H, Gesualdi F, Gherghel-Lascu A, Ghia PL, Giaccari U, Giammarchi M, Giller M, Glombitza J, Gobbi F, Gollan F, Golup G, Gómez Berisso M, Gómez Vitale PF, Gongora JP, González N, Goos I, Góra D, Gorgi A, Gottowik M, Grubb TD, Guarino F, Guedes GP, Guido E, Hahn S, Halliday R, Hampel MR, Hansen P, Harari D, Harvey VM, Haungs A, Hebbeker T, Heck D, Hill GC, Hojvat C, Hörandel JR, Horvath P, Hrabovský M, Huege T, Hulsman J, Insolia A, Isar PG, Johnsen JA, Jurysek J, Kääpä A, Kampert KH, Keilhauer B, Kemp J, Klages HO, Kleifges M, Kleinfeller J, Köpke M, Kukec Mezek G, Lago BL, LaHurd D, Lang RG, Leigui de Oliveira MA, Lenok V, Letessier-Selvon A, Lhenry-Yvon I, Lo Presti D, Lopes L, López R, Lorek R, Luce Q, Lucero A, Machado Payeras A, Malacari M, Mancarella G, Mandat D, Manning BC, Manshanden J, Mantsch P, Marafico S, Mariazzi AG, Mariş IC, Marsella G, Martello D, Martinez H, Martínez Bravo O, Mastrodicasa M, Mathes HJ, Matthews J, Matthiae G, Mayotte E, Mazur PO, Medina-Tanco G, Melo D, Menshikov A, Merenda KD, Michal S, Micheletti MI, Miramonti L, Mockler D, Mollerach S, Montanet F, Morello C, Mostafá M, Müller AL, Muller MA, Mulrey K, Mussa R, Muzio M, Namasaka WM, Nellen L, Nguyen PH, Niculescu-Oglinzanu M, Niechciol M, Nitz D, Nosek D, Novotny V, Nožka L, Nucita A, Núñez LA, Palatka M, Pallotta J, Panetta MP, Papenbreer P, Parente G, Parra A, Pech M, Pedreira F, Pȩkala J, Pelayo R, Peña-Rodriguez J, Perez Armand J, Perlin M, Perrone L, Peters C, Petrera S, Pierog T, Pimenta M, Pirronello V, Platino M, Pont B, Pothast M, Privitera P, Prouza M, Puyleart A, Querchfeld S, Rautenberg J, Ravignani D, Reininghaus M, Ridky J, Riehn F, Risse M, Ristori P, Rizi V, Rodrigues de Carvalho W, Rodriguez Fernandez G, Rodriguez Rojo J, Roncoroni MJ, Roth M, Roulet E, Rovero AC, Ruehl P, Saffi SJ, Saftoiu A, Salamida F, Salazar H, Salina G, Sanabria Gomez JD, Sánchez F, Santos EM, Santos E, Sarazin F, Sarmento R, Sarmiento-Cano C, Sato R, Savina P, Schäfer C, Scherini V, Schieler H, Schimassek M, Schimp M, Schlüter F, Schmidt D, Scholten O, Schovánek P, Schröder FG, Schröder S, Schulz A, Sciutto SJ, Scornavacche M, Shellard RC, Sigl G, Silli G, Sima O, Šmída R, Sommers P, Soriano JF, Souchard J, Squartini R, Stadelmaier M, Stanca D, Stanič S, Stasielak J, Stassi P, Streich A, Suárez-Durán M, Sudholz T, Suomijärvi T, Supanitsky AD, Šupík J, Szadkowski Z, Taboada A, Tapia A, Timmermans C, Tkachenko O, Tobiska P, Todero Peixoto CJ, Tomé B, Torralba Elipe G, Travaini A, Travnicek P, Trimarelli C, Trini M, Tueros M, Ulrich R, Unger M, Urban M, Vaclavek L, Vacula M, Valdés Galicia JF, Valiño I, Valore L, van Vliet A, Varela E, Vargas Cárdenas B, Vásquez-Ramírez A, Veberič D, Ventura C, Vergara Quispe ID, Verzi V, Vicha J, Villaseñor L, Vink J, Vorobiov S, Wahlberg H, Watson AA, Weber M, Weindl A, Wiencke L, Wilczyński H, Winchen T, Wirtz M, Wittkowski D, Wundheiler B, Yushkov A, Zapparrata O, Zas E, Zavrtanik D, Zavrtanik M, Zehrer L, Zepeda A, Ziolkowski M, Zuccarello F. Features of the Energy Spectrum of Cosmic Rays above 2.5×10^{18} eV Using the Pierre Auger Observatory. Phys Rev Lett 2020; 125:121106. [PMID: 33016715 DOI: 10.1103/physrevlett.125.121106] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Accepted: 07/31/2020] [Indexed: 06/11/2023]
Abstract
We report a measurement of the energy spectrum of cosmic rays above 2.5×10^{18} eV based on 215 030 events. New results are presented: at about 1.3×10^{19} eV, the spectral index changes from 2.51±0.03(stat)±0.05(syst) to 3.05±0.05(stat)±0.10(syst), evolving to 5.1±0.3(stat)±0.1(syst) beyond 5×10^{19} eV, while no significant dependence of spectral features on the declination is seen in the accessible range. These features of the spectrum can be reproduced in models with energy-dependent mass composition. The energy density in cosmic rays above 5×10^{18} eV is [5.66±0.03(stat)±1.40(syst)]×10^{53} erg Mpc^{-3}.
Collapse
Affiliation(s)
- A Aab
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - P Abreu
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Aglietta
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - J M Albury
- University of Adelaide, Adelaide, S.A., Australia
| | - I Allekotte
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - A Almela
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | | | - J Alvarez-Muñiz
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - R Alves Batista
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - G A Anastasi
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - L Anchordoqui
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, NY, USA
| | - B Andrada
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - S Andringa
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - C Aramo
- INFN, Sezione di Napoli, Napoli, Italy
| | | | - H Asorey
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - P Assis
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - G Avila
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - A M Badescu
- University Politehnica of Bucharest, Bucharest, Romania
| | - A Bakalova
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Balaceanu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - F Barbato
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II", Dipartimento di Fisica "Ettore Pancini", Napoli, Italy
| | - R J Barreira Luz
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - K H Becker
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - J A Bellido
- University of Adelaide, Adelaide, S.A., Australia
| | - C Berat
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France, France
| | - M E Bertaina
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - X Bertou
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - P L Biermann
- Max-Planck-Institut für Radioastronomie, Bonn, Germany
| | - T Bister
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - J Biteau
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France, France
| | - A Blanco
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - J Blazek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C Bleve
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France, France
| | - M Boháčová
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - D Boncioli
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - C Bonifazi
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, RJ, Brazil
| | | | - N Borodai
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - A M Botti
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - J Brack
- Colorado State University, Fort Collins, CO, USA
| | - T Bretz
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - F L Briechle
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - P Buchholz
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - A Bueno
- Universidad de Granada and C.A.F.P.E., Granada, Spain
| | - S Buitink
- Vrije Universiteit Brussels, Brussels, Belgium
| | - M Buscemi
- Università di Catania, Dipartimento di Fisica e Astronomia, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | | | - L Caccianiga
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - L Calcagni
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - A Cancio
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - F Canfora
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - I Caracas
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - J M Carceller
- Universidad de Granada and C.A.F.P.E., Granada, Spain
| | - R Caruso
- Università di Catania, Dipartimento di Fisica e Astronomia, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - A Castellina
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - F Catalani
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, SP, Brazil
| | - G Cataldi
- INFN, Sezione di Lecce, Lecce, Italy
| | - L Cazon
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Cerda
- Observatorio Pierre Auger, Malargüe, Argentina
| | - J A Chinellato
- Universidade Estadual de Campinas, IFGW, Campinas, SP, Brazil
| | - K Choi
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Chudoba
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - L Chytka
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - R W Clay
- University of Adelaide, Adelaide, S.A., Australia
| | - A C Cobos Cerutti
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
| | - R Colalillo
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II", Dipartimento di Fisica "Ettore Pancini", Napoli, Italy
| | - A Coleman
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, DE, USA
| | - M R Coluccia
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - R Conceição
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - A Condorelli
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Gran Sasso Science Institute, L'Aquila, Italy
| | - G Consolati
- INFN, Sezione di Milano, Milano, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
| | - F Contreras
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - F Convenga
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - C E Covault
- Case Western Reserve University, Cleveland, OH, USA
- also at Radboud Universtiy Nijmegen, Nijmegen, The Netherlands
| | - S Dasso
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
| | - K Daumiller
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - B R Dawson
- University of Adelaide, Adelaide, S.A., Australia
| | - J A Day
- University of Adelaide, Adelaide, S.A., Australia
| | - R M de Almeida
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, RJ, Brazil
| | - J de Jesús
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - S J de Jong
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - G De Mauro
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - J R T de Mello Neto
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, RJ, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, RJ, Brazil
| | - I De Mitri
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Gran Sasso Science Institute, L'Aquila, Italy
| | - J de Oliveira
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, RJ, Brazil
| | | | - V de Souza
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, SP, Brazil
| | - E De Vito
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - J Debatin
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - M Del Río
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - O Deligny
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France, France
| | - H Dembinski
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - N Dhital
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - C Di Giulio
- Università di Roma "Tor Vergata", Dipartimento di Fisica, Roma, Italy
- INFN, Sezione di Roma "Tor Vergata", Roma, Italy
| | | | - M L Díaz Castro
- Universidade Estadual de Campinas, IFGW, Campinas, SP, Brazil
| | - C Dobrigkeit
- Universidade Estadual de Campinas, IFGW, Campinas, SP, Brazil
| | - J C D'Olivo
- Universidad Nacional Autónoma de México, México, D.F., México
| | - Q Dorosti
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - R C Dos Anjos
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
| | - M T Dova
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - J Ebr
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - R Engel
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - I Epicoco
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - M Erdmann
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | | | - A Etchegoyen
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - H Falcke
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
| | - J Farmer
- University of Chicago, Enrico Fermi Institute, Chicago, IL, USA
| | - G Farrar
- New York University, New York, NY, USA
| | - A C Fauth
- Universidade Estadual de Campinas, IFGW, Campinas, SP, Brazil
| | - N Fazzini
- Fermi National Accelerator Laboratory, USA
| | - F Feldbusch
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - F Fenu
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - B Fick
- Michigan Technological University, Houghton, MI, USA
| | - J M Figueira
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Filipčič
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - T Fodran
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - M M Freire
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
| | - T Fujii
- University of Chicago, Enrico Fermi Institute, Chicago, IL, USA
- now at Hakubi Center for Advanced Research and Graduate School of Science, Kyoto University, Kyoto, Japan
| | - A Fuster
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - C Galea
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - C Galelli
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - B García
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
| | - A L Garcia Vegas
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - H Gemmeke
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - F Gesualdi
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - A Gherghel-Lascu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - P L Ghia
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France, France
| | - U Giaccari
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | | | - M Giller
- University of Łódź, Faculty of Astrophysics, Łódź, Poland
| | - J Glombitza
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - F Gobbi
- Observatorio Pierre Auger, Malargüe, Argentina
| | - F Gollan
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - G Golup
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - M Gómez Berisso
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - P F Gómez Vitale
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - J P Gongora
- Observatorio Pierre Auger, Malargüe, Argentina
| | - N González
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - I Goos
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - D Góra
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - A Gorgi
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - M Gottowik
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - T D Grubb
- University of Adelaide, Adelaide, S.A., Australia
| | - F Guarino
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II", Dipartimento di Fisica "Ettore Pancini", Napoli, Italy
| | - G P Guedes
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
| | - E Guido
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - S Hahn
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - R Halliday
- Case Western Reserve University, Cleveland, OH, USA
| | - M R Hampel
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - P Hansen
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - D Harari
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - V M Harvey
- University of Adelaide, Adelaide, S.A., Australia
| | - A Haungs
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - T Hebbeker
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - D Heck
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - G C Hill
- University of Adelaide, Adelaide, S.A., Australia
| | - C Hojvat
- Fermi National Accelerator Laboratory, USA
| | - J R Hörandel
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - P Horvath
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - M Hrabovský
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - T Huege
- Vrije Universiteit Brussels, Brussels, Belgium
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - J Hulsman
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - A Insolia
- Università di Catania, Dipartimento di Fisica e Astronomia, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - P G Isar
- Institute of Space Science, Bucharest-Magurele, Romania
| | | | - J Jurysek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Kääpä
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - K H Kampert
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - B Keilhauer
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - J Kemp
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - H O Klages
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M Kleifges
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | | | - M Köpke
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - G Kukec Mezek
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - B L Lago
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Nova Friburgo, Brazil
| | - D LaHurd
- Case Western Reserve University, Cleveland, OH, USA
| | - R G Lang
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, SP, Brazil
| | | | - V Lenok
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - A Letessier-Selvon
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Universités Paris 6 et Paris 7, CNRS-IN2P3, Paris, France
| | - I Lhenry-Yvon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France, France
| | - D Lo Presti
- Università di Catania, Dipartimento di Fisica e Astronomia, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - L Lopes
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - R López
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - R Lorek
- Case Western Reserve University, Cleveland, OH, USA
| | - Q Luce
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - A Lucero
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | | | - M Malacari
- University of Chicago, Enrico Fermi Institute, Chicago, IL, USA
| | - G Mancarella
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - D Mandat
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - B C Manning
- University of Adelaide, Adelaide, S.A., Australia
| | - J Manshanden
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
| | - P Mantsch
- Fermi National Accelerator Laboratory, USA
| | - S Marafico
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France, France
| | - A G Mariazzi
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - I C Mariş
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - G Marsella
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - D Martello
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - H Martinez
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, SP, Brazil
| | | | - M Mastrodicasa
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - H J Mathes
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - J Matthews
- Louisiana State University, Baton Rouge, LA, USA
| | - G Matthiae
- Università di Roma "Tor Vergata", Dipartimento di Fisica, Roma, Italy
- INFN, Sezione di Roma "Tor Vergata", Roma, Italy
| | - E Mayotte
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - P O Mazur
- Fermi National Accelerator Laboratory, USA
| | - G Medina-Tanco
- Universidad Nacional Autónoma de México, México, D.F., México
| | - D Melo
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Menshikov
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | | | - S Michal
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - M I Micheletti
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
| | - L Miramonti
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- INFN, Sezione di Milano, Milano, Italy
| | - D Mockler
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - S Mollerach
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - F Montanet
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France, France
| | - C Morello
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- INFN, Sezione di Torino, Torino, Italy
| | - M Mostafá
- Pennsylvania State University, University Park, PA, USA
| | - A L Müller
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M A Muller
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, RJ, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, SP, Brazil
- Universidade Federal de Alfenas, Poços de Caldas, Brazil
| | - K Mulrey
- Vrije Universiteit Brussels, Brussels, Belgium
| | - R Mussa
- INFN, Sezione di Torino, Torino, Italy
| | - M Muzio
- New York University, New York, NY, USA
| | - W M Namasaka
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - L Nellen
- Universidad Nacional Autónoma de México, México, D.F., México
| | - P H Nguyen
- University of Adelaide, Adelaide, S.A., Australia
| | - M Niculescu-Oglinzanu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - M Niechciol
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - D Nitz
- Michigan Technological University, Houghton, MI, USA
- Karlsruhe Institute of Technology, Karlsruhe, Germany
| | - D Nosek
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - V Novotny
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - L Nožka
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - A Nucita
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - L A Núñez
- Universidad Industrial de Santander, Bucaramanga, Colombia
| | - M Palatka
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Pallotta
- Centro de Investigaciones en Láseres y Aplicaciones, CITEDEF and CONICET, Villa Martelli, Argentina
| | - M P Panetta
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - P Papenbreer
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - G Parente
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Parra
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - M Pech
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Pedreira
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Pȩkala
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - R Pelayo
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, D.F., México
| | | | - J Perez Armand
- Universidade de São Paulo, Instituto de Física, São Paulo, SP, Brazil
| | - M Perlin
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - L Perrone
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - C Peters
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - S Petrera
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Gran Sasso Science Institute, L'Aquila, Italy
| | - T Pierog
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M Pimenta
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - V Pirronello
- Università di Catania, Dipartimento di Fisica e Astronomia, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - M Platino
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - B Pont
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - M Pothast
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - P Privitera
- University of Chicago, Enrico Fermi Institute, Chicago, IL, USA
| | - M Prouza
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Puyleart
- Michigan Technological University, Houghton, MI, USA
| | - S Querchfeld
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - J Rautenberg
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - D Ravignani
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - M Reininghaus
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - J Ridky
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Riehn
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Risse
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - P Ristori
- Centro de Investigaciones en Láseres y Aplicaciones, CITEDEF and CONICET, Villa Martelli, Argentina
| | - V Rizi
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | | | - G Rodriguez Fernandez
- Università di Roma "Tor Vergata", Dipartimento di Fisica, Roma, Italy
- INFN, Sezione di Roma "Tor Vergata", Roma, Italy
| | | | - M J Roncoroni
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - M Roth
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - E Roulet
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - A C Rovero
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
| | - P Ruehl
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - S J Saffi
- University of Adelaide, Adelaide, S.A., Australia
| | - A Saftoiu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - F Salamida
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - H Salazar
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - G Salina
- INFN, Sezione di Roma "Tor Vergata", Roma, Italy
| | | | - F Sánchez
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - E M Santos
- Universidade de São Paulo, Instituto de Física, São Paulo, SP, Brazil
| | - E Santos
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Sarazin
- Colorado School of Mines, Golden, CO, USA
| | - R Sarmento
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - C Sarmiento-Cano
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - R Sato
- Observatorio Pierre Auger, Malargüe, Argentina
| | - P Savina
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France, France
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi", Lecce, Italy
| | - C Schäfer
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | | | - H Schieler
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M Schimassek
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - M Schimp
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - F Schlüter
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - D Schmidt
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - O Scholten
- Vrije Universiteit Brussels, Brussels, Belgium
- KVI-Center for Advanced Radiation Technology, University of Groningen, Groningen, The Netherlands
| | - P Schovánek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F G Schröder
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, DE, USA
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - S Schröder
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - A Schulz
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - S J Sciutto
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - M Scornavacche
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - R C Shellard
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, RJ, Brazil
| | - G Sigl
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
| | - G Silli
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - O Sima
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- also at Radboud Universtiy Nijmegen, Nijmegen, The Netherlands
| | - R Šmída
- University of Chicago, Enrico Fermi Institute, Chicago, IL, USA
| | - P Sommers
- Pennsylvania State University, University Park, PA, USA
| | - J F Soriano
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, NY, USA
| | - J Souchard
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France, France
| | - R Squartini
- Observatorio Pierre Auger, Malargüe, Argentina
| | - M Stadelmaier
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - D Stanca
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - S Stanič
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - J Stasielak
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - P Stassi
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France, France
| | - A Streich
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - M Suárez-Durán
- Universidad Industrial de Santander, Bucaramanga, Colombia
| | - T Sudholz
- University of Adelaide, Adelaide, S.A., Australia
| | - T Suomijärvi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France, France
| | - A D Supanitsky
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - J Šupík
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - Z Szadkowski
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
| | - A Taboada
- Karlsruhe Institute of Technology, Institute for Experimental Particle Physics (ETP), Karlsruhe, Germany
| | - A Tapia
- Universidad de Medellín, Medellín, Colombia
| | - C Timmermans
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - O Tkachenko
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - P Tobiska
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C J Todero Peixoto
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, SP, Brazil
| | - B Tomé
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - G Torralba Elipe
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Travaini
- Observatorio Pierre Auger, Malargüe, Argentina
| | - P Travnicek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C Trimarelli
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - M Trini
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - M Tueros
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - R Ulrich
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M Unger
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - M Urban
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - L Vaclavek
- Palacky University, RCPTM, Olomouc, Czech Republic
| | - M Vacula
- Palacky University, RCPTM, Olomouc, Czech Republic
| | | | - I Valiño
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Gran Sasso Science Institute, L'Aquila, Italy
| | - L Valore
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II", Dipartimento di Fisica "Ettore Pancini", Napoli, Italy
| | - A van Vliet
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - E Varela
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | | | | | - D Veberič
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - C Ventura
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, RJ, Brazil
| | | | - V Verzi
- INFN, Sezione di Roma "Tor Vergata", Roma, Italy
| | - J Vicha
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - L Villaseñor
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - J Vink
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
| | - S Vorobiov
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - H Wahlberg
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - A A Watson
- School of Physics and Astronomy, University of Leeds, Leeds, United Kingdom
| | - M Weber
- Karlsruhe Institute of Technology, Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - A Weindl
- Karlsruhe Institute of Technology, Institut für Kernphysik, Karlsruhe, Germany
| | - L Wiencke
- Colorado School of Mines, Golden, CO, USA
| | - H Wilczyński
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - T Winchen
- Vrije Universiteit Brussels, Brussels, Belgium
| | - M Wirtz
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - D Wittkowski
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - B Wundheiler
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Yushkov
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - O Zapparrata
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - E Zas
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - D Zavrtanik
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - M Zavrtanik
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - L Zehrer
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - A Zepeda
- Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV), México, D.F., México
| | - M Ziolkowski
- Universität Siegen, Fachbereich 7 Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - F Zuccarello
- Università di Catania, Dipartimento di Fisica e Astronomia, Catania, Italy
- INFN, Sezione di Catania, Catania, Italy
| |
Collapse
|
27
|
Abstract
Forensic examination of hair is commonly performed to trace its origin and make a connection between a suspect and a crime scene. Such examination is based on subjective microscopic analysis of hair. During the last decade, several spectroscopic approaches have been proposed to make forensic analysis of hair more robust and reliable. Surface-enhanced Raman and attenuated total internal reflection infrared spectroscopies allowed for detection and identification of dyes directly on hair and even differentiation between commercial brands of those colorants. However, these is a question that remains unanswered: can artificial dyes be detected on bleached hair or bleaching can be used to fully erase information about hair coloring? In this study, we report experimental results that provide a clear answer to this question. We show that infrared analysis can be used to differentiate between undyed bleached hair and hair that was colored with both permanent and semi-permanent dyes prior to bleaching. We also show that IR analysis can be used to distinguish between undyed unbleached and undyed bleached hair. We demonstrate that in combination with multivariate statistical analysis, IR analysis can be used to distinguish with 96-100% accuracy between those hair classes.
Collapse
Affiliation(s)
- Fernando Contreras
- Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, USA.
| | | | | |
Collapse
|
28
|
Muñoz-Villagrán C, Contreras F, Cornejo F, Figueroa M, Valenzuela-Bezanilla D, Luraschi R, Reinoso C, Rivas-Pardo J, Vásquez C, Castro M, Arenas F. Understanding gold toxicity in aerobically-grown Escherichia coli. Biol Res 2020; 53:26. [PMID: 32513271 PMCID: PMC7278051 DOI: 10.1186/s40659-020-00292-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Accepted: 05/16/2020] [Indexed: 12/03/2022] Open
Abstract
Background There is an emerging field to put into practice new strategies for developing molecules with antimicrobial properties. In this line, several metals and metalloids are currently being used for these purposes, although their cellular effect(s) or target(s) in a particular organism are still unknown. Here we aimed to investigate and analyze Au3+ toxicity through a combination of biochemical and molecular approaches. Results We found that Au3+ triggers a major oxidative unbalance in Escherichia coli, characterized by decreased intracellular thiol levels, increased superoxide concentration, as well as by an augmented production of the antioxidant enzymes superoxide dismutase and catalase. Because ROS production is, in some cases, associated with metal reduction and the concomitant generation of gold-containing nanostructures (AuNS), this possibility was evaluated in vivo and in vitro. Conclusions Au3+ is toxic for E. coli because it triggers an unbalance of the bacterium’s oxidative status. This was demonstrated by using oxidative stress dyes and antioxidant chemicals as well as gene reporters, RSH concentrations and AuNS generation.
Collapse
Affiliation(s)
- C Muñoz-Villagrán
- Laboratorio Microbiología Molecular, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile
| | - F Contreras
- Laboratorio Microbiología Molecular, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile
| | - F Cornejo
- Laboratorio Microbiología Molecular, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile
| | - M Figueroa
- Laboratorio Microbiología Molecular, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile
| | - D Valenzuela-Bezanilla
- Laboratorio de Microbiología Aplicada, Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomás, Sede Santiago, Chile
| | - R Luraschi
- Laboratorio Microbiología Molecular, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile
| | - C Reinoso
- Laboratorio de Microbiología Aplicada, Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomás, Sede Santiago, Chile
| | - J Rivas-Pardo
- Laboratorio Microbiología Molecular, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.,Laboratorio de Biología estructural, Centro de Genómica y Bioinformática, Universidad Mayor, Santiago, Chile
| | - C Vásquez
- Laboratorio Microbiología Molecular, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile
| | - M Castro
- Laboratorio de Microbiología Aplicada, Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomás, Sede Santiago, Chile.
| | - F Arenas
- Laboratorio Microbiología Molecular, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.
| |
Collapse
|
29
|
Mas S, Gassó P, Rodríguez N, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Castro-Fornieles J, Bobes J, Usall J, Saiz-Ruiz J, Contreras F, Parellada E, Bernardo M, Bioque M, Diaz‐Caneja CM, González‐Peñas J, Solis AA, Rebella M, González‐Ortega I, Besga A, SanJuan J, Nacher J, Morro L, Montserrat C, Jimenez E, Costa SGD, Baeza I, de la Serna E, Rivas S, Diaz C, Saiz PA, Garcia‐Álvarez L, Fraile MG, Rabadán AZ, Torio I, Rodríguez‐Jimenez R, Butjosa A, Pardo M, Sarró S, Pomarol‐Clotet E, Cuadrado AI, Cuesta MJ. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort. Acta Psychiatr Scand 2020; 141:541-552. [PMID: 31746462 DOI: 10.1111/acps.13131] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/30/2019] [Revised: 09/16/2019] [Accepted: 11/17/2019] [Indexed: 12/29/2022]
Abstract
AIMS Here, we present a clustering strategy to identify phenotypes of antipsychotic (AP) response by using longitudinal data from patients presenting first-episode psychosis (FEP). METHOD One hundred and ninety FEP with complete data were selected from the PEPs project. The efficacy was assessed using total PANSS, and adverse effects using total UKU, during one-year follow-up. We used the Klm3D method to cluster longitudinal data. RESULTS We identified four clusters: cluster A, drug not toxic and beneficial; cluster B, drug beneficial but toxic; cluster C, drug neither toxic nor beneficial; and cluster D, drug toxic and not beneficial. These groups significantly differ in baseline demographics, clinical, and neuropsychological characteristics (PAS, total PANSS, DUP, insight, pIQ, age of onset, cocaine use and family history of mental illness). CONCLUSIONS The results presented here allow the identification of phenotypes of AP response that differ in well-known simple and classic clinical variables opening the door to clinical prediction and application of personalized medicine.
Collapse
Affiliation(s)
- S Mas
- Pharmacology Unit, Department of Clinical Foundations, University of Barcelona, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain
| | - P Gassó
- Pharmacology Unit, Department of Clinical Foundations, University of Barcelona, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain
| | - N Rodríguez
- Fundació Clinic per la Recerca Biomédica (FCRB), Barcelona, Spain
| | - B Cabrera
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Barcelona Clínic Schizophrenia Unit, Neuroscience Institute Hospital Clínic de Barcelona, Barcelona, Spain
| | - G Mezquida
- Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Barcelona, Spain.,Fundació Clínic per la Recerca Biomèdica (FCRB), Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain
| | - A Lobo
- Department of Medicine and Psychiatry, University of Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain
| | - A González-Pinto
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Department of Psychiatry, Hospital Universitario de Alava, Vitoria, Spain.,BIOARABA Health Research Institute, Vitoria, Spain.,University of the Basque Country, Vitoria, Spain
| | - M Parellada
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain
| | - I Corripio
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Servicio de Psiquiatría, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.,Instituto de Investigación Biomédica Sant Pau (IIB-SANT PAU), Barcelona, Spain.,Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - E Vieta
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Hospital Clínic de Barcelona, Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain
| | - J Castro-Fornieles
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain.,Child and Adolescent Psychiatry and Psychology Department, 2017SGR881, Institute Clinic of Neurosciences, Hospital Clinic of Barcelona, Barcelona, Spain
| | - J Bobes
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Área de Psiquiatría, Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Asturias, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain
| | - J Usall
- Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.,Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain
| | - J Saiz-Ruiz
- Hospital Ramon y Cajal, Universidad de Alcala, IRYCIS, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
| | - F Contreras
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Psychiatric Service, Bellvitge University Hospital, Hospitalet del Llobregat, Spain.,University of Barcelona, Barcelona, Spain
| | - E Parellada
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain.,Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain
| | - M Bernardo
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain.,Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Mai T, Contreras F, Venkat S, Mohan P, Bhatia S. 4:12 PM Abstract No. 306 Survival benefits of drug-eluting bead transarterial chemoembolization in Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma patients. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
31
|
Aab A, Abreu P, Aglietta M, Albuquerque I, Albury J, Allekotte I, Almela A, Alvarez Castillo J, Alvarez-Muñiz J, Anastasi G, Anchordoqui L, Andrada B, Andringa S, Aramo C, Asorey H, Assis P, Avila G, Badescu A, Bakalova A, Balaceanu A, Barbato F, Barreira Luz R, Baur S, Becker K, Bellido J, Berat C, Bertaina M, Bertou X, Biermann P, Biteau J, Blaess S, Blanco A, Blazek J, Bleve C, Boháčová M, Boncioli D, Bonifazi C, Borodai N, Botti A, Brack J, Bretz T, Bridgeman A, Briechle F, Buchholz P, Bueno A, Buitink S, Buscemi M, Caballero-Mora K, Caccianiga L, Calcagni L, Cancio A, Canfora F, Carceller J, Caruso R, Castellina A, Catalani F, Cataldi G, Cazon L, Cerda M, Chinellato J, Chudoba J, Chytka L, Clay R, Cobos Cerutti A, Colalillo R, Coleman A, Coluccia M, Conceição R, Condorelli A, Consolati G, Contreras F, Convenga F, Cooper M, Coutu S, Covault C, Daniel B, Dasso S, Daumiller K, Dawson B, Day J, de Almeida R, de Jong S, De Mauro G, de Mello Neto J, De Mitri I, de Oliveira J, de Oliveira Salles F, de Souza V, Debatin J, del Río M, Deligny O, Dhital N, Díaz Castro M, Diogo F, Dobrigkeit C, D’Olivo J, Dorosti Q, dos Anjos R, Dova M, Dundovic A, Ebr J, Engel R, Erdmann M, Escobar C, Etchegoyen A, Falcke H, Farmer J, Farrar G, Fauth A, Fazzini N, Feldbusch F, Fenu F, Ferreyro L, Figueira J, Filipčič A, Freire M, Fujii T, Fuster A, García B, Gemmeke H, Gherghel-Lascu A, Ghia P, Giaccari U, Giammarchi M, Giller M, Głas D, Glombitza J, Gobbi F, Golup G, Gómez Berisso M, Gómez Vitale P, Gongora J, González N, Goos I, Góra D, Gorgi A, Gottowik M, Grubb T, Guarino F, Guedes G, Guido E, Halliday R, Hampel M, Hansen P, Harari D, Harrison T, Harvey V, Haungs A, Hebbeker T, Heck D, Heimann P, Hill G, Hojvat C, Holt E, Homola P, Hörandel J, Horvath P, Hrabovský M, Huege T, Hulsman J, Insolia A, Isar P, Jandt I, Johnsen J, Josebachuili M, Jurysek J, Kääpä A, Kampert K, Keilhauer B, Kemmerich N, Kemp J, Klages H, Kleifges M, Kleinfeller J, Krause R, Kuempel D, Kukec Mezek G, Kuotb Awad A, Lago B, LaHurd D, Lang R, Legumina R, Leigui de Oliveira M, Lenok V, Letessier-Selvon A, Lhenry-Yvon I, Lippmann O, Lo Presti D, Lopes L, López R, López Casado A, Lorek R, Luce Q, Lucero A, Malacari M, Mancarella G, Mandat D, Manning B, Mantsch P, Mariazzi A, Mariş I, Marsella G, Martello D, Martinez H, Martínez Bravo O, Mastrodicasa M, Mathes H, Mathys S, Matthews J, Matthiae G, Mayotte E, Mazur P, Medina-Tanco G, Melo D, Menshikov A, Merenda KD, Michal S, Micheletti M, Middendorf L, Miramonti L, Mitrica B, Mockler D, Mollerach S, Montanet F, Morello C, Morlino G, Mostafá M, Müller A, Muller M, Müller S, Mussa R, Nellen L, Nguyen P, Niculescu-Oglinzanu M, Niechciol M, Nitz D, Nosek D, Novotny V, Nožka L, Nucita A, Núñez L, Olinto A, Palatka M, Pallotta J, Panetta M, Papenbreer P, Parente G, Parra A, Pech M, Pedreira F, Pȩkala J, Pelayo R, Peña-Rodriguez J, Pereira L, Perlin M, Perrone L, Peters C, Petrera S, Phuntsok J, Pierog T, Pimenta M, Pirronello V, Platino M, Poh J, Pont B, Porowski C, Prado R, Privitera P, Prouza M, Puyleart A, Querchfeld S, Quinn S, Ramos-Pollan R, Rautenberg J, Ravignani D, Reininghaus M, Ridky J, Riehn F, Risse M, Ristori P, Rizi V, Rodrigues de Carvalho W, Rodriguez Rojo J, Roncoroni M, Roth M, Roulet E, Rovero A, Ruehl P, Saffi S, Saftoiu A, Salamida F, Salazar H, Salina G, Sanabria Gomez J, Sánchez F, Santos E, Santos E, Sarazin F, Sarmento R, Sarmiento-Cano C, Sato R, Savina P, Schauer M, Scherini V, Schieler H, Schimassek M, Schimp M, Schlüter F, Schmidt D, Scholten O, Schovánek P, Schröder F, Schröder S, Schumacher J, Sciutto S, Scornavacche M, Shellard R, Sigl G, Silli G, Sima O, Šmída R, Snow G, Sommers P, Soriano J, Souchard J, Squartini R, Stanca D, Stanič S, Stasielak J, Stassi P, Stolpovskiy M, Streich A, Suarez F, Suárez-Durán M, Sudholz T, Suomijärvi T, Supanitsky A, Šupík J, Szadkowski Z, Taboada A, Taborda O, Tapia A, Timmermans C, Todero Peixoto C, Tomé B, Torralba Elipe G, Travaini A, Travnicek P, Trini M, Tueros M, Ulrich R, Unger M, Urban M, Valdés Galicia J, Valiño I, Valore L, van Bodegom P, van den Berg A, van Vliet A, Varela E, Vargas Cárdenas B, Veberič D, Ventura C, Vergara Quispe I, Verzi V, Vicha J, Villaseñor L, Vink J, Vorobiov S, Wahlberg H, Watson A, Weber M, Weindl A, Wiedeński M, Wiencke L, Wilczyński H, Winchen T, Wirtz M, Wittkowski D, Wundheiler B, Yang L, Yushkov A, Zas E, Zavrtanik D, Zavrtanik M, Zehrer L, Zepeda A, Zimmermann B, Ziolkowski M, Zong Z, Zuccarello F. Data-driven estimation of the invisible energy of cosmic ray showers with the Pierre Auger Observatory. Int J Clin Exp Med 2019. [DOI: 10.1103/physrevd.100.082003] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
32
|
Gabrielli L, Garcia L, Fernandez R, Vega J, Ocaranza MP, Contreras F, Salinas M, Chiong M, Jalil J, Munoz M, Yanez F, Lavandero S, Castro P, Sitges M. P4421Increased circulating levels of VCAM-1 correlate with left atrial remodeling in highly trained athletes. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Reports have shown increased risk of atrial fibrillation (AF) in athletes. Vascular cell adhesion molecule-1 (VCAM1) is associated with new onset AF in general population. VCAM1 and its relation with left atrial (LA) remodeling have not been investigated in athletes.
Purpose
To study VCAM1 and LA remodeling in marathon runners.
Methods
Study of 36 male marathon runners in the training period previous to race (42 km) and 18 sedentary controls with no risk factors. Athletes were divided in two groups according to highest training intensity reached (group 1, >100 km/week; group 2, 50–100 km/week). Previous to race in all subjects, VCAM1 serum levels were measured by ELISA and an echocardiogram was performed. In athletes, VCAM1 was measured immediately post-race. Wilcoxon and Spearman were used.
Results
See table. Group 1 showed a significant increment in VCAM1 post-race (651±350 to 905±373 ng/mL; p=0.002) as compared to group 2 with no increment (533±133 to 651±138 ng/mL; p=0.117). In athletes, a moderate correlation between LA volume and VCAM1 was found (rho: 0.483; p=0.007).
Baseline characteristics Group 1 (n=18) Group 2 (n=18) Controls (n=18) p value Age (years) 37±6 38±5 36±4 0.373 Heart rate (bpm) 53±8 57±7 69±6 * 0.001 Body surface area (m2) 1.8±0.1 1.8±0.1 1.9±0.1 0.075 LV diastolic diameter (mm) 49±5 48±5 46±4 0.404 LV systolic diameter (mm) 29±5 30±5 30±4 0.879 Septal wall (mm) 9.1±1.2† 8.2±1.1 8.1±0.8 0.005 Posterior wall (mm) 9.3±2.1† 8.5±1.2 7.6±0.8 0.001 Ejection fraction (%) 55±3 55±6 57±4 0.110 LV mass index (g/m2) 106±27† 78±18 58±11 0.001 LA volume (mL/m2) 42±8† 30±11 25±9 0.001 E wave (cm/sec) 78±13 84±12 77±15 0.217 A wave (cm/sec) 50±12 53±10 48±16 0.438 DT (msec) 233±65 229±65 221±66 0.184 VCAM1 (ng/mL) 651±350† 533±133 440±98 0.022 Mean ± SD. *p<0.05 vs group 1 and 2 post Kruskall-Wallis; †p<0.05 vs other groups post Kruskall-Wallis. LV, left ventricle; LA, left atrium; DT, deceleration time.
Conclusions
Most trained athletes had increased levels of VCAM1 as compared to controls and less trained athletes. They also showed an increment post-effort. VCAM1 is related to LA remodeling in athletes. VCAM1 could be a potential biomarker of AF in athletes which should be confirmed.
Acknowledgement/Funding
FONDECYT 1170963 (LG); FONDAP 15130011 (LG,SL)
Collapse
Affiliation(s)
- L Gabrielli
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - L Garcia
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - R Fernandez
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - J Vega
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - M P Ocaranza
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - F Contreras
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - M Salinas
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - M Chiong
- University of Chile, Advanced Center for Chronic Diseases (ACCDiS) & CEMC, Facultad Ciencias Químicas y Farmacéuticas y F, Santiago, Chile
| | - J Jalil
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - M Munoz
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - F Yanez
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - S Lavandero
- University of Chile, Advanced Center for Chronic Diseases (ACCDiS) & CEMC, Facultad Ciencias Químicas y Farmacéuticas y F, Santiago, Chile
| | - P Castro
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - M Sitges
- Barcelona Hospital Clinic, Barcelona, Spain
| |
Collapse
|
33
|
Bessone F, Hernández N, Mendizábal M, Sánchez A, Paraná R, Arrese M, Tagle M, Girala M, Lizarzábal M, Carrera E, Brahm J, Contreras F, Méndez‐Sánchez N, Santos G, Nunes V, Medina‐Cáliz I, Parra‐Martínez C, Sanz‐Villanueva L, Isabel Lucena M, Andrade RJ. [Not Available]. Clin Liver Dis (Hoboken) 2019; 13:S17-S23. [PMID: 31333824 PMCID: PMC6541044 DOI: 10.1002/cld.840] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/28/2018] [Accepted: 10/29/2018] [Indexed: 02/04/2023] Open
Affiliation(s)
- Fernando Bessone
- Hospital Provincial del Centenario, Facultad de Ciencias Médicas de la Universidad de RosarioRosarioArgentina
| | | | | | | | - Raymundo Paraná
- Hospital Universitario Prof. Edgard SantosSalvador de BahíaBrasil
| | - Marco Arrese
- Universidad Católica Pontificia de ChileSantiagoChile
| | | | | | | | | | - Javier Brahm
- Universidad Católica Pontificia de ChileSantiagoChile
| | - Fernando Contreras
- Universidad Nacional Pedro Henríquez UreñaSanto DomingoRepública Dominicana
| | | | - Genario Santos
- Hospital Universitario Prof. Edgard SantosSalvador de BahíaBrasil
| | - Vinicius Nunes
- Hospital Universitario Prof. Edgard SantosSalvador de BahíaBrasil
| | - Inmaculada Medina‐Cáliz
- Unidad de Gestión Clínica del Aparato Digestivo y Servicio de Farmacología ClínicaInstituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaEspaña
| | - Cecilio Parra‐Martínez
- Unidad de Gestión Clínica del Aparato Digestivo y Servicio de Farmacología ClínicaInstituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaEspaña
| | - Laura Sanz‐Villanueva
- Unidad de Gestión Clínica del Aparato Digestivo y Servicio de Farmacología ClínicaInstituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaEspaña
| | - María Isabel Lucena
- Unidad de Gestión Clínica del Aparato Digestivo y Servicio de Farmacología ClínicaInstituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaEspaña
| | - Raúl J. Andrade
- Unidad de Gestión Clínica del Aparato Digestivo y Servicio de Farmacología ClínicaInstituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaEspaña
| |
Collapse
|
34
|
Amoretti S, Cabrera B, Torrent C, Bonnín CDM, Mezquida G, Garriga M, Jiménez E, Martínez-Arán A, Solé B, Reinares M, Varo C, Penadés R, Grande I, Salagre E, Parellada E, Bioque M, Garcia-Rizo C, Meseguer A, Anmella G, Rosa AR, Contreras F, Safont G, Vieta E, Bernardo M. Cognitive Reserve Assessment Scale in Health (CRASH): Its Validity and Reliability. J Clin Med 2019; 8:E586. [PMID: 31035381 PMCID: PMC6572583 DOI: 10.3390/jcm8050586] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Revised: 04/18/2019] [Accepted: 04/25/2019] [Indexed: 02/03/2023] Open
Abstract
(1) Background: The cognitive reserve (CR) concept has not been precisely defined in severe mental disorders and has been estimated using heterogeneous methods. This study aims to investigate and develop the psychometric properties of the Cognitive Reserve Assessment Scale in Health (CRASH), an instrument designed to measure CR in people with severe mental illness; (2) Methods: 100 patients with severe mental illness (non-affective psychoses and affective disorders) and 66 healthy controls were included. The internal consistency and convergent validity of CRASH were assessed. Spearman's correlations coefficients were also performed to examine the relationship between CRASH and neuropsychological tests, psychosocial functioning, and clinical course; (3) Results: The internal consistency was high (Cronbach's alpha coefficient = 0.903). The CRASH global score had a large positive correlation with the Cognitive reserve questionnaire total score (r = 0.838, p < 0.001), demonstrating good convergent validity. The correlation coefficients between the CRASH total scores and clinical, functional, and neuropsychological performance were different between groups. In order to provide clinical interpretation, severity classification based on diagnosis (non-affective psychotic disorders, affective disorders, and healthy controls) have been created; (4) Conclusions: CRASH is the first CR measure developed specifically for patients with severe mental illness, facilitating reliable and valid measurement of this construct. The scale may aid in the stratification of patients and the implementation of personalized interventions.
Collapse
Affiliation(s)
- Silvia Amoretti
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
| | - Bibiana Cabrera
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
| | - Carla Torrent
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Caterina Del Mar Bonnín
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Gisela Mezquida
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
| | - Marina Garriga
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Esther Jiménez
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Anabel Martínez-Arán
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Brisa Solé
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Maria Reinares
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Cristina Varo
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Rafael Penadés
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
| | - Iria Grande
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Estela Salagre
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Eduard Parellada
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
| | - Miquel Bioque
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
| | - Clemente Garcia-Rizo
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
| | - Ana Meseguer
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
| | - Gerard Anmella
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Adriane R Rosa
- Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-003, Brazil.
- Postgraduate Program: Psychiatry and Behavioral Science, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.
- Department of Pharmacology and Postgraduate Program: Pharmacology and Therapeutics, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90040-060, Brazil.
| | - Fernando Contreras
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- Psychiatry Department, Bellvitge University Hospital-IDIBELL, 08907 L'Hospitalet de Llobregat, Spain.
| | - Gemma Safont
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- Hospital Universitari Mutua Terrassa, 08221 Terrassa, Spain.
| | - Eduard Vieta
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
- Bipolar and Depressive Disorders Unit, Institute of Neurosciences, 08036 Barcelona, Spain.
| | - Miquel Bernardo
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, 08036 Barcelona, Spain.
- Biomedical Research Networking Center for Mental Health (CIBERSAM), 28029 Madrid, Spain.
- University of Barcelona, 08036 Barcelona, Spain.
- August Pi I Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
| |
Collapse
|
35
|
Puig O, Baeza I, de la Serna E, Cabrera B, Mezquida G, Bioque M, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Bobes J, Usall J, Contreras F, Cuesta MJ, Bernardo M, Castro-Fornieles J. Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset. J Clin Psychiatry 2019; 78:1414-1422. [PMID: 28922588 DOI: 10.4088/jcp.16m11122] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/02/2016] [Accepted: 01/30/2017] [Indexed: 10/18/2022]
Abstract
OBJECTIVE To characterize the early cognitive and social functioning characteristics of a sample of first-episode psychosis patients with and without persistent negative symptoms (PNS) and to examine the prevalence and cognitive and functional correlates of PNS in patients with early-onset versus adult-onset first-episode psychosis. METHODS Participants were 235 patients with first-episode psychosis (51 early-onset, 184 adult-onset) and 240 healthy controls from a multicenter longitudinal study (recruited between 2009 and 2011). Standard instruments were used to evaluate symptoms, cognition, and social functioning. Diagnoses were determined according to DSM-IV criteria. PNS proxy was derived from clinical assessments (Positive and Negative Syndrome Scale and Montgomery-Asberg Depression Scale) at 2-, 6-, and 12-month follow-up. Association tests were used to compare the prevalence of PNS in the early-onset versus adult-onset groups. Multivariate analysis of variance was used to examine differences in early cognitive and social functioning (at the 2-month assessment) between patients with and without PNS and between early-onset and adult-onset patients with PNS. RESULTS Thirty-eight patients (16.2%) met criteria for PNS during the first year. This PNS group showed a selective deficit in executive functions and in global, community, and occupational functioning (P < .05). Having PNS was associated with a diagnosis of a schizophrenia spectrum disorder at the 12-month follow-up. The prevalence of PNS was almost double for those patients with an early-onset (0.25 vs 0.14; OR = 2.18; 95% CI, 1.02-4.64), and this was associated with greater cognitive (P < .05) but not social deficits. CONCLUSIONS There was an early, detectable, social and executive dysfunction associated with PNS in first-episode psychosis and a high risk of having PNS in early-onset first-episode psychosis, which in turn was associated with more widespread cognitive impairment. Specific therapeutic interventions for PNS in early-onset first-episode psychosis might be needed.
Collapse
Affiliation(s)
- Olga Puig
- Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic of Barcelona, Villarroel 170, 08036, Spain. .,Department of Child and Adolescent Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
| | - Immaculada Baeza
- Department of Child and Adolescent Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,Barcelona Clínic Schizophrenia Unit, Hospital Clínic of Barcelona, Catalonia, Spain.,CERCA-IDIBAPS, Barcelona, Catalonia, Spain
| | - Elena de la Serna
- Department of Child and Adolescent Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
| | - Bibiana Cabrera
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,Barcelona Clínic Schizophrenia Unit, Hospital Clínic of Barcelona, Catalonia, Spain
| | - Gisela Mezquida
- Barcelona Clínic Schizophrenia Unit, Hospital Clínic of Barcelona, Catalonia, Spain.,University of Barcelona, Barcelona, Catalonia, Spain
| | - Miquel Bioque
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,Barcelona Clínic Schizophrenia Unit, Hospital Clínic of Barcelona, Catalonia, Spain
| | - Antonio Lobo
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,Instituto Investigación Sanitaria Aragón (IIS-Aragón), Universidad de Zaragoza, Zaragoza, Spain
| | - Ana González-Pinto
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,Servicio de Psiquiatría, Hospital Universitario Araba (sede Santiago), BIOARABA, UPV/EHU, Vitoria, Spain
| | - Mara Parellada
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, Madrid, Spain
| | - Iluminada Corripio
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,Department of Psychiatry, Sant Pau Hospital, Barcelona, Autonomous University of Barcelona, Barcelona, Spain
| | - Eduard Vieta
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,CERCA-IDIBAPS, Barcelona, Catalonia, Spain.,University of Barcelona, Barcelona, Catalonia, Spain.,Institute of Neuroscience, Hospital Clinic of Barcelona, Barcelona, Catalonia, Spain
| | - Julio Bobes
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain
| | - Judith Usall
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,University of Barcelona, Barcelona, Catalonia, Spain.,Research Unit Parc Sanitari Sant Joan de Déu, Barcelona, Catalonia, Spain
| | - Fernando Contreras
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,University of Barcelona, Barcelona, Catalonia, Spain.,Psychiatry Department, Bellvitge University Hospital-IDIBELL, Barcelona, Spain
| | - Manuel J Cuesta
- Department of Psychiatry, Complejo Hospitalario de Navarra, IdiSNA, Pamplona, Spain
| | - Miquel Bernardo
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,Barcelona Clínic Schizophrenia Unit, Hospital Clínic of Barcelona, Catalonia, Spain.,CERCA-IDIBAPS, Barcelona, Catalonia, Spain.,University of Barcelona, Barcelona, Catalonia, Spain.,Institute of Neuroscience, Hospital Clinic of Barcelona, Barcelona, Catalonia, Spain
| | - Josefina Castro-Fornieles
- Department of Child and Adolescent Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain .,CERCA-IDIBAPS, Barcelona, Catalonia, Spain.,University of Barcelona, Barcelona, Catalonia, Spain.,Institute of Neuroscience, Hospital Clinic of Barcelona, Barcelona, Catalonia, Spain
| | | |
Collapse
|
36
|
Zoubek ME, Pinazo-Bandera J, Ortega-Alonso A, Hernández N, Crespo J, Contreras F, Medina-Cáliz I, Sanabria-Cabrera J, Sanjuan-Jiménez R, González-Jiménez A, García-Cortés M, Lucena MI, Andrade RJ, Robles-Díaz M. Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review. United European Gastroenterol J 2019; 7:825-837. [PMID: 31316787 DOI: 10.1177/2050640619840147] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/31/2018] [Accepted: 02/17/2019] [Indexed: 01/29/2023] Open
Abstract
Background and Objectives Corticosteroids are often empirically used to treat idiosyncratic hepatotoxicity with severe features. Interestingly, intravenous methylprednisolone (MP) is increasingly being recognized as being responsible for liver injury. We aimed to characterize MP-induced liver injury by analyzing demographical, clinical, laboratory and outcome data of three MP-induced hepatotoxicity cases and compared this information with that of previously published cases. Case series Three females with multiple sclerosis (MS) were treated intravenously with MP, mean daily dose 767 mg. Liver damage occurred 2 to 6 weeks after exposure. Severity was mild to moderate. Two patients suffered positive rechallenge. Literature review We identified 50 published cases of MP hepatotoxicity. Most of these cases were female (86%) and main treatment indications were MS (29 cases) and Graves' ophthalmopathy (13 cases). Hepatocellular damage predominated and mean time to onset was 6 weeks. Four patients died and rechallenge occurred in 19 cases. Conclusion MP pulses can induce severe liver injury, often with an autoimmune phenotype, particularly in patients with MS and Graves' ophthalmopathy. Consequently, these patient groups should have liver tests monitored when treated with MP to provide safer patient care.
Collapse
Affiliation(s)
- Miguel Eugenio Zoubek
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain.,Department of Toxicology, School for Nutrition, Toxicology and Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands
| | - José Pinazo-Bandera
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain
| | - Aida Ortega-Alonso
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain
| | - Nelia Hernández
- Hospital de Clínicas, Clínica Gastroenterología, F Medicina, Montevideo, Uruguay
| | - Javier Crespo
- Unidad de Gestión Clínica de Enfermedades Digestivas, Hospital Marqués de Valdecilla, Instituto de Investigación Biomédica Marques de Valdecilla (IDIVAL), Santander, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBERehd, Madrid, Spain
| | - Fernando Contreras
- Departamento de Gastroenterología, National University Pedro Henríquez Ureña, Santo Domingo, Dominican Republic
| | - Inmaculada Medina-Cáliz
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain
| | - Judith Sanabria-Cabrera
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain.,Unidad Investigación Clínica y Ensayos ClÚcos (UICEC)-Instituto de Investigacióe Biomedicina de Málaga (IBIMA), Plataforma Spanish Clinical Research Network (SCReN), Málaga Spain
| | - Rocío Sanjuan-Jiménez
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain.,Unidad Investigación Clínica y Ensayos ClÚcos (UICEC)-Instituto de Investigacióe Biomedicina de Málaga (IBIMA), Plataforma Spanish Clinical Research Network (SCReN), Málaga Spain
| | - Andrés González-Jiménez
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain
| | - Miren García-Cortés
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain
| | - M Isabel Lucena
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain.,Unidad Investigación Clínica y Ensayos ClÚcos (UICEC)-Instituto de Investigacióe Biomedicina de Málaga (IBIMA), Plataforma Spanish Clinical Research Network (SCReN), Málaga Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBERehd, Madrid, Spain
| | - Raúl J Andrade
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBERehd, Madrid, Spain
| | - Mercedes Robles-Díaz
- UGC Digestivo y Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), H U Virgen de la Victoria, Malaga, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBERehd, Madrid, Spain
| |
Collapse
|
37
|
Bessone F, Hernandez N, Mendizabal M, Sanchez A, Paraná R, Arrese M, Tagle M, Girala M, Lizarzabal M, Carrera E, Brahm J, Contreras F, Mendez‐Sanchez N, Santos G, Nunes V, Medina‐Caliz I, Parra‐Martinez C, Sanz‐Villanueva L, Isabel Lucena M, Andrade RJ. When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN). Clin Liver Dis (Hoboken) 2019; 13:51-57. [PMID: 31139356 PMCID: PMC6465791 DOI: 10.1002/cld.778] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/28/2018] [Accepted: 10/29/2018] [Indexed: 02/04/2023] Open
Affiliation(s)
- Fernando Bessone
- Hospital Provincial del Centenario, University of Rosario School of MedicineRosarioArgentina
| | | | | | | | - Raymundo Paraná
- Hospital Universitario Prof. Edgard SantosSalvador de BahiaBrazil
| | - Marco Arrese
- Universidad Católica Pontificia de ChileSantiagoChile
| | | | | | | | | | - Javier Brahm
- Universidad Católica Pontificia de ChileSantiagoChile
| | | | | | - Genario Santos
- Hospital Universitario Prof. Edgard SantosSalvador de BahiaBrazil
| | - Vinicius Nunes
- Hospital Universitario Prof. Edgard SantosSalvador de BahiaBrazil
| | - Inmaculada Medina‐Caliz
- Unidad de Gestión Clínica de Ap Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de MálagaHospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaSpain
| | - Cecilio Parra‐Martinez
- Unidad de Gestión Clínica de Ap Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de MálagaHospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaSpain
| | - Laura Sanz‐Villanueva
- Unidad de Gestión Clínica de Ap Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de MálagaHospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaSpain
| | - Maria Isabel Lucena
- Unidad de Gestión Clínica de Ap Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de MálagaHospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaSpain
| | - Raul J. Andrade
- Unidad de Gestión Clínica de Ap Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de MálagaHospital Universitario Virgen de la Victoria, Universidad de MálagaMálagaSpain
| |
Collapse
|
38
|
|
39
|
Amoretti S, Cabrera B, Torrent C, Mezquida G, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, de la Serna E, Butjosa A, Contreras F, Sarró S, Penadés R, Sánchez-Torres AM, Cuesta M, Bernardo M. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis. Acta Psychiatr Scand 2018; 138:441-455. [PMID: 30105820 DOI: 10.1111/acps.12949] [Citation(s) in RCA: 54] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/25/2018] [Indexed: 02/06/2023]
Abstract
OBJECTIVE Cognitive reserve (CR) refers to the brain's capacity to cope with pathology in order to minimize the symptoms. CR is associated with different outcomes in severe mental illness. This study aimed to analyze the impact of CR according to the diagnosis of first-episode affective or non-affective psychosis (FEP). METHOD A total of 247 FEP patients (211 non-affective and 36 affective) and 205 healthy controls were enrolled. To assess CR, common proxies have been integrated (premorbid IQ; education-occupation; leisure activities). The groups were divided into high and low CR. RESULTS In non-affective patients, those with high CR were older, had higher socioeconomic status (SES), shorter duration of untreated psychosis, and a later age of onset. They also showed greater performance in most cognitive domains. In affective patients, those with a greater CR showed a higher SES, better functioning, and greater verbal memory performance. CONCLUSION CR plays a differential role in the outcome of psychoses according to the diagnosis. Specifically, in order to address the needs of non-affective patients with low CR, cognitive rehabilitation treatments will need to be 'enriched' by adding pro-cognitive pharmacological agents or using more sophisticated approaches. However, a functional remediation therapy may be of choice for those with an affective psychosis and low CR.
Collapse
Affiliation(s)
- S Amoretti
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, University of Barcelona, Barcelona, Spain.,Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain
| | - B Cabrera
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, University of Barcelona, Barcelona, Spain.,Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain
| | - C Torrent
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.,Barcelona Bipolar Disorders Program, Institute of Neurosciences, University of Barcelona, Barcelona, Spain
| | - G Mezquida
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, University of Barcelona, Barcelona, Spain.,Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain
| | - A Lobo
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,Department of Medicine and Psychiatry, Zaragoza University, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain
| | - A González-Pinto
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,Araba University Hospital, Bioaraba Research Institute, Vitoria, Spain.,University of the Basque Country (UPV-EHU), Vitoria, Spain
| | - M Parellada
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, Madrid, Spain
| | - I Corripio
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,Department of Psychiatry, Institut d'Investigació Biomèdica-Sant Pau (IIB-SANT PAU), Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - E Vieta
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.,Barcelona Bipolar Disorders Program, Institute of Neurosciences, University of Barcelona, Barcelona, Spain
| | - E de la Serna
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,Department of Child and Adolescent Psychiatry and Psychology, Hospital Clinic of Barcelona, Barcelona, Spain
| | - A Butjosa
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, SantBoi de Llobregat, Barcelona, Spain.,Fundació Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain
| | - F Contreras
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,Psychiatry Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - S Sarró
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.,Neuroscience Research Australia, Sydney, NSW, Australia.,School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.,ARC Centre of Excellence in Cognition and its Disorders, Sydney, NSW, Australia
| | - R Penadés
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, University of Barcelona, Barcelona, Spain.,Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
| | - A M Sánchez-Torres
- Department of Psychiatry, Complejo Hospitalario de Navarra, Pamplona, Spain.,IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - M Cuesta
- Department of Psychiatry, Complejo Hospitalario de Navarra, Pamplona, Spain.,IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - M Bernardo
- Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, University of Barcelona, Barcelona, Spain.,Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain.,August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
| | | |
Collapse
|
40
|
Ballesteros A, Sánchez-Torres AM, López-Ilundain JM, Cabrera B, Lobo A, González-Pinto AM, Díaz-Caneja C, Corripio I, Vieta E, de la Serna E, Bobes J, Usall J, Contreras F, Lorente-Omeñaca R, Mezquida G, Bernardo M, Cuesta MJ. Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis? Psychol Med 2018; 48:2247-2256. [PMID: 29331153 DOI: 10.1017/s0033291717003774] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
BACKGROUND Cognitive deficits are a core feature of early stages in schizophrenia. However, the extent to which antipsychotic (AP) have a deleterious effect on cognitive performance remains under debate. We aim to investigate whether anticholinergic loadings and dose of AP drugs in first episode of psychosis (FEP) in advanced phase of remission are associated with cognitive impairment and the differences between premorbid intellectual quotient (IQ) subgroups. METHODS Two hundred and sixty-six patients participated. The primary outcomes were cognitive dimensions, dopaminergic/anticholinergic load of AP [in chlorpromazine equivalents (Eq-CPZ) and the Anticholinergic Risk Scale (ARS), respectively]. RESULTS Impairments in processing speed, verbal memory and global cognition were significantly associated with high Eq-CPZ and verbal impairment with high ARS score. Moreover, this effect was higher in the low IQ subgroup. CONCLUSIONS Clinicians should be aware of the potential cognitive impairment associated with AP in advanced remission FEP, particularly in lower premorbid IQ patients.
Collapse
Affiliation(s)
| | | | | | - Bibiana Cabrera
- Barcelona Clínic Schizophrenia Unit,Neuroscience Institute,Hospital Clínic de Barcelona,Barcelona,Spain
| | - Antonio Lobo
- Department of Medicine and Psychiatry,University of Zaragoza. Aragon Institute for Health Research (IIS Aragon),Zaragoza,Spain
| | | | | | - Iluminada Corripio
- Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain
| | - Eduard Vieta
- Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain
| | - Elena de la Serna
- Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain
| | - Julio Bobes
- Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain
| | - Judith Usall
- Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain
| | - Fernando Contreras
- Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain
| | | | - Gisela Mezquida
- Barcelona Clínic Schizophrenia Unit,Neuroscience Institute,Hospital Clínic de Barcelona,Barcelona,Spain
| | - Miguel Bernardo
- Barcelona Clínic Schizophrenia Unit,Neuroscience Institute,Hospital Clínic de Barcelona,Barcelona,Spain
| | | |
Collapse
|
41
|
Torrent C, Reinares M, Martinez-Arán A, Cabrera B, Amoretti S, Corripio I, Contreras F, Sarró S, González-Pinto A, Lobo A, Cuesta MJ, Sánchez-Torres A, Bergé D, Castro-Fornieles J, Moreno C, Bernardo M, Vieta E. Affective versus non-affective first episode psychoses: A longitudinal study. J Affect Disord 2018; 238:297-304. [PMID: 29902733 DOI: 10.1016/j.jad.2018.06.005] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/09/2018] [Revised: 05/31/2018] [Accepted: 06/01/2018] [Indexed: 12/23/2022]
Abstract
OBJECTIVE This study aimed to assess (1) whether there were clinical, neuropsychological and functional differences between and within affective and non-affective psychoses at baseline and two years-follow-up and (2) to explore clinical and neuropsychological predictors of psychosocial functioning in the whole sample. METHOD This is a subanalysis from a multicentre, naturalistic, longitudinal prospective study ('Phenotype-genotype and environmental interaction. Application of a predictive model in first psychotic episodes'). The sample consisted of 192 patients with a first psychotic episode (FEP): 142 with non-affective psychoses and 50 with affective psychoses. Student t-tests, paired t-tests, Pearson correlations, ANOVAs and regression analyses were performed. RESULTS At baseline, the groups differed in perseverative errors (WCST), Premorbid Adjustment Scale (PAS), family history of psychiatric disorder, negative (PANSS) and manic symptoms (YMRS). At two years follow-up, the groups differed in all the PANSS subscales and in depressive symptoms assessed by the MADRS. When the whole sample was considered, the regression model which best explained the estimated variance in functioning at follow-up (41%) was composed by PANSS total score and verbal fluency assessed by the FAS (COWAT). CONCLUSIONS We found clinical and neurocognitive differences at baseline which decreased in the follow-up. Reduced performances at baseline in executive functions in combination with symptom severity (PANSS) were predictors of FEP patients' poor functional outcome.
Collapse
Affiliation(s)
- C Torrent
- Barcelona Bipolar Disorders Program, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
| | - M Reinares
- Barcelona Bipolar Disorders Program, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
| | - A Martinez-Arán
- Barcelona Bipolar Disorders Program, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
| | - B Cabrera
- Barcelona Clínic Schizophrenia Unit, Hospital Clinic de Barcelona, CIBERSAM, Barcelona, Spain
| | - S Amoretti
- Barcelona Clínic Schizophrenia Unit, Hospital Clinic de Barcelona, CIBERSAM, Barcelona, Spain
| | - I Corripio
- Department of Psychiatry, Biomedical Research Institute Sant Pau (IIB-SANT PAU), Santa Creu and Sant Pau Hospital; Autonomous University of Barcelona (UAB), CIBERSAM, Barcelona, Spain
| | - F Contreras
- Psychiatry Department, Bellvitge University Hospital-IDIBELL, Barcelona, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain
| | - S Sarró
- FIDMAG Research Foundation Germanes Hospitalàries, CIBERSAM, Barcelona, Spain
| | - A González-Pinto
- Department of Psychiatry, University Hospital of Alava-Santiago, Vitoria, Spain
| | - A Lobo
- Department of Medicine and Psychiatry. Universidad de Zaragoza. Instituto de Investigación Aragón, CIBERSAM, Zaragoza, Spain
| | - M J Cuesta
- Department of Psychiatry, Complejo Hospitalario of Navarra, Pamplona, Spain. Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain, IdiSNA
| | - A Sánchez-Torres
- Department of Psychiatry, Complejo Hospitalario of Navarra, Pamplona, Spain. Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain, IdiSNA
| | - D Bergé
- Hospital del Mar Medical Research Institute (IMIM), Autonomous University of Barcelona and CIBERSAM, Barcelona, Spain
| | - J Castro-Fornieles
- Department of Child and Adolescent Psychiatry and Psychology. Institut Clínic of Neurosciences, IDIBAPS, Hospital Clínic de Barcelona, CIBERSAM, Barcelona, Spain
| | - C Moreno
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM. Madrid, Spain
| | - M Bernardo
- Barcelona Clínic Schizophrenia Unit, Hospital Clinic de Barcelona, CIBERSAM, Barcelona, Spain
| | - E Vieta
- Barcelona Bipolar Disorders Program, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
| | | |
Collapse
|
42
|
Sánchez-Torres AM, Moreno-Izco L, Lorente-Omeñaca R, Cabrera B, Lobo A, González-Pinto AM, Merchán-Naranjo J, Corripio I, Vieta E, de la Serna E, Butjosa A, Contreras F, Sarró S, Mezquida G, Ribeiro M, Bernardo M, Cuesta MJ. Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study. Eur Arch Psychiatry Clin Neurosci 2018; 268:699-711. [PMID: 29164332 DOI: 10.1007/s00406-017-0857-z] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2017] [Accepted: 11/14/2017] [Indexed: 11/28/2022]
Abstract
Individual changes over time in cognition in patients with psychotic disorders have been studied very little, especially in the case of first episode psychosis (FEP). We aimed to establish whether change in individual trajectories in cognition over 2 years of a sample of 159 FEP patients was reliable and clinically significant, using the reliable change index (RCI) and clinically significant change (CSC) methods. We also studied a sample of 151 matched healthy controls. Patients and controls were assessed with a set of neuropsychological tests, as well as premorbid, clinical and functionality measures. We analysed the course of cognitive measures over time, using analysis of variance, and the individual trajectories in the cognitive measures with the regression-based RCI (RCISRB) and the CSC. The RCISRB showed that between 5.4 and 31.2% of the patients showed deterioration patterns, and between 0.6 and 8.8% showed improvement patterns in these tests over time. Patients showing better cognitive profiles according to RCISRB (worsening in zero to two cognitive measures) showed better premorbid, clinical and functional profiles than patients showing deterioration patterns in more than three tests. When combining RCISRB and CSC values, we found that less than 10% of patients showed improvement or deterioration patterns in executive function and attention measures. These results support the view that cognitive impairments are stable over the first 2 years of illness, but also that the analysis of individual trajectories could help to identify a subgroup of patients with particular phenotypes, who may require specific interventions.
Collapse
Affiliation(s)
- A M Sánchez-Torres
- Department of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - L Moreno-Izco
- Department of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - R Lorente-Omeñaca
- Department of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - B Cabrera
- Barcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Barcelona, Spain
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
| | - A Lobo
- Department of Medicine and Psychiatry, Aragon Institute for Health Research (IIS Aragon), University of Zaragoza, Saragossa, Spain
| | - A M González-Pinto
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
- BIOARABA Health Research Institute, OSI Araba University Hospital, Vitoria, Spain
- University of the Basque Country, Vitoria, Spain
| | - J Merchán-Naranjo
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
- Child and Adolescent Psychiatry Department, School of Medicine, Hospital General Universitario Gregorio Marañón, IISGM, Universidad Complutense, Madrid, Spain
| | - I Corripio
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - E Vieta
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
- Department of Psychiatry and Psychology, Clinical Institute for the Neurosciences, Hospital Clinic of Barcelona, Catalonia, Spain
- August Pi i Sunyer Institute for Biomedical Research (IDIBAPS), Catalonia, Barcelona, Spain
- Department of Psychiatry and Clinical Psychology, University of Barcelona, Catalonia, Spain
- Department of Psychiatry and Clinical Psychobiology, University of Barcelona, IDIBAPS, Barcelona, Spain
| | - E de la Serna
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
- Department of Child and Adolescent Psychiatry and Psychology, Hospital Clinic of Barcelona, Barcelona, Spain
| | - A Butjosa
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
- Parc Sanitari Sant Joan de Déu, Teaching, Research & Innovation Unit, Sant Boi de Llobregat, Barcelona, Spain
- Sant Joan de Déu Research Foundation. Esplugues de Llobregat, Barcelona, Spain
- Department of Personality, Evaluation and Psychological Treatment, Faculty of Psychology, University of Barcelona, Barcelona, Spain
| | - F Contreras
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
- Psychiatry Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Spain
- Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain
| | - S Sarró
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
- FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain
| | - G Mezquida
- Barcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Barcelona, Spain
| | - M Ribeiro
- Department of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - M Bernardo
- Barcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Barcelona, Spain
- Network Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain
- Department of Psychiatry and Clinical Psychobiology, University of Barcelona, IDIBAPS, Barcelona, Spain
| | - M J Cuesta
- Department of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain.
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
| |
Collapse
|
43
|
Sánchez-Gutiérrez T, García-Portilla MP, Parellada M, Bobes J, Calvo A, Moreno-Izco L, González-Pinto A, Lobo A, de la Serna E, Cabrera B, Torrent C, Roldán L, Sanjuan J, Ibáñez Á, Sánchez-Torres AM, Corripio I, Bernardo M, Cuesta MJ, Martínez-Arán A, Castro-Fornieles J, Baeza I, Bioque M, Mezquida G, Lopez-Ilundain JM, Alonso A, Rabela M, López P, Zorrilla I, Arbej J, Rivero G, Aguilar EJ, Mané A, Bergé D, Contreras F, Albacete A, García-Álvarez L, Al-Halabí S, Gutiérrez M, Segarra R, Morales-Muñoz I, Rodriguez-Jimenez R, Butjosa A, Usall J, Sarró S, Landín-Romero R, Ruiz JS, Balanzá V. Smoking does not impact social and non-social cognition in patients with first episode psychosis. Schizophr Res 2018; 199:64-74. [PMID: 29606546 DOI: 10.1016/j.schres.2018.03.025] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2017] [Revised: 02/27/2018] [Accepted: 03/14/2018] [Indexed: 01/08/2023]
Abstract
BACKGROUND Many studies having shown significant improvements in non-social and social cognitive performance in smoking FEP patients compared to non-smoking FEP patients. The findings are controversial. This study analyzed the effects of tobacco use on non-social and social cognitive function in a large group of FEP patients and a matched healthy control group. METHODS A sample of 335 patients with FEP and 253 healthy controls was divided into four subgroups: control tobacco users (CTU), control non-tobacco users (CNTU), patient tobacco users (PTU) and patient non-tobacco users (PNTU). Demographic variables, tobacco use variables (presence or absence, frequency and duration of tobacco use), neurocognitive (non-social) performance and social cognition were assessed. RESULTS Comparison of 4 subgroups in non-social cognitive function revealed significant differences after controlling for covariables in executive functions (F=13.45; p≤0.001) and working memory domains (F=4.30; p=0.005). CTU and CNTU subgroups scored higher in all the domains compared to the PTU and the PNTU subgroups respectively. Social cognitive function was also significantly different within the four subgroups, with control subgroups showing better social cognition than patient subgroups. Significant differences in the executive functions domain were observed when comparing PTU and CTU groups (F=19.60; p≤0.001). No significant differences were revealed in the comparison between the patient groups. CONCLUSIONS This large study suggests that tobacco use in FEP patients is not related to better non-social or social cognitive performance.
Collapse
Affiliation(s)
- Teresa Sánchez-Gutiérrez
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain; Faculty of Health Science, Universidad Internacional de la Rioja (UNIR), Spain.
| | | | - Mara Parellada
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain
| | - Julio Bobes
- Department of Psychiatry, School of Medicine, CIBERSAM, University of Oviedo, Spain
| | - Ana Calvo
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain; Faculty of Health Science, Universidad Internacional de la Rioja (UNIR), Spain
| | - Lucía Moreno-Izco
- Department of Psychiatry, Complejo Hospitalario de Navarra, IdiSNA, Navarra, Institute for Health Research, Pamplona, Spain
| | - Ana González-Pinto
- Hospital Universitario de Alava, Servicio de Psiquiatría, BIOARABA, Cibersam, Universidad del País Vasco, Spain
| | - Antonio Lobo
- Departamento de Medicina y Psiquiatría, Universidad de Zaragoza e Instituto de Investigación Sanitaria Aragón (IIS Aragón), CIBERSAM, Spain
| | - Elena de la Serna
- Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clinic of Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
| | - Bibiana Cabrera
- Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Department of Psychiatry and Clinical Psychobiology, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
| | - Carla Torrent
- Hospital Clínic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain
| | - Laura Roldán
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain
| | | | - Ángela Ibáñez
- Servicio de Psiquiatría, Hospital Ramón y Cajal, Universidad de Alcalá, CIBERSAM, IRYCIS, Madrid, Spain
| | - Ana María Sánchez-Torres
- Department of Psychiatry, Complejo Hospitalario de Navarra, IdiSNA, Navarra, Institute for Health Research, Pamplona, Spain
| | - Iluminada Corripio
- Servicio de Psiquiatría, Hospital de la Santa Reu i Sant Pau, CIBERSAM, Barcelona, Spain
| | - Miquel Bernardo
- Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
| | - Manuel J Cuesta
- Department of Psychiatry, Complejo Hospitalario de Navarra, IdiSNA, Navarra, Institute for Health Research, Pamplona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Gabrielli L, Saavedra R, Herrera S, Vega J, Salinas M, Fernandez R, Contreras F, Vergara L, Yanez F, Jalil J, Ocaranza MP, Lavandero S, Chiong M, Castro P, Sitges M. P653Cardiac remodeling in highly trained athletes is associated with rho kinase activation and increased levels of cardiotrophin-1. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- L Gabrielli
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - R Saavedra
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - S Herrera
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - J Vega
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - M Salinas
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - R Fernandez
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - F Contreras
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - L Vergara
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - F Yanez
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - J Jalil
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - M P Ocaranza
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - S Lavandero
- University of Chile, Advanced Center for Chronic Diseases (ACCDiS) & CEMC, Facultad Ciencias Químicas y Farmacéuticas y F, Santiago, Chile
| | - M Chiong
- University of Chile, Advanced Center for Chronic Diseases (ACCDiS) & CEMC, Facultad Ciencias Químicas y Farmacéuticas y F, Santiago, Chile
| | - P Castro
- Pontifical Catholic University of Chile, Cardiovascular Disease Division, Santiago, Chile
| | - M Sitges
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Cardiology Department, Barcelona, Spain
| |
Collapse
|
45
|
Ayesa-Arriola R, Setién-Suero E, Neergaard KD, Belzunces ÀA, Contreras F, van Haren NEM, Crespo-Facorro B. Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognition. Schizophr Res 2018; 197:370-377. [PMID: 29275855 DOI: 10.1016/j.schres.2017.12.006] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/28/2017] [Revised: 12/07/2017] [Accepted: 12/13/2017] [Indexed: 12/11/2022]
Abstract
BACKGROUND Low IQ has been associated with schizophrenia, even to the point of being posited as a possible causal factor for psychosis. However, individuals with normal and high IQ also develop psychotic illnesses. The aim of this study was to characterize premorbid IQ subgroups at first episode of psychosis (FEP). METHODS The study sample comes from a large epidemiological, 3-year longitudinal, intervention program on psychosis containing individuals living in a catchment area in Spain. Estimated premorbid IQ (epIQ) scores were used to build low (<90), normal (90-110) and high (>110) epIQ subgroups in samples of FEP patients (N=292) and healthy controls (N=199). The epIQ subgroups were compared in sociodemographic, neuropsychological, clinical and premorbid characteristics. Long-term functional and cognitive outcome, with a focus on sex differences, were also explored. RESULTS Low-epIQ was more frequently found in FEP patients (28.8%) than in healthy controls (14.6%). Low-epIQ patients were more likely to have worse premorbid adjustment, belong to low socioeconomic status families, have less years of education, and to be single, unemployed, and younger. They presented more severe impairments in processing speed, executive and global cognitive function. Female patients with low-epIQ showed better baseline function and more stable outcome than males. CONCLUSIONS Our results indicate that low premorbid IQ is a morbid manifestation, easily detected in a subgroup of FEP patients that predicts poorer outcome particularly in males. This perspective provides important information for the tailoring of subgroup-specific early intervention programs for psychosis.
Collapse
Affiliation(s)
- Rosa Ayesa-Arriola
- Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain; Centro Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
| | - Esther Setién-Suero
- Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain
| | - Karl David Neergaard
- Department of Chinese and Bilingual Studies, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Àuria Albacete Belzunces
- Psychiatry Department, Bellvitge University Hospital - Institut d'Investigació Biomèdica de Bellvitge, Barcelona, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain
| | - Fernando Contreras
- Centro Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Psychiatry Department, Bellvitge University Hospital - Institut d'Investigació Biomèdica de Bellvitge, Barcelona, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain
| | - Neeltje E M van Haren
- Brain Centre Rudolf Magnus, Department of Psychiatry, University Medical Centre Utrecht, Utrecht, Netherlands
| | - Benedicto Crespo-Facorro
- Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain; Centro Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
| |
Collapse
|
46
|
Manov J, Contreras F, Langston M, Doshi M, Mohan P. 4:03 PM Abstract No. 228 Ultrasound-assisted catheter-directed thrombolysis for submassive pulmonary embolism: efficacy in relief of right heart strain. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
47
|
Kapoor B, Contreras F, Katz M, Arepally A, Fischman A, Rose S, Kim A, Ferraro J. 3:18 PM Abstract No. 133 Surefire Infusion System (SIS) hepatocellular carcinoma registry study interim results: a multicenter study of the safety, feasibility, and outcomes of the SIS expandable-tip microcatheter in DEB-TACE. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
48
|
Aab A, Abreu P, Aglietta M, Al Samarai I, Albuquerque I, Allekotte I, Almela A, Alvarez Castillo J, Alvarez-Muñiz J, Anastasi G, Anchordoqui L, Andrada B, Andringa S, Aramo C, Arqueros F, Arsene N, Asorey H, Assis P, Aublin J, Avila G, Badescu A, Balaceanu A, Barbato F, Barreira Luz R, Beatty J, Becker K, Bellido J, Berat C, Bertaina M, Bertou X, Biermann P, Biteau J, Blaess S, Blanco A, Blazek J, Bleve C, Boháčová M, Boncioli D, Bonifazi C, Borodai N, Botti A, Brack J, Brancus I, Bretz T, Bridgeman A, Briechle F, Buchholz P, Bueno A, Buitink S, Buscemi M, Caballero-Mora K, Caccianiga L, Cancio A, Canfora F, Caramete L, Caruso R, Castellina A, Catalani F, Cataldi G, Cazon L, Chavez A, Chinellato J, Chudoba J, Clay R, Cobos A, Colalillo R, Coleman A, Collica L, Coluccia M, Conceição R, Consolati G, Contreras F, Cooper M, Coutu S, Covault C, Cronin J, D’Amico S, Daniel B, Dasso S, Daumiller K, Dawson B, de Almeida R, de Jong S, De Mauro G, de Mello Neto J, De Mitri I, de Oliveira J, de Souza V, Debatin J, Deligny O, Díaz Castro M, Diogo F, Dobrigkeit C, D’Olivo J, Dorosti Q, dos Anjos R, Dova M, Dundovic A, Ebr J, Engel R, Erdmann M, Erfani M, Escobar C, Espadanal J, Etchegoyen A, Falcke H, Farmer J, Farrar G, Fauth A, Fazzini N, Fenu F, Fick B, Figueira J, Filipčič A, Fratu O, Freire M, Fujii T, Fuster A, Gaior R, García B, Garcia-Pinto D, Gaté F, Gemmeke H, Gherghel-Lascu A, Ghia P, Giaccari U, Giammarchi M, Giller M, Głas D, Glaser C, Golup G, Gómez Berisso M, Gómez Vitale P, González N, Gorgi A, Gorham P, Grillo A, Grubb T, Guarino F, Guedes G, Halliday R, Hampel M, Hansen P, Harari D, Harrison T, Harton J, Haungs A, Hebbeker T, Heck D, Heimann P, Herve A, Hill G, Hojvat C, Holt E, Homola P, Hörandel J, Horvath P, Hrabovský M, Huege T, Hulsman J, Insolia A, Isar P, Jandt I, Johnsen J, Josebachuili M, Jurysek J, Kääpä A, Kambeitz O, Kampert K, Keilhauer B, Kemmerich N, Kemp E, Kemp J, Kieckhafer R, Klages H, Kleifges M, Kleinfeller J, Krause R, Krohm N, Kuempel D, Kukec Mezek G, Kunka N, Kuotb Awad A, Lago B, LaHurd D, Lang R, Lauscher M, Legumina R, Leigui de Oliveira M, Letessier-Selvon A, Lhenry-Yvon I, Link K, Lo Presti D, Lopes L, López R, López Casado A, Lorek R, Luce Q, Lucero A, Malacari M, Mallamaci M, Mandat D, Mantsch P, Mariazzi A, Mariş I, Marsella G, Martello D, Martinez H, Martínez Bravo O, Masías Meza J, Mathes H, Mathys S, Matthews J, Matthews J, Matthiae G, Mayotte E, Mazur P, Medina C, Medina-Tanco G, Melo D, Menshikov A, Merenda KD, Michal S, Micheletti M, Middendorf L, Miramonti L, Mitrica B, Mockler D, Mollerach S, Montanet F, Morello C, Mostafá M, Müller A, Müller G, Muller M, Müller S, Mussa R, Naranjo I, Nellen L, Nguyen P, Niculescu-Oglinzanu M, Niechciol M, Niemietz L, Niggemann T, Nitz D, Nosek D, Novotny V, Nožka L, Núñez L, Ochilo L, Oikonomou F, Olinto A, Palatka M, Pallotta J, Papenbreer P, Parente G, Parra A, Paul T, Pech M, Pedreira F, Pękala J, Pelayo R, Peña-Rodriguez J, Pereira L, Perlin M, Perrone L, Peters C, Petrera S, Phuntsok J, Piegaia R, Pierog T, Pimenta M, Pirronello V, Platino M, Plum M, Porowski C, Prado R, Privitera P, Prouza M, Quel E, Querchfeld S, Quinn S, Ramos-Pollan R, Rautenberg J, Ravignani D, Ridky J, Riehn F, Risse M, Ristori P, Rizi V, Rodrigues de Carvalho W, Rodriguez Fernandez G, Rodriguez Rojo J, Rogozin D, Roncoroni M, Roth M, Roulet E, Rovero A, Ruehl P, Saffi S, Saftoiu A, Salamida F, Salazar H, Saleh A, Salesa Greus F, Salina G, Sánchez F, Sanchez-Lucas P, Santos E, Santos E, Sarazin F, Sarmento R, Sarmiento-Cano C, Sato R, Schauer M, Scherini V, Schieler H, Schimp M, Schmidt D, Scholten O, Schovánek P, Schröder F, Schröder S, Schulz A, Schumacher J, Sciutto S, Segreto A, Shadkam A, Shellard R, Sigl G, Silli G, Sima O, Śmiałkowski A, Šmída R, Smith B, Snow G, Sommers P, Sonntag S, Squartini R, Stanca D, Stanič S, Stasielak J, Stassi P, Stolpovskiy M, Strafella F, Streich A, Suarez F, Suarez Durán M, Sudholz T, Suomijärvi T, Supanitsky A, Šupík J, Swain J, Szadkowski Z, Taboada A, Taborda O, Theodoro V, Timmermans C, Todero Peixoto C, Tomankova L, Tomé B, Torralba Elipe G, Travnicek P, Trini M, Ulrich R, Unger M, Urban M, Valdés Galicia J, Valiño I, Valore L, van Aar G, van Bodegom P, van den Berg A, van Vliet A, Varela E, Vargas Cárdenas B, Varner G, Vázquez R, Veberič D, Ventura C, Vergara Quispe I, Verzi V, Vicha J, Villaseñor L, Vorobiov S, Wahlberg H, Wainberg O, Walz D, Watson A, Weber M, Weindl A, Wiencke L, Wilczyński H, Wileman C, Wirtz M, Wittkowski D, Wundheiler B, Yang L, Yushkov A, Zas E, Zavrtanik D, Zavrtanik M, Zepeda A, Zimmermann B, Ziolkowski M, Zong Z, Zuccarello F. Inferences on mass composition and tests of hadronic interactions from 0.3 to 100 EeV using the water-Cherenkov detectors of the Pierre Auger Observatory. Int J Clin Exp Med 2017. [DOI: 10.1103/physrevd.96.122003] [Citation(s) in RCA: 63] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
49
|
Contreras F, Albacete A, Tebé C, Benejam B, Caño A, Menchón JM. Patients with schizophrenia activate behavioural intentions facilitated by counterfactual reasoning. PLoS One 2017; 12:e0178860. [PMID: 28586400 PMCID: PMC5460856 DOI: 10.1371/journal.pone.0178860] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2016] [Accepted: 05/19/2017] [Indexed: 11/18/2022] Open
Abstract
METHOD The main variables assessed were: answer to complete a target task (wrong or correctly), and percentage gain in the reaction time (RT) to complete a target task correctly depending on whether the prime was a counterfactual or a neutral-control cue. These variables were assessed in 37 patients with schizophrenia and 37 healthy controls. Potential associations with clinical status and socio-demographic characteristics were also explored. RESULTS When a counterfactual prime was presented, the probability of giving an incorrect answer was lower for the entire sample than when a neutral prime was presented (OR 0.58; CI 95% 0.42 to 0.79), but the schizophrenia patients showed a higher probability than the controls of giving an incorrect answer (OR 3.89; CI 95% 2.0 to 7.6). Both the schizophrenia patients and the controls showed a similar percentage gain in RT to a correct answer of 8%. CONCLUSIONS Challenging the results of previous research, our findings suggest a normal activation of behavioural intentions facilitated by CFT in schizophrenia. Nevertheless, the patients showed more difficulty than the controls with the task, adding support to the concept of CFT as a potential new target for consideration in future therapeutic approaches for this illness.
Collapse
Affiliation(s)
- Fernando Contreras
- Department of Psychiatry, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat, Spain
- Department of Clinical Sciences, School of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Spain
- Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
- * E-mail:
| | - Auria Albacete
- Department of Psychiatry, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat, Spain
- Department of Clinical Sciences, School of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Spain
- Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
| | - Cristian Tebé
- Statistical Advisory Service, Bellvitge Biomedical Institute-IDIBELL, L'Hospitalet de Llobregat, Spain
- Faculty of Medicine and Health Sciences, University Rovira i Virgili, Tarragona, Spain
| | - Bessy Benejam
- Department of Psychiatry, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat, Spain
| | - Agnes Caño
- Department of Psychology, University of Girona, Girona, Spain
| | - José Manuel Menchón
- Department of Psychiatry, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat, Spain
- Department of Clinical Sciences, School of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Spain
- Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
| |
Collapse
|
50
|
Chomsky-Higgins K, Miclau TA, Mackechnie MC, Aguilar D, Avila JR, Dos Reis FB, Balmaseda R, Barquet A, Ceballos A, Contreras F, Escalante I, Elias N, Vincenti SI, Lozano C, Medina F, Merchan G, Segovia J, Guerado E, Quintero JE, Morshed S, Bhandari M, Miclau T. Barriers to Clinical Research in Latin America. Front Public Health 2017; 5:57. [PMID: 28459047 PMCID: PMC5394164 DOI: 10.3389/fpubh.2017.00057] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2017] [Accepted: 03/03/2017] [Indexed: 11/13/2022] Open
Abstract
Enhancing health research capacity in developing countries is a global health priority. Understanding the orthopedic burden of disease in Latin America will require close partnership between more-developed and less-developed countries. To this end, the Osteosynthesis and Trauma Care Foundation assembled a research consortium of Latin-American orthopedic leaders. Prior to the meeting, we surveyed attendees on perceived barriers to conducting research at their institutions. During the event, working groups discussed these barriers, developed strategies for addressing them, and planned future steps for collaboration. The participants established the need for global relationships that allow colleagues from Latin America to access to training and established investigational infrastructure of North American centers to address research questions relevant to their communities. As a result of the discussion, the International Orthopaedic Multicenter Study (INORMUS) in Fracture Care was initiated. Since then, an expanded international working group, Associación de Cirujanos Traumatológicos en las Americas (ACTUAR), has been created with the purpose of promoting increased global partnership for research capacity development.
Collapse
Affiliation(s)
| | | | - Madeline C Mackechnie
- Department of Orthopaedic Surgery, Institute for Global Orthopaedics and Traumatology (IGOT), University of California, San Francisco, CA, USA.,Department of Orthopaedic Surgery, Orthopaedic Trauma Institute, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA
| | | | | | | | - Roberto Balmaseda
- Department of Orthopaedic Surgery, Centro de Investigaciones Médico-Quirúricas (CIMEQ), La Habana, Cuba
| | - Antonio Barquet
- Department of Traumatology and Orthopaedics, AEPSM, Montevideo, Uruguay
| | - Alfredo Ceballos
- Department of Orthopaedic Surgery, Centro de Investigaciones Médico-Quirúricas (CIMEQ), La Habana, Cuba
| | | | | | | | | | | | - Fryda Medina
- Hospital de Traumtologia Instituto Mexicano del Seguro Social, Mexico City, Mexico
| | | | - Julio Segovia
- Instituto de Prevision Social, Servicio de Ortopaedia y Traumatologia, Asunción, Paraguay
| | - Enrique Guerado
- Department of Orthopaedic Surgery, Traumatology, and Rehabilitation, University of Malaga, Hospital Costa del Sol, Marbella, Málaga, Spain
| | - Jose Eduardo Quintero
- Hospital Universitario San Jorge, Clinica de Ortopedia y Traumatología, Pereira-Risaralda, Colombia
| | - Saam Morshed
- Department of Orthopaedic Surgery, Institute for Global Orthopaedics and Traumatology (IGOT), University of California, San Francisco, CA, USA.,Department of Orthopaedic Surgery, Orthopaedic Trauma Institute, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA
| | - Mohit Bhandari
- Division of Orthopaedic Surgery, McMaster University, Hamilton, ON, Canada
| | - Theodore Miclau
- Department of Orthopaedic Surgery, Institute for Global Orthopaedics and Traumatology (IGOT), University of California, San Francisco, CA, USA.,Department of Orthopaedic Surgery, Orthopaedic Trauma Institute, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA
| |
Collapse
|